A0_Samples	A17_Age	A18_Sex	A19_Height	A1_OS	A20_Weight	A21_BMI	A22_histological_type	A23_Tumor_tissue_site	A2_Event	A3_T	A4_N	A5_M	A6_Stage	A7_Grade	A8_New_Event	A8_New_Event_Time	A8_New_Event_Tissue	A8_New_Event_Type	A9_Cancer_Status	ablations	ablations.ablation.ablation_treatments.ablation_performed_indicator	ablations.ablation.ablation_treatments.ablation_treatment.ablation_type	ablations.ablation.ablation_treatments.ablation_treatment.ablation_type_other	ablations.ablation.ablation_treatments.ablation_treatment.days_to_ablation_performed	ablations.ablation.ablation_treatments.ablation_treatment.lesions_count	ablations.ablation.ablation_treatments.ablation_treatment.treatment_cycles_count	ablations.ablation.bcr_ablation_barcode	ablations.ablation.bcr_ablation_uuid	ablations.ablation.day_of_form_completion	ablations.ablation.embolization_treatments.embolization_performed_indicator	ablations.ablation.embolization_treatments.embolization_treatment.days_to_embolization_performed	ablations.ablation.embolization_treatments.embolization_treatment.embolization_therapy_drug_name	ablations.ablation.embolization_treatments.embolization_treatment.embolization_therapy_drug_name_other	ablations.ablation.embolization_treatments.embolization_treatment.embolization_type	ablations.ablation.embolization_treatments.embolization_treatment.embolizing_agent_utilized	ablations.ablation.embolization_treatments.embolization_treatment.embolizing_agent_utilized_other	ablations.ablation.month_of_form_completion	ablations.ablation.year_of_form_completion	additional_studies	adjacent_hepatic_tissue_inflammation_extent_type	age_at_initial_pathologic_diagnosis	albumin_result_lower_limit	albumin_result_specified_value	albumin_result_upper_limit	bcr_patient_barcode	bcr_patient_uuid	bilirubin_lower_limit	bilirubin_upper_limit	cancer_first_degree_relative	child_pugh_classification_grade	creatinine_lower_level	creatinine_upper_limit	creatinine_value_in_mg_dl	day_of_form_completion	days_to_birth	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_last_known_alive	drugs.drug.bcr_drug_barcode	drugs.drug.bcr_drug_uuid	drugs.drug.clinical_trail_drug_classification	drugs.drug.day_of_form_completion	drugs.drug.days_to_drug_therapy_end	drugs.drug.days_to_drug_therapy_start	drugs.drug.drug_name	drugs.drug.measure_of_response	drugs.drug.month_of_form_completion	drugs.drug.number_cycles	drugs.drug.prescribed_dose	drugs.drug.prescribed_dose_units	drugs.drug.regimen_indication	drugs.drug.regimen_indication_notes	drugs.drug.regimen_number	drugs.drug.route_of_administrations.route_of_administration	drugs.drug.therapy_ongoing	drugs.drug.therapy_types.therapy_type	drugs.drug.therapy_types.therapy_type_notes	drugs.drug.total_dose	drugs.drug.total_dose_units	drugs.drug.tx_on_clinical_trial	drugs.drug.year_of_form_completion	eastern_cancer_oncology_group	ethnicity	fetoprotein_outcome_lower_limit	fetoprotein_outcome_upper_limit	fetoprotein_outcome_value	fibrosis_ishak_score	follow_ups.follow_up.bcr_followup_barcode	follow_ups.follow_up.bcr_followup_uuid	follow_ups.follow_up.day_of_form_completion	follow_ups.follow_up.days_to_death	follow_ups.follow_up.days_to_last_followup	follow_ups.follow_up.followup_case_report_form_submission_reason	follow_ups.follow_up.lost_follow_up	follow_ups.follow_up.month_of_form_completion	follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy	follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_radiation_therapy	follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure	follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment	follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_transplant	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_occurrence_anatomic_site	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_type	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_occurrence_anatomic_site_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_event_ablation_embo_tx	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_event_liver_transplant	follow_ups.follow_up.new_tumor_events.new_tumor_event.residual_disease_post_new_tumor_event_margin_status	follow_ups.follow_up.new_tumor_events.new_tumor_event_after_initial_treatment	follow_ups.follow_up.person_neoplasm_cancer_status	follow_ups.follow_up.post_op_ablation_embolization_tx	follow_ups.follow_up.postoperative_rx_tx	follow_ups.follow_up.radiation_therapy	follow_ups.follow_up.vital_status	follow_ups.follow_up.year_of_form_completion	gender	height	histological_type	history_hepato_carcinoma_risk_factors.hist_hepato_carc_fact	history_hepato_carcinoma_risk_factors.hist_hepato_carcinoma_risk	history_of_neoadjuvant_treatment	history_prior_surgery_type_other	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	inter_norm_ratio_lower_limit	intern_norm_ratio_upper_limit	month_of_form_completion	neoplasm_histologic_grade	new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy	new_tumor_events.new_tumor_event.additional_radiation_therapy	new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure	new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment	new_tumor_events.new_tumor_event.days_to_new_tumor_event_transplant	new_tumor_events.new_tumor_event.new_neoplasm_event_occurrence_anatomic_site	new_tumor_events.new_tumor_event.new_neoplasm_event_type	new_tumor_events.new_tumor_event.new_neoplasm_occurrence_anatomic_site_text	new_tumor_events.new_tumor_event.new_tumor_event_ablation_embo_tx	new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure	new_tumor_events.new_tumor_event.new_tumor_event_liver_transplant	new_tumor_events.new_tumor_event.residual_disease_post_new_tumor_event_margin_status	new_tumor_events.new_tumor_event_after_initial_treatment	other_dx	patient_id	person_neoplasm_cancer_status	platelet_result_count	platelet_result_lower_limit	platelet_result_upper_limit	post_op_ablation_embolization_tx	postoperative_rx_tx	prothrombin_time_result_value	race_list.race	radiation_therapy	radiations.radiation.anatomic_treatment_site	radiations.radiation.bcr_radiation_barcode	radiations.radiation.bcr_radiation_uuid	radiations.radiation.course_number	radiations.radiation.day_of_form_completion	radiations.radiation.days_to_radiation_therapy_end	radiations.radiation.days_to_radiation_therapy_start	radiations.radiation.measure_of_response	radiations.radiation.month_of_form_completion	radiations.radiation.numfractions	radiations.radiation.radiation_dosage	radiations.radiation.radiation_treatment_ongoing	radiations.radiation.radiation_type	radiations.radiation.radiation_type_notes	radiations.radiation.regimen_indication	radiations.radiation.regimen_indication_notes	radiations.radiation.units	radiations.radiation.year_of_form_completion	relative_family_cancer_history	residual_tumor	specimen_collection_method_name	stage_event.ann_arbor.b_symptoms	stage_event.ann_arbor.extranodal_involvement	stage_event.clinical_stage	stage_event.gleason_grading.gleason_score	stage_event.gleason_grading.primary_pattern	stage_event.gleason_grading.secondary_pattern	stage_event.gleason_grading.tertiary_pattern	stage_event.igcccg_stage	stage_event.masaoka_stage	stage_event.pathologic_stage	stage_event.psa.days_to_psa	stage_event.psa.psa_value	stage_event.serum_markers	stage_event.system_version	stage_event.tnm_categories.clinical_categories.clinical_M	stage_event.tnm_categories.clinical_categories.clinical_N	stage_event.tnm_categories.clinical_categories.clinical_T	stage_event.tnm_categories.pathologic_categories.pathologic_M	stage_event.tnm_categories.pathologic_categories.pathologic_N	stage_event.tnm_categories.pathologic_categories.pathologic_T	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	total_bilirubin_upper_limit	tumor_tissue_site	vascular_tumor_cell_type	viral_hepatitis_serologies.viral_hepatitis_serology	vital_status	weight	year_of_form_completion	year_of_initial_pathologic_diagnosis
TCGA-DD-A1EA	68	MALE	168	2415	94	33.30498866213152	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	1	754.0	Liver	Locoregional Recurrence	WITH TUMOR		YES	Radiofrequency Ablation;Radiofrequency Ablation	Not Applicable;Not Applicable	769;1176	1;2	2;2	TCGA-DD-A1EA-A42205	D8522937-A679-4256-A8E3-256EA53BD593	15	NO	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	4	2013		Mild	68	3.5	3.3	5.0	TCGA-DD-A1EA	8052c374-9435-4588-b970-68565c56dbb7	0.1	0.9	1	A	0.8	1.3	1.2	16	-24925	Not Applicable	0	2415	Not Available																								0	NOT HISPANIC OR LATINO	0	6	3	1,2 - Portal Fibrosis	TCGA-DD-A1EA-F42204	D57AFF97-ACA4-4F7C-858C-BA2B10F73B53	15	Not Applicable	2415	Not Available	NO	4	NO	NO	Not Available	754	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	Unknown	NO	NO	NO	Alive	2013	MALE	168	Hepatocellular Carcinoma	Hepatitis B	smoking	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	10.8	5	G2													Not Available	No	A1EA	WITH TUMOR	209	150	450	Not Available	Not Available	10.2	ASIAN	Not Available																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.0	Liver	Micro	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody;HBV DNA	Alive	94	2011	2002
TCGA-KR-A7K0	65	MALE	174	65	66	21.79944510503369	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G1	0	65			TUMOR FREE																					Not Available	65	3.5	2.8	4.9	TCGA-KR-A7K0	5A7706BA-3CEA-41EB-B78A-FD69206DAA93	0.2	1.3	Not Available	Unknown	0.7	1.3	0.7	28	-23974	65	0	Not Available	Not Available																								Unknown	Not Evaluated	0	8	11	Not Available																												MALE	174	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	5	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Yes	A7K0	TUMOR FREE	102	150	400	NO	NO	1.4	WHITE	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	KR	1.2	Liver	None	Hepatitis  C Antibody	Dead	66	2014	2013
TCGA-DD-A4NS	61	FEMALE	167	2456	58	20.7967298935064	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G2	1	893.0	Other, specify	Extrahepatic Recurrence	WITH TUMOR																					None	61	Not Available	Not Available	Not Available	TCGA-DD-A4NS	A6A3F07C-CED4-451B-B2E5-C93E4ED622C1	0.1	0.9	2	Unknown	0.7	1.2	1.1	11	-22638	2456	0	Not Available	Not Available	TCGA-DD-A4NS-D43384;TCGA-DD-A4NS-D43386;TCGA-DD-A4NS-D43387;TCGA-DD-A4NS-D59877	4ECFB11B-261D-4F2A-9E49-090F4C27457C;05CF4554-4A7D-44D1-8AC1-B3A150B3961C;13B7F0AF-30AA-4D7C-930B-06B8D9644F32;36919E0E-FE64-42DA-A63C-712E27F3AF55	Not Available;Not Available;Not Available;Not Available	20;20;20;22	1314;1425;1903;1425	1116;1349;1685;1349	Sorafenib;ABT-888;LY228820;Temozolomide	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	5;5;5;5	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;YES;YES;YES	2013;2013;2013;2014	0	NOT HISPANIC OR LATINO	0	6	2	0 - No Fibrosis	TCGA-DD-A4NS-F49671	3FECE32A-D425-4DFA-BD49-6E67DE340C78	7	2456	Not Available	Not Available	NO	10	NO;YES	NO;YES	913;Not Available	893;1091	Not Available;Not Available	Bone;Bone	Extrahepatic Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable	No;No	YES;NO	No;No	Not Available;Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2013	FEMALE	167	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	2	G2	YES	YES	923	893	Not Available	Other, specify	Extrahepatic Recurrence	L1 vertebra	Not Available	YES	No	RX	YES	No	A4NS	WITH TUMOR	270	150	450	NO	NO	8.8	WHITE	NO	Regional site	TCGA-DD-A4NS-R43382	9568B44D-1A87-42DB-9AE1-6A57D0A1756B	Not Available	20	1099	1092	Not Available	5	5	20	NO	Systemic	Not Applicable	Not Available	Not Available	Gy	2013	YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Dead	58	2013	2005
TCGA-CC-A5UC	63	MALE	165	347	57	20.9366391184573	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G3	1	312.0	Lung	New Primary Tumor	TUMOR FREE																					Not Available	63	Not Available	Not Available	Not Available	TCGA-CC-A5UC	7E589EE1-FFCC-448A-A275-829CA26A597E	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	21	-23156	Not Applicable	0	0	Not Available																								2	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A5UC-F69917	A84BDF28-AA3C-4B37-A8A5-2314297A9DC3	22	347	Not Available	Not Available	NO	1	NO	NO	Not Available	312	Not Available	Lung	New Primary Tumor	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2015	MALE	165	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A5UC	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	57	2014	2012
TCGA-G3-AAV7	38	MALE	165	361	58	21.30394857667585	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	0	361			TUMOR FREE																					Mild	38	3.3	4	4.8	TCGA-G3-AAV7	5D259F26-3BEF-4FE4-948B-495183F5F8BE	0	0.9	Not Available	A	0.6	1.4	1.1	16	-14229	Not Applicable	0	92	Not Available																								0	NOT HISPANIC OR LATINO	0	10	3	5 - Nodular Formation and Incomplete Cirrhosis	TCGA-G3-AAV7-F67249	D5C36D39-DD0E-4691-A2EC-4DB0B847A268	3	Not Applicable	361	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	165	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAV7	TUMOR FREE	179	150	400	NO	NO	1	ASIAN	NO																			Unknown	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	G3	1.4	Liver	Micro	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV DNA	Alive	58	2014	2013
TCGA-DD-AAED	51	MALE	166	763	69	25.039918710988534	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	1	198.0	Liver	Intrahepatic Recurrence	TUMOR FREE		YES	Radiofrequency Ablation;Radiofrequency Ablation;Radiofrequency Ablation	Not Applicable;Not Applicable;Not Applicable	365;468;594	1;1;1	2;2;1	TCGA-DD-AAED-A68425	A79F710A-661B-4E19-BED7-1E5CA8496A81	3	YES	215;331;401	Other;Other;Other	adriamycin;adriamycin;adriamycin	Chemoembolization;Chemoembolization;Chemoembolization	Gelfoam;Gelfoam;Gelfoam	Not Applicable;Not Applicable;Not Applicable	11	2014		Mild	51	3.8	4.0	5.3	TCGA-DD-AAED	527D2BC3-7FDD-4B08-839D-67E2F246DB04	0.2	0.6	Not Available	A	0.7	1.5	0.5	15	-18722	Not Applicable	0	470	Not Available																								0	NOT HISPANIC OR LATINO	0	8	2405	1,2 - Portal Fibrosis	TCGA-DD-AAED-F68424	5F2C15FE-E5AF-448F-890E-513211AF3674	17	Not Applicable	763	Not Available	NO	11	NO	NO	Not Available	198	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	MALE	166	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	NO	NO	Not Available	198	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AAED	TUMOR FREE	211	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	69	2014	2012
TCGA-DD-AAE0	45	FEMALE	159	555	56	22.151022507021082	Hepatocellular Carcinoma	Liver	Alive	T3a	N0	M0	Stage IIIA	G4	0	555			TUMOR FREE																					Mild	45	3.8	4.8	5.3	TCGA-DD-AAE0	5E4136E4-DDD8-4FAF-8A8E-5F836FD97F49	0.2	0.9	Not Available	A	0.7	1.5	0.5	14	-16732	Not Applicable	0	300	Not Available																								0	NOT HISPANIC OR LATINO	0	8	8751	3,4 - Fibrous Speta	TCGA-DD-AAE0-F68410	30937D04-EFAD-4353-81FD-8B5180BA0187	17	Not Applicable	555	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	159	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAE0	TUMOR FREE	226	130	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3a	NO	YES	DD	1.2	Liver	None	Unknown	Alive	56	2014	2013
TCGA-CC-A3M9	45	MALE	174	300	61	20.147971991015986	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G3	1	219.0		Locoregional Recurrence	TUMOR FREE																					Not Available	45	Not Available	Not Available	Not Available	TCGA-CC-A3M9	8E938868-D992-47C4-BECB-93B0F7FFFE07	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	-16460	Not Applicable	0	3	Not Available																								2	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A3M9-F70909	4467C477-8CCC-4C2C-8B55-05BB799BB062	10	300	Not Available	Not Available	NO	3	NO	NO	Not Available	219	Not Available	Not Available	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2015	MALE	174	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8173/3	C22.0	YES	Not Available	Not Available	3	G3													Not Available	No	A3M9	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	Not Available	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	61	2012	2011
TCGA-DD-A3A4	37	MALE	189	612	65	18.196579043139888	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G3	1	87.0	Liver	Intrahepatic Recurrence	WITH TUMOR		NO						TCGA-DD-A3A4-A42699	E888B66F-EC27-412B-8CDF-A97F9598C732	27	YES	231;270;375	Other;Other;Other	Mitomycin C and cis-platinum;Mitomycin C and cis-platinum;Mitomycin C and cis-platinum	Chemoembolization;Chemoembolization;Chemoembolization	Other, specify;Other, specify;Other, specify	chemoembolic agent;chemoembolic agent;chemoembolic agen	4	2013		None	37	3.5	3.3	5.0	TCGA-DD-A3A4	AB35C9F9-3040-424D-A89F-DFF3A1365BC6	0.1	1.0	2	B	0.4	1.2	1.0	6	-13739	612	0	Not Available	Not Available	TCGA-DD-A3A4-D42698	6A8F862A-4110-49E6-8866-C53975BFECBF	Not Available	27	486	459	Gemcitabine	Clinical Progressive Disease	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	0 - No Fibrosis	TCGA-DD-A3A4-F42697	0FEE4F43-5013-4734-81A8-7FFA4CBA00A5	27	612	Not Available	Not Available	NO	4	YES	NO	Not Available	87	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	YES	NO	NO	Dead	2013	MALE	189	Hepatocellular Carcinoma	Other	Tobacco use	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	1	G3													Not Available	No	A3A4	WITH TUMOR	283	150	450	Not Available	Not Available	11.0	WHITE	Not Available																			YES	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	DD	1.0	Liver	None	Not Available	Dead	65	2012	1998
TCGA-DD-AADB	51	MALE	165	1242	68	24.977043158861342	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G4	0	1242			TUMOR FREE																					Unknown	51	3.8	4.5	5.3	TCGA-DD-AADB	5EAAF7AE-36AF-4FB4-8940-E0861983CEB0	0.2	1.5	Not Available	A	0.7	1.5	0.8	7	-18728	Not Applicable	0	890	Not Available																								0	NOT HISPANIC OR LATINO	0	8	419	Unknown	TCGA-DD-AADB-F68391	6083DBC5-8FAF-4F7E-A8D7-BE5052445015	17	Not Applicable	1242	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	165	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AADB	TUMOR FREE	180	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	68	2014	2011
TCGA-G3-A25V	68	MALE	187	860	90	25.73708141496754	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	1	489.0	Liver	Intrahepatic Recurrence	TUMOR FREE		YES	Radiofrequency Ablation	Not Applicable	770	1	1	TCGA-G3-A25V-A40090	0E4F99EC-723C-4BA0-A89F-2C181F9054EE	12	NO	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	2	2013		None	68	0.3	0.4	0.5	TCGA-G3-A25V	F435EC00-0DB8-46B4-96BF-890A9D931DF3	0	0.6	0	A	0.6	1.4	0.7	27	-25144	Not Applicable	0	69	Not Available																								2	NOT HISPANIC OR LATINO	0	10	15	6 - Established Cirrhosis	TCGA-G3-A25V-F40088	DFF7FBA7-5652-43BF-B939-4640160E995A	12	Not Applicable	860	Not Available	NO	2	NO	NO	Not Available	489	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2013	MALE	187	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	7	G2													Not Available	No	A25V	TUMOR FREE	139	150	400	Not Available	Not Available	1.1	WHITE	Not Available																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	G3	1.4	Liver	None	Not Available	Alive	90	2011	2010
TCGA-DD-AAE7	72	MALE	172	644	74	25.01352082206598	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	644			TUMOR FREE																					Severe	72	3.8	4.7	5.3	TCGA-DD-AAE7	427FDBF8-1603-466F-A5C6-963BB2EC3DAC	0.2	1.1	Not Available	A	0.7	1.5	0.9	14	-26568	Not Applicable	0	382	Not Available																								0	NOT HISPANIC OR LATINO	0	8	1	3,4 - Fibrous Speta	TCGA-DD-AAE7-F68418	83D4031A-F634-403D-9AAF-E34722794F34	17	Not Applicable	644	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	172	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Yes	AAE7	TUMOR FREE	188	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	74	2014	2012
TCGA-LG-A9QC	48	MALE	188	425	103	29.142145767315526	Hepatocellular Carcinoma	Liver	Alive	T1	NX	M0	Stage I	G2	0	425			TUMOR FREE																					Mild	48	3.5	4.7	5.0	TCGA-LG-A9QC	8C2783EF-AA41-44C9-BE87-FA4C84108F1E	0.2	2.8	1	Unknown	0.5	1.3	0.8	7	-17842	Not Applicable	0	180	Not Available																								Unknown	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Unknown	TCGA-LG-A9QC-F69223	84BC8E4F-A6B0-4B10-B7AE-7F3E96B47235	30	Not Applicable	425	Not Available	NO	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	188	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.4	12.2	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9QC	TUMOR FREE	275	150	450	Unknown	Unknown	12.1	WHITE	Unknown																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1	YES	NO	LG	1.0	Liver	Micro	Not Available	Alive	103	2014	2013
TCGA-DD-AAEH	73	MALE	163	784	62	23.335466144755166	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	1	644.0	Bone	Extrahepatic Recurrence	TUMOR FREE																					None	73	3.8	2.9	5.3	TCGA-DD-AAEH	FBB0E4BC-5398-4A7E-963C-86EA1108A2DE	0.2	0.9	Not Available	A	0.7	1.5	0.6	15	-26894	Not Applicable	0	476	Not Available																								2	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	1,2 - Portal Fibrosis	TCGA-DD-AAEH-F68431	6008F582-5CC7-41D8-B974-63F1C249EE2A	17	Not Applicable	784	Not Available	NO	11	NO	NO	660	644	Not Available	Bone	Extrahepatic Recurrence	Not Applicable	No	YES	No	RX	YES	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	163	Hepatocellular Carcinoma	Unknown	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAEH	TUMOR FREE	223	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	62	2014	2012
TCGA-DD-AAW1	55	MALE	167	1989	60	21.513858510523864	Hepatocellular Carcinoma	Liver	Alive	T3	N0	M0	Stage IIIA	G2	0	1989			TUMOR FREE																					Severe	55	3.3	4.0	5.3	TCGA-DD-AAW1	31C7D56B-4AF7-4FDB-BA83-63BF615FCC3D	0.2	0.7	Not Available	A	0.7	1.4	1.2	13	-20288	Not Applicable	0	1644	Not Available																								0	NOT HISPANIC OR LATINO	0	15	4	6 - Established Cirrhosis	TCGA-DD-AAW1-F67591	ECD782E1-2357-459A-B6C4-1518EEF70A11	6	Not Applicable	1989	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	167	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	6	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAW1	TUMOR FREE	126	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	60	2014	2009
TCGA-2Y-A9H9	70	MALE	178	697	88	27.77427092538821	Hepatocellular Carcinoma	Liver	Alive	T1	N0	MX	Stage I	G2	1	59.0	Liver	Locoregional Recurrence	WITH TUMOR		NO						TCGA-2Y-A9H9-A67255	36E9FF5F-3F7D-48FC-B27F-3D2A7718C96B	3	YES	281;400;434	Doxorubicin;Other;Other	Not Applicable;Unknown;lipiodol/doxyrubicin	Chemoembolization;Chemoembolization;Chemoembolization	Other, specify;Other, specify;Other, specify	LC Beads;Unknown;embospheres	11	2014		None	70	3.5	4.7	5	TCGA-2Y-A9H9	EFC3E5E4-0D8E-4BEF-A259-29F8ED21684F	0.2	0.6	2	A	0.8	1.2	0.8	3	-25670	Not Applicable	0	456	Not Available	TCGA-2Y-A9H9-D67254	3A75D221-5FD8-459B-B5CC-CC8FA03BD3F2	Not Available	3	Not Available	1017	Naxavar	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	NOT HISPANIC OR LATINO	0	7	12	Unknown	TCGA-2Y-A9H9-F69092	54F0058B-7B9D-4D76-B355-451F00869416	29	Not Applicable	697	Not Available	NO	12	YES	NO	Not Available	701	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	Unknown	Unknown	Unknown	Alive	2014	MALE	178	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G2	YES	NO	Not Available	59	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	A9H9	WITH TUMOR	203	143	382	NO	NO	11	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	NO	YES	2Y	1.3	Liver	Unknown	Unknown	Alive	88	2014	2011
TCGA-5C-AAPD	61	MALE	172	20	69	23.32341806381828	Hepatocholangiocarcinoma (Mixed)	Liver	Alive	T2	N0	M0	Stage II	G1	0	20			TUMOR FREE																					None	61	Not Available	Not Available	Not Available	TCGA-5C-AAPD	7A6162A4-1166-4310-84CD-FFC2B06F124C	Not Available	Not Available	Not Available	A	Not Available	Not Available	Not Available	27	-22552	Not Applicable	0	20	Not Available																								1	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-5C-AAPD-F68938	11AFD471-1D53-4782-86E2-D911E42E9AB7	23	Not Applicable	20	Not Available	NO	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	172	Hepatocholangiocarcinoma (Mixed)	Hepatitis B	Not Available	No	Not Applicable	C22.0	8180/3	C22.0	YES	Not Available	Not Available	6	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAPD	TUMOR FREE	Not Available	Not Available	Not Available	NO	NO	Not Available	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	5C	Not Available	Liver	None	HBV Surface Antibody	Alive	69	2014	2013
TCGA-EP-A2KA	52	FEMALE	178	627	Not Available		Hepatocellular Carcinoma	Liver	Dead	T3a	NX	MX	Stage IIIA	G3	1	293.0	Lung	Extrahepatic Recurrence	Not Available																					Not Available	52	Not Available	Not Available	Not Available	TCGA-EP-A2KA	440375D7-CDCD-418A-8992-0A8CA42D290D	Not Available	Not Available	2	Not Available	Not Available	1.0	0.7	18	-19214	Not Applicable	0	111	Not Available	TCGA-EP-A2KA-D31989	436550BB-A2DE-4EFA-A2F3-702BF8BAAEC5	Not Available	14	Not Available	312	Sorafenib	Not Applicable	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Targeted Molecular therapy	Not Available	Not Available	Not Available	NO	2012	0	NOT HISPANIC OR LATINO	0	Not Available	13	1,2 - Portal Fibrosis	TCGA-EP-A2KA-F31967;TCGA-EP-A2KA-F41362	8A1E2B55-9C1A-476E-8FE2-A2CFF23FB7E2;7BCAF80E-CF70-4541-AF24-2F4E45C4EB60	14;15	Not Applicable;627	357;Not Available	Scheduled Follow-up Submission;Not Available	Not Available;NO	5;3	YES;NO	NO;YES	Not Available;433	293;433	Not Available;Not Available	Lung;Brain	Extrahepatic Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable	No;No	NO;YES	No;No	Not Available;Not Available	YES;YES	WITH TUMOR;WITH TUMOR	NO;NO	NO;NO	NO;NO	Alive;Dead	2012;2013	FEMALE	178	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	10	G3													Not Available	No	A2KA	Not Available	435	140	415	Not Available	Not Available	Not Available	WHITE	Not Available																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3a	YES	NO	EP	Not Available	Liver	Not Available	Not Available	Alive	Not Available	2011	2011
TCGA-DD-A73B	72	FEMALE	154	283	74	31.202563670096136	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G2	1	240.0	Liver	Locoregional Recurrence	WITH TUMOR																					Unknown	72	3.5	3.5	5.0	TCGA-DD-A73B	5449C232-56F1-4E03-9421-ABA3AE180107	0.1	2.1	1	B	0.6	1.1	0.9	30	-26390	283	0	Not Available	Not Available																								0	HISPANIC OR LATINO	0	6	30	6 - Established Cirrhosis																												FEMALE	154	Hepatocellular Carcinoma	Alpha-1 Antitrypsin Deficiency;Other	Gilbert's syndrome.	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	9	G2	NO	NO	Not Available	240	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	A73B	WITH TUMOR	88	150	450	NO	NO	1.1	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen	Dead	74	2013	2012
TCGA-UB-A7MD	67	MALE	175	52	57	18.612244897959183	Hepatocellular Carcinoma	Liver	Dead	T1	N0	MX	Stage I	G3	0	52			TUMOR FREE																					Unknown	67	3.5	3.5	4.8	TCGA-UB-A7MD	C49B41BF-0025-4682-966B-CFE8FB2B2546	0.2	0.8	Not Available	A	0.7	1.2	1.0	15	-24717	52	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	8	23	6 - Established Cirrhosis	TCGA-UB-A7MD-F63729	C7730933-EC6A-4613-9484-81A5D0AEB8A6	15	52	Not Available	Not Available	NO	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Dead	2014	MALE	175	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.2	8	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7MD	TUMOR FREE	201	140	450	NO	NO	1.0	BLACK OR AFRICAN AMERICAN	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	YES	NO	UB	1.3	Liver	Micro	Hepatitis  C Antibody;Hepatitis C Virus RNA;HCV Genotype;Hepatitis B Surface Antigen	Dead	57	2014	2013
TCGA-DD-A113	55	FEMALE	154	2425	56	23.612750885478157	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G3	1	1676.0	Liver	Intrahepatic Recurrence	WITH TUMOR		YES	Other;Other;Other	percutaneous laser ablation;percutaneous laser ablation;percutaneous laser ablation	1994;2232;2351	1;3;1	1;1;1	TCGA-DD-A113-A43738	EE8FD1C9-41B0-4929-BDE9-08321DBA7EF2	2	NO	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	6	2013		None	55	3.5	4.3	5.0	TCGA-DD-A113	aeb17d2b-fa8c-4989-bf3a-d2c74b785455	0.1	0.5	Not Available	A	0.7	1.2	0.8	29	-20188	Not Applicable	0	1678	Not Available																								1	NOT HISPANIC OR LATINO	0	6	133	0 - No Fibrosis	TCGA-DD-A113-F38777	008714FB-854E-48F9-AA5A-6376B6ACAAFC	21	Not Applicable	2425	Not Available	NO	12	NO	NO	1678	1676	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	YES	No	R0	YES	WITH TUMOR	NO	NO	NO	Alive	2012	FEMALE	154	Hepatocellular Carcinoma	Other	Smoking	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.2	12	G3													Not Available	No	A113	WITH TUMOR	365	150	450	Not Available	Not Available	0.9	WHITE	Not Available																			Not Available	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.0	Liver	Micro	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	56	2010	2006
TCGA-5C-A9VH	70	MALE	165	322	69	25.34435261707989	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	322			TUMOR FREE																					None	70	Not Available	Not Available	Not Available	TCGA-5C-A9VH	60FCD491-0170-46C0-AB14-D71F88267A14	Not Available	Not Available	Not Available	A	Not Available	Not Available	Not Available	26	-25608	Not Applicable	0	322	Not Available																								0	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-5C-A9VH-F68937	08681A99-F480-475A-9900-86A8F96FD5B1	23	Not Applicable	322	Not Available	NO	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	165	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	6	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9VH	TUMOR FREE	Not Available	Not Available	Not Available	NO	NO	Not Available	WHITE	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	YES	NO	5C	Not Available	Liver	None	Not Available	Alive	69	2014	2013
TCGA-ED-A5KG	60	FEMALE	160	854	61	23.828125	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	1	110.0	Other, specify	Intrahepatic Recurrence	TUMOR FREE																					Severe	60	3.8	6.0	5.1	TCGA-ED-A5KG	CEBDAFEE-8FFD-4EE2-8DD1-9225E06623C2	0.1	0.4	Not Available	Unknown	4.1	5.8	3.9	22	-22258	Not Applicable	0	6	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	20	3177	Not Available	TCGA-ED-A5KG-F56100;TCGA-ED-A5KG-F70201	B639EE2D-31D8-4683-8CDD-4127B1DFA397;5AB06D2C-2313-4079-B523-F51916E05816	27;30	Not Applicable;Not Applicable	482;854	Not Available;Not Available	NO;NO	1;3	NO;NO;Not Available	NO;NO;Not Available	Not Available;Not Available;Not Available	110;110;Not Available	Not Available;Not Available;Not Available	Other, specify;Not Available;Not Available	New Primary Tumor;Intrahepatic Recurrence;Not Available	Kidney;Not Applicable;Not Applicable	No;No;Not Available	NO;NO;Not Available	No;No;Not Available	Not Available;Not Available;Not Available	YES;NO	WITH TUMOR;WITH TUMOR	NO;NO	NO;NO	NO;NO	Alive;Alive	2014;2015	FEMALE	160	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.3	1.3	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A5KG	TUMOR FREE	147	150	400	NO	Unknown	0.9	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	ED	1.3	Liver	Micro	Hepatitis B Surface Antigen	Alive	61	2013	2012
TCGA-BC-A10U	69	MALE	Not Available	837	Not Available		Hepatocellular Carcinoma	Liver	Dead	T2	NX	MX		G2	1	586.0		Intrahepatic Recurrence	WITH TUMOR		YES	Radiofrequency Ablation	Not Applicable	614	2	1	TCGA-BC-A10U-A13749	C5B24C75-28AD-46A1-ACEB-8F74FEED26F8	4	NO	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	4	2011		Not Available	69	3.5	4.3	5.0	TCGA-BC-A10U	23103931-cc29-4f89-ae9c-79d53401ecea	0.0	0.4	4	Not Available	0.8	1.4	0.9	23	-25305	837	0	Not Available	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	38	Not Available	TCGA-BC-A10U-F9923	03B73B3E-C325-4DAE-8980-B564EA1A0E44	4	837	Not Available	Not Available	Not Available	4	NO	NO	Not Available	586	Not Available	Not Available	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2011	MALE	Not Available	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G2													Not Available	No	A10U	WITH TUMOR	204000	150	440	Not Available	Not Available	1.1	WHITE	Not Available																			YES	R1	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	NO	YES	BC	1.2	Liver	Not Available	Not Available	Dead	Not Available	2011	2000
TCGA-DD-A39V	77	MALE	174	643	79	26.09327520147972	Hepatocellular Carcinoma	Liver	Dead	T2	NX	M0	Stage II	G3	1	455.0	Other, specify	Extrahepatic Recurrence	WITH TUMOR																					None	77	3.5	4.0	5.0	TCGA-DD-A39V	DD056692-4E2A-4E45-A4D0-357AF9754F0E	Not Available	Not Available	3	A	0.8	1.2	0.9	5	-28254	643	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	0 - No Fibrosis	TCGA-DD-A39V-F42707	24803DB2-042B-42C0-B197-6F8E25D57DDD	27	643	Not Available	Not Available	NO	4	NO	YES	Not Available	455	Not Available	Other, specify	Extrahepatic Recurrence	second or third rib posteriorly	No	NO	No	Not Available	YES	Unknown	NO	NO	YES	Dead	2013	MALE	174	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	1	G3													Not Available	No	A39V	WITH TUMOR	193	150	450	Not Available	Not Available	11.4	WHITE	Not Available	Distant Recurrence	TCGA-DD-A39V-R42708	8AFB1417-AA43-4832-A030-84FDCF7A6348	Not Available	27	444	430	Radiographic Progressive Disease	4	Not Available	Not Available	NO	Unknown	Not Applicable	Not Available	Not Available	Not Available	2013	YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2	NO	YES	DD	Not Available	Liver	None	Not Available	Dead	79	2012	2000
TCGA-ED-A627	74	MALE	176	423	74	23.889462809917354	Hepatocellular Carcinoma	Liver	Alive	T1	NX	M0	Stage I	G2	0	423			TUMOR FREE																					Unknown	74	Not Available	Not Available	Not Available	TCGA-ED-A627	A4AF0084-EDD4-4DCD-8975-4A59EE5DA64C	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	28	-27303	Not Applicable	0	0	Not Available																								2	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Unknown	TCGA-ED-A627-F55716	F7B7E800-1743-4A6F-B4E5-2E87A528726B	14	Not Applicable	423	Not Available	NO	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	176	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A627	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	WHITE	Unknown																			Unknown	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1	YES	NO	ED	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	74	2013	2012
TCGA-G3-AAV2	50	MALE	Not Available	372	Not Available		Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G1	0	372			TUMOR FREE																					Not Available	50	3.3	4.2	4.8	TCGA-G3-AAV2	1724C96A-2AA3-43D4-992A-08AF948C0F45	0	0.7	Not Available	A	0.6	1.4	1	15	-18363	Not Applicable	0	295	Not Available																								0	NOT HISPANIC OR LATINO	0	10	4	6 - Established Cirrhosis	TCGA-G3-AAV2-F67246	C6FA59AA-5A29-47AD-A927-95DCB3DC2246	3	Not Applicable	372	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	Not Available	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	7	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAV2	TUMOR FREE	110	150	400	NO	NO	1	WHITE	NO																			Unknown	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	YES	NO	G3	1.4	Liver	None	Hepatitis  C Antibody;Hepatitis C Virus RNA;Hepatitis B Surface Antigen;HBV Surface Antibody	Alive	Not Available	2014	2013
TCGA-ZS-A9CD	73	MALE	Not Available	1386	Not Available		Hepatocellular Carcinoma	Liver	Dead	T2	NX	MX	Stage II	G2	1	371.0	Liver	Intrahepatic Recurrence	Unknown																					Mild	73	36	48	50	TCGA-ZS-A9CD	9197CA4C-E48C-43AF-BA61-D894FAF3CC24	0	8	Not Available	A	62	106	73	30	-26915	1386	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	5 - Nodular Formation and Incomplete Cirrhosis																												MALE	Not Available	Hepatocellular Carcinoma	Unknown	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9	12	4	G2	NO	NO	Not Available	371	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	RX	YES	No	A9CD	Unknown	198	150	400	NO	NO	11.7	WHITE	NO																			Unknown	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	NO	YES	ZS	17	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Dead	Not Available	2014	2010
TCGA-GJ-A9DB	68	MALE	187	67	96	27.452886842632047	Hepatocellular Carcinoma	Liver	Dead	T1	N0	MX	Stage I	G2	0	67			Unknown																					Unknown	68	3.5	4.5	5	TCGA-GJ-A9DB	45F00F00-D793-4DCA-AEB9-7626D4575C90	0.0	0.5	1	Unknown	0.8	1.4	1.1	7	-25020	67	0	Not Available	Not Available																								Unknown	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Unknown																												MALE	187	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	right hepatectomy	C22.0	8170/3	C22.0	YES	0.7	1.2	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9DB	Unknown	144	150	450	NO	NO	0.9	WHITE	NO																			YES	R0	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	YES	NO	GJ	1.0	Liver	None	Not Available	Dead	96	2014	2013
TCGA-G3-AAV4	83	FEMALE	156	27	56	23.011176857330703	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G1	0	27			TUMOR FREE																					Not Available	83	3.3	2.7	4.8	TCGA-G3-AAV4	0955D871-5413-4AB2-8FDF-B4FEB3AEEF5D	0	0.8	2	A	0.4	1.1	1.1	15	-30466	27	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	10	4	3,4 - Fibrous Speta	TCGA-G3-AAV4-F65940	10A19B7D-7B09-46EB-A00B-F5EF21339159	1	27	Not Available	Not Available	NO	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Dead	2014	FEMALE	156	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	7	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAV4	TUMOR FREE	79	150	400	NO	NO	1.2	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	YES	NO	G3	1.2	Liver	None	Unknown	Dead	56	2014	2012
TCGA-DD-AADP	45	MALE	167	458	67	24.02380867008498	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	458			TUMOR FREE																					Unknown	45	3.8	3.7	5.3	TCGA-DD-AADP	96D42ECC-1157-453A-9661-9248DDF8F273	0.2	0.6	Not Available	A	0.7	1.5	0.5	7	-16760	Not Applicable	0	120	Not Available																								0	NOT HISPANIC OR LATINO	0	8	9	Unknown	TCGA-DD-AADP-F68402	D09C9F69-44A4-4C8C-877E-7802131FBB3D	17	Not Applicable	458	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	167	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AADP	TUMOR FREE	102	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	67	2014	2013
TCGA-DD-A4NL	46	MALE	173	1711	113	37.75602258678873	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G1	0	1711			TUMOR FREE																					None	46	3.5	4.4	5.0	TCGA-DD-A4NL	E0067280-2722-46F2-A5A8-352C77B47E38	0.1	0.3	Not Available	Unknown	0.8	1.3	1.0	5	-16874	Not Applicable	0	1711	Not Available																								1	NOT HISPANIC OR LATINO	0	6	2	0 - No Fibrosis	TCGA-DD-A4NL-F49656;TCGA-DD-A4NL-F59645;TCGA-DD-A4NL-F59644	B210A260-1AC2-47ED-A109-FBE4F7810D1B;830C1787-4544-4218-8101-5418C0C85759;62E6FCC5-E450-49B3-8CBE-80757071734F	7;17;16	Not Applicable;Not Applicable;Not Applicable	1711;1711;Not Available	Not Available;Not Available;Not Available	NO;YES;YES	10;5;7	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Applicable;Not Applicable;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	NO;NO;Not Available	TUMOR FREE;TUMOR FREE;Not Available	NO;NO;Not Available	NO;NO;Not Available	NO;NO;Not Available	Alive;Alive;Not Available	2013;2014;2014	MALE	173	Hepatocellular Carcinoma	Alcohol consumption;Other	Tobacco use	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	2	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A4NL	TUMOR FREE	266	150	450	NO	NO	Not Available	WHITE	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	113	2013	2007
TCGA-CC-5261	44	MALE	175	97	58	18.93877551020408	Hepatocellular Carcinoma	Liver	Dead	T2	N0	M0	Stage II	G2	0	97			TUMOR FREE																					Not Available	44	Not Available	Not Available	Not Available	TCGA-CC-5261	1ad7f17e-b3b8-40e9-aab8-5a17e0aec408	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	18	-16373	Not Applicable	0	12	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-5261-F20332	A6A91644-489A-4A68-9F55-33BA67DF2E66	9	97	Not Available	Scheduled Follow-up Submission	Not Available	1													NO	TUMOR FREE	NO	NO	NO	Dead	2012	MALE	175	Hepatocellular Carcinoma	Not Available	Not Available	No	Hepatic Resection	C22.0	8170/3	C22.0	YES	Not Available	Not Available	4	G2													Not Available	No	5261	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			Not Available	RX	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	CC	Not Available	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	58	2011	2010
TCGA-UB-A7MC	59	MALE	176	500	78	25.180785123966942	Hepatocellular Carcinoma	Liver	Alive	T3a	N0	MX	Stage IIIA	G3	1	359.0	Other, specify	Extrahepatic Recurrence	Unknown		NO;NO						TCGA-UB-A7MC-A67162;TCGA-UB-A7MC-A67164	57299E12-8A0A-4F20-9874-3303A63E1F71;E6E52CBB-FBEB-4D02-BD48-1EF63DFBB83C	31;31	YES;YES	343;351;371;471;471;343;351;371	Doxorubicin;Doxorubicin;Doxorubicin;Doxorubicin;Mitomycin C;Mitomycin C;Mitomycin C;Mitomycin C	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Chemoembolization;Chemoembolization;Chemoembolization;Chemoembolization;Chemoembolization;Chemoembolization;Chemoembolization;Chemoembolization	Other, specify;Other, specify;Other, specify;Other, specify;Other, specify;Other, specify;Other, specify;Other, specify	Lipiodol;Lipiodol;Lipiodol;Lipiodol;Lipiodol;Lipiodol;Lipiodol;Lipiodol	10;10	2014;2014		Mild	59	3.5	3.9	4.8	TCGA-UB-A7MC	F82AFF25-0725-48D1-AEFD-D60800F7D1AB	0.2	1.5	Not Available	A	0.7	1.2	0.7	15	-21733	Not Applicable	0	438	Not Available																								0	NOT HISPANIC OR LATINO	0	8	126	1,2 - Portal Fibrosis	TCGA-UB-A7MC-F67161	68D77AAC-DE4E-418A-AC16-79316AC9BCC0	31	Not Applicable	500	Not Available	NO	10	NO	YES	Not Available	359	Not Available	Other, specify	Extrahepatic Recurrence	Adrenal glands	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	MALE	176	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.2	8	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	No	A7MC	Unknown	200	140	450	NO	NO	0.9	WHITE	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3a	YES	NO	UB	1.3	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV DNA	Alive	78	2014	2013
TCGA-CC-A7IF	59	MALE	169	649	58	20.30741220545499	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G1	1	254.0	Lung	New Primary Tumor	TUMOR FREE																					Not Available	59	Not Available	Not Available	Not Available	TCGA-CC-A7IF	E0674B82-2FBA-421E-BE62-58EFD0348D44	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	22	-21845	Not Applicable	0	0	Not Available																								3	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A7IF-F69922	4B311E67-CCB9-4D6F-9AC4-0959DC8726BF	22	649	Not Available	Not Available	NO	1	NO	NO	Not Available	254	Not Available	Lung	New Primary Tumor	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2015	MALE	169	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7IF	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	58	2014	2013
TCGA-4R-AA8I	66	MALE	171	262	103	35.224513525529225	Hepatocellular Carcinoma	Liver	Dead	T2	NX	MX	Stage II	G2	1	158.0	Liver	Locoregional Recurrence	WITH TUMOR																					None	66	3.5	3.8	4.8	TCGA-4R-AA8I	91A0C8CD-4F23-4569-8E5C-E5442F7AF530	0.4	1.2	Not Available	A	0.6	1.3	0.7	5	-24279	Not Applicable	0	216	Not Available																								1	NOT HISPANIC OR LATINO	0	9	5	6 - Established Cirrhosis	TCGA-4R-AA8I-F67448	1F426420-3B19-412D-A602-861BFF8C2585	5	262	Not Available	Not Available	NO	11	Not Available	Not Available	Not Available	247	Not Available	Liver	Locoregional Recurrence	Not Applicable	Not Available	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2014	MALE	171	Hepatocellular Carcinoma	Non-Alcoholic Fatty Liver Disease	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.1	6	G2	NO	NO	Not Available	158	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	Yes	AA8I	WITH TUMOR	96	150	450	NO	NO	1.1	WHITE	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	NO	YES	4R	1.5	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	103	2014	2013
TCGA-DD-A73C	65	FEMALE	159	701	49	19.382144693643447	Hepatocellular Carcinoma	Liver	Alive	T3a	N0	M0	Stage IIIA	G1	1	566.0	Liver	Locoregional Recurrence	TUMOR FREE																					None	65	3.5	4.9	5.0	TCGA-DD-A73C	79F9331C-9E00-4277-A9D1-7C848E132134	0.1	0.7	1	A	0.6	1.1	0.8	30	-23782	Not Applicable	0	230	Not Available																								0	NOT HISPANIC OR LATINO	0	6	3	0 - No Fibrosis	TCGA-DD-A73C-F66595	3F61663B-224C-497A-92C1-A4D8C4FE8EF9	21	Not Applicable	701	Not Available	NO	10	NO	NO	Not Available	566	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	Not Available	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	FEMALE	159	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.5	13.8	9	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A73C	TUMOR FREE	247	150	450	NO	NO	11.7	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3a	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	49	2013	2012
TCGA-CC-5259	60	FEMALE	153	250	49	20.932120124738347	Hepatocellular Carcinoma	Liver	Alive	T4	N0	M0	Stage IIIC	G2	1	180.0	Liver	Locoregional Recurrence	TUMOR FREE																					Not Available	60	Not Available	Not Available	Not Available	TCGA-CC-5259	7444EEA6-90E8-42DD-A7B5-0AFC6D96E1E8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	-21946	Not Applicable	0	5	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-5259-F70915	772935F7-35B5-4EEC-A7E0-DCFA88F83FF9	10	Not Applicable	250	Not Available	NO	3	NO	NO	Not Available	180	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2015	FEMALE	153	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G2													Not Available	No	5259	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4	YES	NO	CC	Not Available	Liver	Not Available	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	49	2012	2010
TCGA-2Y-A9GW	64	MALE	182	1271	139	41.96353097451998	Hepatocellular Carcinoma	Liver	Dead	T1	N0	MX	Stage I	G2	1	1229.0	Liver	Locoregional Recurrence	WITH TUMOR																					None	64	3.5	4.5	5	TCGA-2Y-A9GW	3E1920B3-3BD4-4506-A0CF-567257154BCF	0.2	0.6	1	Unknown	0.8	1.5	1	3	-23587	1271	0	Not Available	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	6	2	Unknown																												MALE	182	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G2	NO	NO	Not Available	1229	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	A9GW	WITH TUMOR	175	143	382	NO	NO	9.7	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	NO	YES	2Y	1.3	Liver	Unknown	Unknown	Dead	139	2014	2007
TCGA-BC-A10S	81	MALE	Not Available	1423	74		Hepatocellular Carcinoma	Liver	Dead	T3	NX	MX		G1	1	1130.0		Intrahepatic Recurrence	WITH TUMOR																					None	81	Not Available	3.6	Not Available	TCGA-BC-A10S	592ef526-176a-42e0-bbeb-fb62d369a343	Not Available	0.6	Not Available	Not Available	Not Available	Not Available	Not Available	23	-29842	1423	0	Not Available	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-BC-A10S-F9875	9E018ECA-2E5F-40F5-8A12-530B3F89B9D8	1	1423	Not Available	Not Available	Not Available	4	NO	NO	Not Available	1130	Not Available	Not Available	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2011	MALE	Not Available	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G1													Not Available	No	A10S	WITH TUMOR	217000	150	440	Not Available	Not Available	1.1	WHITE	Not Available																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3	NO	YES	BC	Not Available	Liver	Micro	Unknown	Dead	74	2011	1999
TCGA-UB-A7ME	51	MALE	165	486	75	27.548209366391184	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G2	0	486			TUMOR FREE																					Mild	51	3.5	4.2	4.8	TCGA-UB-A7ME	BE1240F0-34DC-4205-B152-C26F11D28462	0.2	0.6	Not Available	B	0.7	1.2	1.1	16	-18846	Not Applicable	0	486	Not Available																								0	NOT HISPANIC OR LATINO	0	8	1388	1,2 - Portal Fibrosis	TCGA-UB-A7ME-F67165	2FF3898B-1205-45EB-BDC9-FDF6B99416E2	31	Not Applicable	486	Not Available	NO	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	165	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.2	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7ME	TUMOR FREE	181	140	450	NO	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	UB	1.3	Liver	None	Hepatitis B Surface Antigen;HBV Core Antibody;HBV DNA	Alive	75	2014	2013
TCGA-ED-A97K	54	MALE	170	6	64	22.14532871972318	Hepatocholangiocarcinoma (Mixed)	Liver	Alive	T3a	N0	M0	Stage IIIA	G2	0	6			TUMOR FREE																					Mild	54	3.8	8	5.1	TCGA-ED-A97K	8778DC9E-A7DB-4464-A8AF-11ADDB5E441A	0.1	1.0	Not Available	Unknown	4.0	5.8	4.6	18	-20073	Not Applicable	0	6	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	20	3	Not Available	TCGA-ED-A97K-F68560	E9A8575A-7B0E-48B7-97D3-980FBD644315	2	Not Applicable	Not Available	Not Available	YES	12													Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2014	MALE	170	Hepatocholangiocarcinoma (Mixed)	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8180/3	C22.0	YES	0.3	1.3	4	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A97K	TUMOR FREE	264	150	400	NO	Unknown	0.9	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3a	YES	NO	ED	1.3	Liver	Micro	Hepatitis B Surface Antigen	Alive	64	2014	2013
TCGA-XR-A8TF	74	MALE	166	693	57	20.685150239512264	Hepatocellular Carcinoma	Liver	Dead	T1	NX	MX	Stage I	G1	1	231.0	Liver	Intrahepatic Recurrence	TUMOR FREE																					None	74	3.5	3.9	4.8	TCGA-XR-A8TF	1E9F910C-82C0-4222-A62F-B656839307FC	0.2	0.8	Not Available	A	0.7	1.5	0.8	20	-27145	693	0	Not Available	Not Available																								0	HISPANIC OR LATINO	6	6	39	3,4 - Fibrous Speta	TCGA-XR-A8TF-F72323	AB32CA3C-2ADB-4F5B-9C92-21631EA79E2A	20	693	Not Available	Not Available	NO	5	NO	NO	271	231	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	YES	No	R1	YES	TUMOR FREE	NO	NO	NO	Dead	2015	MALE	166	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0	1.3	5	G1	NO	NO	271	231	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	YES	No	R1	YES	No	A8TF	TUMOR FREE	194000	150000	450000	NO	NO	1.1	WHITE	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	XR	1.2	Liver	None	Not Available	Dead	57	2015	2012
TCGA-CC-A7II	54	MALE	168	399	52	18.424036281179138	Hepatocellular Carcinoma	Liver	Alive	T3	N0	M0	Stage IIIA	G3	1	278.0		Locoregional Recurrence	TUMOR FREE																					Not Available	54	Not Available	Not Available	Not Available	TCGA-CC-A7II	AAF7C9B5-6CB7-42BF-A0D1-07975EAE3BE9	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	22	-20079	Not Applicable	0	0	Not Available																								2	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A7II-F69918	68BB2E8B-036F-4875-9D73-147044CF3AF5	22	Not Applicable	399	Not Available	NO	1	NO	NO	Not Available	278	Not Available	Not Available	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2015	MALE	168	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7II	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	52	2014	2013
TCGA-DD-AADQ	59	MALE	165	436	64	23.507805325987142	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G3	0	436			TUMOR FREE																					Unknown	59	3.8	4.4	5.3	TCGA-DD-AADQ	485D283A-552C-485A-84FB-3ABDB98DC797	0.2	0.3	Not Available	A	0.7	1.5	0.7	7	-21756	Not Applicable	0	161	Not Available																								0	NOT HISPANIC OR LATINO	0	8	7	Unknown	TCGA-DD-AADQ-F68403	D305B594-8E0C-4FA8-8DDF-9F20182E0ED7	17	Not Applicable	436	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	165	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AADQ	TUMOR FREE	163	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.2	Liver	None	Unknown	Alive	64	2014	2013
TCGA-K7-A6G5	66	MALE	184	512	80	23.629489603024574	Hepatocellular Carcinoma	Liver	Alive	T1	N0	MX	Stage I	G2	0	512			TUMOR FREE																					Not Available	66	Not Available	Not Available	Not Available	TCGA-K7-A6G5	81EDDCDA-0069-4652-9DC6-8AAC89CBA1FF	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	-24233	Not Applicable	0	122	Not Available																								0	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-K7-A6G5-F64040	1635B892-E129-416E-9BD0-CD25947966F8	25	Not Applicable	512	Not Available	NO	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	184	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B;Hepatitis C;Hemochromatosis	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	9	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A6G5	TUMOR FREE	Not Available	Not Available	Not Available	NO	NO	Not Available	WHITE	NO																			Not Available	RX	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	YES	NO	K7	Not Available	Liver	None	HCV Genotype	Alive	80	2013	2013
TCGA-CC-5264	71	MALE	160	102	52	20.3125	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G2	0	102			TUMOR FREE																					Not Available	71	Not Available	Not Available	Not Available	TCGA-CC-5264	61902cb6-b041-48ac-aacc-483a28949865	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	18	-25979	Not Applicable	0	0	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-5264-F20329	F1608DF9-061A-49F9-A02B-0377AF6FB8BB	9	102	Not Available	Scheduled Follow-up Submission	Not Available	1													NO	TUMOR FREE	NO	NO	NO	Dead	2012	MALE	160	Hepatocellular Carcinoma	Not Available	Not Available	No	Hepatic Resection	C22.0	8170/3	C22.0	YES	Not Available	Not Available	4	G2													Not Available	No	5264	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			Not Available	RX	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	52	2011	2010
TCGA-DD-A39Y	67	MALE	176	171	85	27.440599173553718	Hepatocellular Carcinoma	Liver	Dead	T1	NX	M0	Stage I	G3	0	171			TUMOR FREE																					None	67	3.5	4.0	5.0	TCGA-DD-A39Y	BED1D731-E382-4B80-9604-E6DD68D9C0AB	0.1	1.1	Not Available	A	1.2	12.0	0.8	5	-24769	171	0	Not Available	Not Available																								2	NOT HISPANIC OR LATINO	0	6	5600	0 - No Fibrosis	TCGA-DD-A39Y-F42701	8A1FFED2-8F3F-4458-9850-1043AA6876C6	27	171	Not Available	Not Available	NO	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Dead	2013	MALE	176	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	1	G3													Not Available	No	A39Y	TUMOR FREE	243	150	450	Not Available	Not Available	10.2	ASIAN	Not Available																			YES	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Dead	85	2012	2002
TCGA-ED-A8O6	50	FEMALE	165	56	45	16.52892561983471	Hepatocellular Carcinoma	Liver	Dead	T3a	N0	M0	Stage IIIA	G3	0	56			TUMOR FREE																					Mild	50	3.8	2.8	5.1	TCGA-ED-A8O6	7FB03840-5153-4DC6-A302-5A89AA4E1FB6	0.1	2.3	Not Available	Unknown	4.1	5.8	2.8	12	-18572	Not Applicable	0	6	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	20	3000	Not Available	TCGA-ED-A8O6-F68512	ECBD888B-CC75-4C38-BB07-22A57712227F	21	56	Not Available	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	NO	NO	NO	Dead	2014	FEMALE	165	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.3	1.3	2	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A8O6	TUMOR FREE	Not Available	150	400	NO	NO	Not Available	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3a	YES	NO	ED	1.3	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	45	2014	2013
TCGA-DD-A1E9	70	MALE	172	2759	101	34.14007571660357	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G2	1	720.0	Liver	Intrahepatic Recurrence	Not Available		YES	Radiofrequency Ablation	Not Applicable	1839	Not Available	1	TCGA-DD-A1E9-A42014	487D20F2-3074-4B10-93BF-D379E4A91665	9	YES	1924	Other	chemoembolic mixture	Chemoembolization	Other, specify	chemoembolic mixture	4	2013		Severe	70	3.5	4.1	5.0	TCGA-DD-A1E9	8153a862-0790-4a33-80db-ed47fedcd4ef	0.1	13	4	A	0.8	1.3	0.9	10	-25808	2759	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	6	202	6 - Established Cirrhosis	TCGA-DD-A1E9-F42012	5CDDBF25-18E8-4A2E-B6FB-38E86CA83853	9	2759	Not Available	Not Available	NO	4	NO;NO	NO;NO	Not Available;Not Available	720;1838	Not Available;Not Available	Liver;Liver	Intrahepatic Recurrence;Locoregional Recurrence	Not Applicable;Not Applicable	Yes;Yes	NO;NO	No;No	Not Available;Not Available	NO	Unknown	NO	NO	NO	Dead	2013	MALE	172	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	5	G2													Not Available	No	A1E9	Not Available	110	150	450	Not Available	Not Available	10.4	WHITE	Not Available																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Dead	101	2011	2002
TCGA-DD-A1EC	20	FEMALE	157	602	50	20.28479857195018	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	1	299.0	Other, specify	Extrahepatic Recurrence	Not Available																					None	20	3.5	3.2	5.0	TCGA-DD-A1EC	520a709a-87f6-4f3d-b2a2-9192e3b65c5b	0.1	0.4	Not Available	A	0.7	1.2	0.8	6	-7363	Not Applicable	0	602	Not Available	TCGA-DD-A1EC-D42203	A9E3B60E-52B2-4611-9D09-B6BC02287480	phase III	15	Not Available	330	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	YES	2013	1	NOT HISPANIC OR LATINO	0	6	2	0 - No Fibrosis	TCGA-DD-A1EC-F42201	0E071E1E-1F66-4F17-9305-F3AABC339C88	15	Not Applicable	602	Not Available	YES	4	YES	NO	Not Available	299	Not Available	Other, specify	Extrahepatic Recurrence	peritoneal	No	NO	No	Not Available	YES	Unknown	NO	NO	NO	Alive	2013	FEMALE	157	Hepatocellular Carcinoma	Not Available	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	4	G3													Not Available	No	A1EC	Not Available	556	150	450	Not Available	Not Available	11.0	WHITE	Not Available																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Unknown	Alive	50	2011	2004
TCGA-DD-A115	53	MALE	168	2542	79	27.990362811791382	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G2	1	469.0	Liver	Intrahepatic Recurrence	WITH TUMOR		YES	Other	alcohol ablation	855	Not Available	1	TCGA-DD-A115-A42009	78525079-E6FC-4EFF-9561-63014E747D02	9	YES	1121;1170;1281;1477	Doxorubicin;Doxorubicin;Doxorubicin;Doxorubicin	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Chemoembolization;Chemoembolization;Chemoembolization;Chemoembolization	Other, specify;Not Available;Other, specify;Other, specify	Doxorubicin, mitomycin, and Ivalon;Not Applicable;chemoembolic mixture;chemoembolic mixture	4	2013		None	53	3.5	4.1	5.0	TCGA-DD-A115	45b566d7-f120-471c-a94a-be7936889f2d	0.1	0.6	Not Available	A	0.1	1.2	1.1	29	-19697	2542	0	Not Available	Not Available	TCGA-DD-A115-D42008	3E81299F-E306-4CB2-910E-62C3C022D4A4	Phase II	9	841	502	Not Available	Stable Disease	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	YES	2013	0	Not Available	0	6	10	0 - No Fibrosis	TCGA-DD-A115-F38780	6D6B8B11-0E91-402C-8665-65BDC1A5738E	21	2542	Not Available	Not Available	NO	12	YES	NO	Not Available	469	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2012	MALE	168	Hepatocellular Carcinoma	Alcohol consumption	Smoking	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	12	G2													Not Available	No	A115	WITH TUMOR	337	150	450	Not Available	Not Available	1.0	WHITE	Not Available																			NO	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Dead	79	2010	2002
TCGA-HP-A5MZ	78	MALE	185	91	82	23.9590942293645	Hepatocellular Carcinoma	Liver	Dead	T1	NX	M0	Stage I	G2	0	91			TUMOR FREE																					Not Available	78	Not Available	Not Available	Not Available	TCGA-HP-A5MZ	2D00F09F-0074-46C8-B357-B5F33567762A	Not Available	Not Available	Not Available	Unknown	62	120	124	26	-22702	91	0	Not Available	Not Available																								Unknown	Not Evaluated	Not Available	Not Available	Not Available	Not Available	TCGA-HP-A5MZ-F64772	B83AFF23-D6A4-44AD-87A8-AE62EC624D9F	11	91	Not Available	Not Available	NO	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Dead	2014	MALE	185	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	9	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A5MZ	TUMOR FREE	231	150	400	NO	NO	1.0	Not Evaluated	NO																			Unknown	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1	NO	YES	HP	Not Available	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Surface Antibody	Dead	82	2013	Not Available
TCGA-DD-A1EK	64	FEMALE	159	558	97	38.368735413947235	Hepatocellular Carcinoma	Liver	Dead	T4	N0	M1	Stage IVB	G2	1	167.0	Liver	Locoregional Recurrence	WITH TUMOR		YES	Radiofrequency Ablation	Not Applicable	0	3	1	TCGA-DD-A1EK-A42206	61C165ED-E7E2-41EE-B4E9-C9368BA49FAC	15	YES	286	Not Available	Not Applicable	Chemoembolization	Not Available	Not Applicable	4	2013		Mild	64	3.5	4.3	5.0	TCGA-DD-A1EK	A5E4412B-0E49-4D86-9CCE-71F440A84048	0.1	0.5	1	A	0.6	1.1	0.7	9	-23437	558	0	Not Available	Not Available	TCGA-DD-A1EK-D42207	91BF0C5B-D368-4354-930D-07933F900F0F	Not Available	15	349	188	Sorafenib	Clinical Progressive Disease	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	NOT HISPANIC OR LATINO	0	6	19	0 - No Fibrosis	TCGA-DD-A1EK-F42001	2AA7B806-A0E6-4200-BA48-E19624E72226	9	558	Not Available	Not Available	NO	4	YES;YES	NO;NO	Not Available;Not Available	167;167	Not Available;Not Available	Liver;Lung	Locoregional Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable	Yes;Yes	NO;NO	No;No	Not Available;Not Available	YES	WITH TUMOR	YES	NO	NO	Dead	2013	FEMALE	159	Hepatocellular Carcinoma	Other	tobacco, birth control bills	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	10.8	4	G2	YES;YES	NO;NO	Not Available;Not Available	167;167	Not Available;Not Available	Liver;Lung	Locoregional Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable	Yes;Yes	NO;NO	No;No	Not Available;Not Available	YES	No	A1EK	WITH TUMOR	387	150	450	YES	NO	10.3	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N0	T4	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Dead	97	2013	2008
TCGA-DD-AAE2	51	MALE	174	638	82	27.084159069890344	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	638			TUMOR FREE																					None	51	3.8	4.4	5.3	TCGA-DD-AAE2	56447EB8-C50C-4E31-A29E-BDE6BFD31AF4	0.2	0.4	Not Available	A	0.7	1.5	0.8	14	-18695	Not Applicable	0	288	Not Available																								0	NOT HISPANIC OR LATINO	0	8	41	6 - Established Cirrhosis	TCGA-DD-AAE2-F68412	650E5A3B-0A1F-40F7-8655-D71AECEA98FA	17	Not Applicable	638	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	174	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAE2	TUMOR FREE	238	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	82	2014	2013
TCGA-CC-A5UE	48	MALE	175	272	65	21.224489795918366	Hepatocellular Carcinoma	Liver	Dead	T4	N0	M0	Stage IIIB	G2	1	175.0		Locoregional Recurrence	TUMOR FREE																					Not Available	48	Not Available	Not Available	Not Available	TCGA-CC-A5UE	23D8E6A0-FA79-4323-A0A6-2DEA2A319667	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	21	-17805	Not Applicable	0	0	Not Available																								3	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A5UE-F69701	CE7739A5-8E11-415D-BE22-753666A66FDC	16	272	Not Available	Not Available	NO	1	NO	NO	Not Available	175	Not Available	Not Available	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2015	MALE	175	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A5UE	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	65	2014	2012
TCGA-NI-A8LF	74	MALE	171	799	104	35.566499093738244	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G3	0	799			TUMOR FREE																					None	74	Not Available	1.2	Not Available	TCGA-NI-A8LF	420DC176-E9A8-484B-BFA3-1B84E039C26B	Not Available	0.6	1	Unknown	Not Available	Not Available	15	3	-27162	Not Applicable	0	498	Not Available																								1	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Unknown	TCGA-NI-A8LF-F67430;TCGA-NI-A8LF-F69826	408E647F-2F96-4038-A3F6-192D33BB13BF;9A1A17A8-AF9F-4896-B19E-0C01E62B0CFA	5;21	Not Applicable;Not Applicable	606;799	Not Available;Not Available	NO;NO	11;1	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE	NO;NO	NO;NO	NO;NO	Alive;Alive	2014;2015	MALE	171	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Laproscopic Left Partial Hepectomy Segments 2 & 3	C22.0	8170/3	C22.0	YES	Not Available	Not Available	4	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A8LF	TUMOR FREE	132	Not Available	Not Available	NO	NO	Not Available	WHITE	NO																			YES	R0	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	NI	Not Available	Liver	None	Unknown	Alive	104	2014	2012
TCGA-BW-A5NO	50	MALE	Not Available	20	Not Available		Hepatocellular Carcinoma	Liver	Alive	T3a	NX	MX	Stage IIIA	G2	0	20			TUMOR FREE																					Unknown	50	Not Available	Not Available	Not Available	TCGA-BW-A5NO	EE63C44B-91F4-4004-8DEA-192EAB527036	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	26	-18510	Not Applicable	0	20	Not Available																								1	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	3,4 - Fibrous Speta																												MALE	Not Available	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A5NO	TUMOR FREE	Not Available	Not Available	Not Available	NO	NO	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Unknown	RX	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3a	YES	NO	BW	Not Available	Liver	None	Not Available	Alive	Not Available	2014	2010
TCGA-CC-A5UD	45	MALE	170	304	62	21.453287197231834	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G2	1	182.0		Locoregional Recurrence	TUMOR FREE																					Not Available	45	Not Available	Not Available	Not Available	TCGA-CC-A5UD	3837C8AC-6C9E-499B-A4E7-D42C870BCB49	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	21	-16702	Not Applicable	0	0	Not Available																								1	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A5UD-F69700	1AEE3EFA-CFEF-4BFA-AE85-83A53E875056	16	304	Not Available	Not Available	NO	1	NO	NO	Not Available	182	Not Available	Not Available	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2015	MALE	170	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A5UD	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	62	2014	2012
TCGA-DD-A1EF	57	FEMALE	164	394	81	30.116002379535992	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G3	0	394			WITH TUMOR																					Mild	57	3.5	4.5	5.0	TCGA-DD-A1EF	1c1e8987-676f-417b-b3b4-e0321367df55	0.1	1.0	9	B	0.6	1.1	0.9	10	-21165	394	0	Not Available	Not Available																								2	NOT HISPANIC OR LATINO	0	6	16211	3,4 - Fibrous Speta	TCGA-DD-A1EF-F42200	47AD5204-D003-453C-87E7-016B94CE33E3	15	394	Not Available	Not Available	NO	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	Unknown	Unknown	Unknown	Dead	2013	FEMALE	164	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	5	G3													Not Available	No	A1EF	WITH TUMOR	337	150	450	Not Available	Not Available	8.5	WHITE	Not Available																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Dead	81	2011	2007
TCGA-GJ-A3OU	59	MALE	167	879	172	61.67306106350174	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G2	1	879.0	Liver	Intrahepatic Recurrence	TUMOR FREE																					Unknown	59	3.5	3.2	5.0	TCGA-GJ-A3OU	FB2ABC2A-ECF1-4184-912F-26A649F861FF	0.0	0.9	1	Unknown	0.6	1.4	0.6	3	-21671	Not Applicable	0	697	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	25	8	Unknown	TCGA-GJ-A3OU-F70294	22B63EF5-8E96-419E-BE86-94D99EC9A976	27	Not Applicable	879	Not Available	NO	3	Not Available	Not Available	Not Available	879	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Not Available	NO	No	Not Available	YES	Discrepancy	NO	NO	NO	Alive	2015	MALE	167	Hepatocellular Carcinoma	Alcohol consumption;Non-Alcoholic Fatty Liver Disease;Other	hepatic cirrhosis	No	Not Applicable	C22.0	8174/3	C22.0	YES	0.8	1.2	2	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A3OU	TUMOR FREE	178	150	450	NO	NO	1.1	WHITE	NO																			YES	RX	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	GJ	1.0	Liver	None	Hepatitis  C Antibody	Alive	172	2015	2011
TCGA-DD-AAVU	46	MALE	160	2202	88	34.375	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	1	1630.0	Liver	Intrahepatic Recurrence	TUMOR FREE																					Mild	46	3.3	4.6	5.2	TCGA-DD-AAVU	146C5332-1AF5-4C49-B740-9A9EDC795F24	0.2	0.6	Not Available	A	0	1.4	1.2	13	-16889	Not Applicable	0	1882	Not Available																								1	NOT HISPANIC OR LATINO	0	15	2	3,4 - Fibrous Speta	TCGA-DD-AAVU-F67577	C75FD416-761F-456D-BE3B-989500EE2185	6	Not Applicable	2202	Not Available	NO	11	NO	NO	Not Available	1630	1648	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	Yes	Not Available	YES	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	160	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	6	G2	NO	NO	Not Available	1630	1648	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	Yes	Not Available	YES	No	AAVU	TUMOR FREE	166	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	88	2014	2008
TCGA-G3-A6UC	65	MALE	182	671	91	27.47252747252747	Hepatocellular Carcinoma	Liver	Alive	T3b	N0	M0	Stage IIIB	G2	1	639.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					Mild	65	3.3	4.6	4.8	TCGA-G3-A6UC	87AA894E-7676-40B7-9557-6541446D8CEA	0	1.0	Not Available	A	0.6	1.4	0.9	3	-23793	Not Applicable	0	236	Not Available																								0	NOT HISPANIC OR LATINO	0	10	4	6 - Established Cirrhosis	TCGA-G3-A6UC-F64551	34B10480-D5C6-468C-8457-0A8B186CAB7A	4	Not Applicable	671	Not Available	NO	9	NO	NO	Not Available	639	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	MALE	182	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	10	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Yes	A6UC	WITH TUMOR	257	150	400	NO	NO	1.1	WHITE	NO																			Unknown	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3b	YES	NO	G3	1.4	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Surface Antibody	Alive	91	2013	2012
TCGA-CC-A9FU	52	FEMALE	153	0	48	20.504933999743688	Hepatocellular Carcinoma	Liver	Alive	T3a	N0	M0	Stage IIIA	G2	0	0			TUMOR FREE																					Not Available	52	Not Available	Not Available	Not Available	TCGA-CC-A9FU	5E2A99A1-41C1-49CA-97D6-69F9B9938D24	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	22	-19326	Not Applicable	0	0	Not Available																								Unknown	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available																												FEMALE	153	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9FU	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3a	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	48	2014	2013
TCGA-DD-AAD3	43	MALE	178	1295	77	24.302487059714682	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	1295			TUMOR FREE																					Mild	43	3.8	3.9	5.3	TCGA-DD-AAD3	0D13229A-304A-48A6-A761-12E68E94A4B4	0.2	0.4	Not Available	A	0.7	1.5	0.8	29	-15706	Not Applicable	0	1029	Not Available																								0	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	1,2 - Portal Fibrosis	TCGA-DD-AAD3-F68386	62BF6E6B-E245-4EA6-8DE1-4FC5F4896BE5	17	Not Applicable	1295	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	178	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAD3	TUMOR FREE	181	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	77	2014	2011
TCGA-2Y-A9GU	55	FEMALE	154	1939	78	32.889188733344575	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G2	0	1939			TUMOR FREE																					None	55	3.5	4.4	5	TCGA-2Y-A9GU	B27720A2-E240-413C-A0F1-0B1AF3621DE2	0.2	0.3	2	Unknown	0.8	1.5	0.9	3	-20187	Not Applicable	0	1569	Not Available																								0	NOT HISPANIC OR LATINO	0	6	304	Unknown	TCGA-2Y-A9GU-F69082	FB05E6D4-A090-475A-92A3-DED79D7B91FA	29	Not Applicable	1939	Not Available	NO	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	154	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9GU	TUMOR FREE	281	143	382	NO	NO	10.8	WHITE	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	2Y	1.3	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Core Antibody	Alive	78	2014	2009
TCGA-MI-A75G	63	MALE	178	698	69	21.777553339224845	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	0	698			TUMOR FREE																					Not Available	63	3.5	2.3	4.9	TCGA-MI-A75G	22DD3876-1F2C-4DDD-8FAE-F5FB820993BA	0.2	1.7	1	B	0.6	1.3	0.5	20	-23284	Not Applicable	0	433	Not Available																								1	NOT HISPANIC OR LATINO	0	9	6	6 - Established Cirrhosis	TCGA-MI-A75G-F58603	5D08E603-3352-4F32-8E91-07DEDF5051AD	28	Not Applicable	698	Not Available	YES	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	178	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	11	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A75G	TUMOR FREE	160	150	450	NO	NO	Not Available	WHITE	NO																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	MI	1.2	Liver	None	HCV Genotype	Alive	69	2013	2012
TCGA-FV-A4ZP	78	MALE	168	2486	69	24.447278911564627	Hepatocellular Carcinoma	Liver	Dead	T3	NX	M0	Stage IIIA	G2	1		Other, specify	Extrahepatic Recurrence	TUMOR FREE																					Unknown	78	Not Available	Not Available	Not Available	TCGA-FV-A4ZP	5C08008D-5ED4-4480-BD00-C8A2D8C787DC	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	15	-28771	Not Applicable	0	1836	Not Available																								Unknown	NOT HISPANIC OR LATINO	Not Available	Not Available	20326	Unknown	TCGA-FV-A4ZP-F64063	A53A080B-0460-484F-BF29-2329F565D546	25	2486	Not Available	Not Available	NO	8	NO	NO	Not Available	Not Available	Not Available	Other, specify	Extrahepatic Recurrence	Adrenal Gland	No	YES	No	RX	YES	Unknown	NO	NO	NO	Dead	2014	MALE	168	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Yes	A4ZP	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	WHITE	Unknown																			Unknown	R1	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T3	NO	YES	FV	Not Available	Liver	Micro	Not Available	Alive	69	2013	2005
TCGA-PD-A5DF	58	FEMALE	167	639	72	25.816630212628635	Hepatocellular Carcinoma	Liver	Dead	T4	N0	M0	Stage IIIB	G2	0	639			WITH TUMOR																					Not Available	58	Not Available	Not Available	Not Available	TCGA-PD-A5DF	1987B453-F97D-45C7-9C89-B9A33313D645	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	30	-21414	639	0	Not Available	Not Available																								Unknown	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available																												FEMALE	167	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	4	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A5DF	WITH TUMOR	Not Available	Not Available	Not Available	NO	YES	Not Available	WHITE	NO																			YES	Not Available	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4	NO	YES	PD	Not Available	Liver	Not Available	Unknown	Dead	72	2013	2007
TCGA-DD-A3A9	64	FEMALE	168	931	62	21.967120181405896	Hepatocellular Carcinoma	Liver	Dead	T4	N0	M1	Stage IVB	G2	1	289.0	Lung	Extrahepatic Recurrence	WITH TUMOR																					None	64	3.5	4.0	5.0	TCGA-DD-A3A9	457CCA7C-A8B4-414E-A3C0-7FCCF0EE2034	0.1	0.3	Not Available	A	0.6	0.9	0.9	5	-23526	931	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	6	19930	0 - No Fibrosis	TCGA-DD-A3A9-F42709	B64DA5E3-3DC1-4F7D-B36F-B76C344C42E1	27	931	Not Available	Not Available	NO	4	Unknown	Unknown	Not Available	289	Not Available	Lung	Extrahepatic Recurrence	Not Applicable	Unknown	NO	Not Available	Not Available	YES	WITH TUMOR	Unknown	Unknown	Unknown	Dead	2013	FEMALE	168	Hepatocellular Carcinoma	Other	smoker	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	1	G2													Not Available	No	A3A9	WITH TUMOR	317	150	450	Not Available	Not Available	9.3	WHITE	Not Available																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M1	N0	T4	NO	YES	DD	1.0	Liver	None	Unknown	Dead	62	2012	2001
TCGA-DD-AACA	65	MALE	165	2301	70	25.711662075298438	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	1	776.0	Liver	Locoregional Recurrence	WITH TUMOR																					Mild	65	3.8	3.7	5.3	TCGA-DD-AACA	D6486001-240A-455A-980C-E06C25C61FA5	0.2	0.7	Not Available	A	0.7	1.5	1.2	28	-23973	Not Applicable	0	2000	Not Available																								0	NOT HISPANIC OR LATINO	0	8	7	6 - Established Cirrhosis	TCGA-DD-AACA-F68364	B5F856AE-E0EE-43E1-BB70-143716B96F84	17	Not Applicable	2301	Not Available	NO	11	NO	NO	797	776	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	YES	No	R0	YES	WITH TUMOR	NO	NO	NO	Alive	2014	MALE	165	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	NO;NO;NO	NO;NO;NO	797;1882;Not Available	776;1854;2163	Not Available;Not Available;Not Available	Liver;Liver;Liver	Locoregional Recurrence;Locoregional Recurrence;Locoregional Recurrence	Not Applicable;Not Applicable;Not Applicable	No;No;Yes	YES;YES;NO	No;No;No	R0;R0;Not Available	YES	No	AACA	WITH TUMOR	136	130	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	70	2014	2008
TCGA-DD-AAW2	69	MALE	156	1855	50	20.5456936226167	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	1	391.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					None	69	3.3	4.0	5.2	TCGA-DD-AAW2	03DF105E-A005-4577-BFDB-9644758D778E	0.2	0.4	1	A	0.7	1.4	1.1	13	-25420	Not Applicable	0	1505	Not Available																								1	NOT HISPANIC OR LATINO	0	15	3	6 - Established Cirrhosis	TCGA-DD-AAW2-F67592	20ABE3CC-5E57-4596-8252-CED8DA6EA6B8	30	Not Applicable	1855	Not Available	NO	12	YES;YES	NO;YES	Not Available;Not Available	391;391	Not Available;Not Available	Liver;Lung	Intrahepatic Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable	Yes;No	NO;NO	No;No	Not Available;Not Available	YES	WITH TUMOR	Discrepancy	YES	Discrepancy	Alive	2014	MALE	156	Hepatocellular Carcinoma	Non-Alcoholic Fatty Liver Disease	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	6	G2	NO	NO	Not Available	391	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AAW2	WITH TUMOR	164	130	400	NO	NO	1.0	ASIAN	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	50	2014	2009
TCGA-DD-AADD	51	MALE	168	1231	68	24.09297052154195	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G4	0	1231			TUMOR FREE																					Unknown	51	3.8	4.1	5.3	TCGA-DD-AADD	B44F664C-444C-4C64-A407-52FD9B55F178	0.2	0.4	Not Available	A	0.7	1.5	0.9	7	-18752	Not Applicable	0	864	Not Available																								1	NOT HISPANIC OR LATINO	0	8	9804	Unknown	TCGA-DD-AADD-F68392	B729BAA6-F7E2-4480-BB7B-51FF9D09AF66	17	Not Applicable	1231	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	168	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AADD	TUMOR FREE	299	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	68	2014	2011
TCGA-XR-A8TG	58	MALE	184	898	71	20.97117202268431	Hepatocellular Carcinoma	Liver	Alive	T1	NX	M0	Stage I	G2	1	350.0	Liver	Intrahepatic Recurrence	TUMOR FREE																					Mild	58	3.5	4.3	4.8	TCGA-XR-A8TG	1D7D5166-6582-4EA1-B242-37C2C3919A3C	0.2	0.5	2	Not Available	0.7	1.5	0.9	20	-21544	Not Applicable	0	867	Not Available																								0	HISPANIC OR LATINO	6	6	1	6 - Established Cirrhosis	TCGA-XR-A8TG-F72325	9DAD67A4-B43D-4AA3-BC05-C2D4C30A2972	20	Not Applicable	898	Not Available	NO	5	NO	NO	Not Available	350	713	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	Yes	R0	YES	TUMOR FREE	YES	NO	YES	Alive	2015	MALE	184	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0	1.5	5	G2	NO	NO	Not Available	350	713	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	Yes	Not Available	YES	Yes	A8TG	TUMOR FREE	80000	150000	450000	YES	NO	1.1	WHITE	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1	NO	YES	XR	1.2	Liver	None	Not Available	Alive	71	2015	2012
TCGA-UB-AA0V	69	FEMALE	175	314	57	18.612244897959183	Hepatocellular Carcinoma	Liver	Alive		NX	MX	Stage I	G1	0	314			TUMOR FREE																					Mild	69	3.5	3.8	4.8	TCGA-UB-AA0V	EA214F79-0F6B-403F-8693-C844BF4B77CB	0.2	1.0	1	A	0.5	1.0	0.7	16	-25340	Not Applicable	0	139	Not Available																								0	NOT HISPANIC OR LATINO	0	8	3	0 - No Fibrosis	TCGA-UB-AA0V-F67169	73D8DC83-7471-4962-AF2A-A127CEDA0A90	31	Not Applicable	314	Not Available	NO	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	175	Hepatocellular Carcinoma	Hemochromatosis	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.2	8	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Yes	AA0V	TUMOR FREE	273	140	450	NO	NO	0.9	WHITE	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	Discrepancy	YES	NO	UB	1.3	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Core Antibody	Alive	57	2014	2013
TCGA-CC-A7IE	57	MALE	172	217	62	20.9572742022715	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G2	1	169.0	Lung	New Primary Tumor	TUMOR FREE																					Not Available	57	Not Available	Not Available	Not Available	TCGA-CC-A7IE	220F75D7-08A4-4936-B4B2-0750E87CCDF5	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	22	-20985	Not Applicable	0	0	Not Available																								3	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A7IE-F69923	129BA9C7-AA91-4890-ABBE-7E52A44CE11B	22	217	Not Available	Not Available	NO	1	NO	NO	Not Available	169	Not Available	Lung	New Primary Tumor	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2015	MALE	172	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7IE	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	62	2014	2012
TCGA-BC-A69I	69	MALE	180	387	95	29.320987654320987	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G1	0	387			TUMOR FREE																					None	69	Not Available	Not Available	Not Available	TCGA-BC-A69I	70AECC90-17F0-4064-8EBB-BE81F9B1D7FD	0.0	1.2	1	Unknown	0.7	1.3	1.2	18	-25370	Not Applicable	0	16	Not Available																								0	Not Evaluated	0	10	2	Not Available	TCGA-BC-A69I-F59405	CECFA011-1120-4E2C-B521-CE94CFA191F7	12	Not Applicable	387	Not Available	NO	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	180	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.9	13.0	6	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A69I	TUMOR FREE	171000	150000	440000	NO	NO	10.4	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	YES	NO	BC	1.2	Liver	None	Not Available	Alive	95	2013	2013
TCGA-DD-AAE3	50	MALE	165	566	73	26.813590449954088	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	566			TUMOR FREE																					None	50	3.8	4.7	5.3	TCGA-DD-AAE3	3C969BDF-CAE8-44F5-839F-5ABD4CBA0EC8	0.2	1.1	Not Available	A	0.7	1.5	0.8	14	-18271	Not Applicable	0	300	Not Available																								0	NOT HISPANIC OR LATINO	0	8	2	1,2 - Portal Fibrosis	TCGA-DD-AAE3-F68413	D6F39E13-1EF0-499F-AD1D-3AE17ED10BE6	17	Not Applicable	566	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	165	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAE3	TUMOR FREE	180	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	73	2014	2013
TCGA-CC-A1HT	50	MALE	163	101	54	20.32443825510934	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G3	0	101			TUMOR FREE																					Not Available	50	Not Available	Not Available	Not Available	TCGA-CC-A1HT	670c1cbc-4494-45f1-bb8b-18db82d4f7e0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	-18553	Not Applicable	0	0	Not Available																								4	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A1HT-F20333	101473A4-4DDF-43E1-9FDA-1393FC24E2A2	9	101	Not Available	Scheduled Follow-up Submission	Not Available	1													NO	TUMOR FREE	NO	NO	NO	Dead	2012	MALE	163	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Hepatic Resection	C22.0	8170/3	C22.0	YES	Not Available	Not Available	6	G3													Not Available	No	A1HT	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			NO	Not Available	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	Not Available	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	54	2011	2010
TCGA-ZP-A9D1	56	FEMALE	170	21	130	44.982698961937714	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX		G2	0	21			TUMOR FREE																					Not Available	56	Not Available	Not Available	Not Available	TCGA-ZP-A9D1	447AC9E3-0533-461A-BC92-906A7B2180C3	Not Available	Not Available	1	A	Not Available	Not Available	Not Available	28	-20584	Not Applicable	0	21	Not Available																								0	NOT HISPANIC OR LATINO	0	8	8	5 - Nodular Formation and Incomplete Cirrhosis	TCGA-ZP-A9D1-F57746	7AFDEBEA-8140-4A0A-836F-07A6216C4B2D	28	Not Applicable	21	Not Available	NO	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	170	Hepatocellular Carcinoma	Non-Alcoholic Fatty Liver Disease	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.6	12.6	3	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Yes	A9D1	TUMOR FREE	Not Available	Not Available	Not Available	NO	NO	12	WHITE	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	ZP	Not Available	Liver	None	Unknown	Alive	130	2014	2012
TCGA-EP-A3JL	76	MALE	168	303	73	25.864512471655328	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G2	0	303			TUMOR FREE																					Not Available	76	3.2	4.1	4.8	TCGA-EP-A3JL	A196A937-B17D-4D4A-965B-8AF0F4F41367	0	0.6	Not Available	A	0.60	1.10	Not Available	19	-27886	Not Applicable	0	97	Not Available																								0	NOT HISPANIC OR LATINO	0	9	13	Not Available	TCGA-EP-A3JL-F37140	9F81BFF2-2A0F-475F-B4E7-313D76A77AEA	27	Not Applicable	303	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2012	MALE	168	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Laparoscopic Partial Hepatectomy in segment 4B and 5, Laproscopic Cholecystectomy, Ultrasound guided Radiofrequency Ablation of 4cm for a 2.2cm lesion between the Left pportal vein and middle hepatic vein	C22.0	8170/3	C22.0	YES	0.9	1.10	3	G2													Not Available	Yes	A3JL	TUMOR FREE	149	130	386	Not Available	Not Available	Not Available	WHITE	Not Available																			NO	Not Available	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	EP	1.2	Liver	None	Not Available	Alive	73	2012	2011
TCGA-CC-A7IL	61	MALE	174	278	63	20.808561236623067	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G1	1	179.0		Locoregional Recurrence	TUMOR FREE																					Not Available	61	Not Available	Not Available	Not Available	TCGA-CC-A7IL	B54DF65F-8A6B-4405-9918-90D53418804C	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	22	-22319	Not Applicable	0	0	Not Available																								2	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A7IL-F69706	2F46E732-9FB1-4E02-97C3-99EC6D6CFDC6	16	278	Not Available	Not Available	NO	1	NO	NO	Not Available	179	Not Available	Not Available	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2015	MALE	174	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7IL	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	63	2014	2013
TCGA-CC-5263	35	MALE	163	129	59	22.20633068613798	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G1	0	129			TUMOR FREE																					Not Available	35	Not Available	Not Available	Not Available	TCGA-CC-5263	a6af3061-1484-4f6c-bb4b-c8f4626b4161	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	18	-12863	129	0	Not Available	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-5263-F20328	4F8D0A6A-7108-4465-AFEF-511D3BF8AEEE	9	129	Not Available	Scheduled Follow-up Submission	Not Available	1													NO	TUMOR FREE	NO	NO	NO	Dead	2012	MALE	163	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Hepatic Resection	C22.0	8170/3	C22.0	YES	Not Available	Not Available	4	G1													Not Available	No	5263	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			NO	RX	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Dead	59	2011	2010
TCGA-G3-A25X	73	MALE	165	1779	65	23.875114784205692	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G3	0	1779			TUMOR FREE																					Mild	73	0.3	0.4	0.5	TCGA-G3-A25X	08428220-ABD4-484E-85CA-3673454C837E	0.0	1.1	Not Available	A	0.4	1.4	0.8	27	-26988	Not Applicable	0	1359	Not Available																								0	NOT HISPANIC OR LATINO	0	10	11	1,2 - Portal Fibrosis	TCGA-G3-A25X-F33634	760DCAB0-1B6D-4EB0-B802-4938BBA8157E	11	Not Applicable	1779	Scheduled Follow-up Submission	Not Available	7													NO	TUMOR FREE	NO	NO	NO	Alive	2012	MALE	165	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	7	G3													Not Available	No	A25X	TUMOR FREE	102	150	400	Not Available	Not Available	1.0	ASIAN	Not Available																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	G3	1.4	Liver	None	Not Available	Alive	65	2011	2007
TCGA-WQ-A9G7	71	FEMALE	157	30	69	27.99302202929125	Hepatocellular Carcinoma	Liver	Alive	T3a	NX	M0		G3	0	30			TUMOR FREE																					Unknown	71	3.5	3.5	5	TCGA-WQ-A9G7	491A3734-DCB8-4779-B098-0B5567F13F87	0.3	0.7	Not Available	Unknown	0.4	1	0.4	21	Not Available	Not Applicable	0	30	Not Available																								Unknown	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Unknown	TCGA-WQ-A9G7-F66632	9527E766-8635-415D-8A89-29EAB5706BAE	21	Not Applicable	30	Not Available	NO	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	157	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Partial hepatectomy	C22.0	8170/3	C22.0	YES	0.8	1.2	5	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9G7	TUMOR FREE	266	150	400	NO	NO	1.3	WHITE	NO																			NO	R0	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T3a	NO	YES	WQ	1.2	Liver	None	Unknown	Alive	69	2014	2013
TCGA-G3-A25Z	58	MALE	173	655	69	23.054562464499316	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	655			TUMOR FREE																					Mild	58	0.3	0.4	0.5	TCGA-G3-A25Z	2F3D22AD-6917-4189-89D9-2A06C2D2DE0A	0	0.9	1	A	0.6	1.4	1.1	27	-21509	Not Applicable	0	269	Not Available																								0	NOT HISPANIC OR LATINO	0	15	44	5 - Nodular Formation and Incomplete Cirrhosis	TCGA-G3-A25Z-F33635	64ED8CB9-9D62-45AA-9560-B4850A748E6B	11	Not Applicable	655	Scheduled Follow-up Submission	Not Available	7													NO	TUMOR FREE	NO	NO	NO	Alive	2012	MALE	173	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	7	G2													Not Available	No	A25Z	TUMOR FREE	115	150	400	Not Available	Not Available	1.0	ASIAN	Not Available																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	G3	1.4	Liver	None	Not Available	Alive	69	2011	2010
TCGA-DD-AACX	66	MALE	155	170	53	22.06035379812695	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G3	1	42.0	Other, specify	Extrahepatic Recurrence	WITH TUMOR																					Mild	66	3.8	4.2	5.3	TCGA-DD-AACX	431A72E1-EA03-4E40-89C4-2F02D454C897	0.2	0.5	Not Available	A	0.7	1.5	0.8	29	-24329	Not Applicable	0	170	Not Available																								1	NOT HISPANIC OR LATINO	0	8	3	3,4 - Fibrous Speta	TCGA-DD-AACX-F68381	67260B4F-32F4-49B9-B58F-6AC885DF67FB	17	Not Applicable	170	Not Available	NO	11	YES	NO	Not Available	42	Not Available	Other, specify	Extrahepatic Recurrence	lymph node	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	MALE	155	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	YES	NO	Not Available	42	Not Available	Other, specify	Extrahepatic Recurrence	lymph node	No	NO	No	Not Available	YES	No	AACX	WITH TUMOR	179	130	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.2	Liver	None	Unknown	Alive	53	2014	2010
TCGA-DD-AAE6	59	FEMALE	159	141	46	18.195482773624462	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	1	105.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					None	59	3.8	4.4	5.3	TCGA-DD-AAE6	A61F823B-9164-4BD6-92F4-0A8D8FF0F55E	0.2	0.9	Not Available	A	0.7	1.5	0.8	14	-21764	Not Applicable	0	141	Not Available																								0	NOT HISPANIC OR LATINO	0	8	113	6 - Established Cirrhosis	TCGA-DD-AAE6-F68416	5A7BA12C-C626-4220-AC7E-2A9911C316BB	17	Not Applicable	141	Not Available	NO	11	NO	NO	Not Available	105	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	FEMALE	159	Hepatocellular Carcinoma	Unknown	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G2	NO	NO	Not Available	105	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AAE6	WITH TUMOR	209	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	46	2014	2012
TCGA-UB-AA0U	60	MALE	178	327	93	29.352354500694357	Hepatocellular Carcinoma	Liver	Alive	T2	NX	MX	Stage II	G2	1	106.0	Liver	Intrahepatic Recurrence	WITH TUMOR		NO;YES	Radiofrequency Ablation	Not Applicable	326	1	3	TCGA-UB-AA0U-A63752;TCGA-UB-AA0U-A67167	77D7BFCB-AB00-4BE5-9602-0FFCA3FAF0BE;22C851AD-089C-49DA-8125-1D131A0ACF03	16;31	YES;NO	161;205;Not Available	Doxorubicin;Doxorubicin;Not Available	Not Applicable;Not Applicable;Not Applicable	Chemoembolization;Chemoembolization;Not Available	Other, specify;Other, specify;Not Available	Ethiodol;Ethiodol;Not Applicable	8;10	2014;2014		Mild	60	3.5	3.9	4.8	TCGA-UB-AA0U	AE8D4B34-D40A-482D-9D45-23242843DF00	0.2	0.7	2	A	0.7	1.2	0.6	16	-21985	Not Applicable	0	253	Not Available																								0	NOT HISPANIC OR LATINO	0	8	26	0 - No Fibrosis	TCGA-UB-AA0U-F67166	6C743EC2-C280-435C-B1C3-319361ADA9E7	31	Not Applicable	327	Not Available	NO	10	NO	YES	Not Available	106	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	178	Hepatocellular Carcinoma	Non-Alcoholic Fatty Liver Disease	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.2	8	G2	NO	NO	Not Available	106	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AA0U	WITH TUMOR	227	140	450	NO	NO	1.1	WHITE	NO																			YES	R1	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	YES	NO	UB	1.3	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Core Antibody	Alive	93	2014	2013
TCGA-RG-A7D4	69	MALE	172	1098	87	29.407787993510006	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	0	1098			TUMOR FREE																					Unknown	69	3	3	5	TCGA-RG-A7D4	08CBBB39-D05A-48B0-A966-5212C5923C8B	1	1	2	A	1	2	1	27	-25302	Not Applicable	0	734	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	9	5650	Unknown	TCGA-RG-A7D4-F71159	ECDBEA25-F657-4FDE-9E2A-227F340245EE	19	Not Applicable	1098	Not Available	NO	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2015	MALE	172	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1	2	6	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7D4	TUMOR FREE	175	150	400	NO	NO	1	BLACK OR AFRICAN AMERICAN	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	RG	2	Liver	Unknown	Hepatitis  C Antibody	Alive	87	2014	2012
TCGA-MI-A75I	61	MALE	188	630	100	28.293345405160707	Hepatocellular Carcinoma	Liver	Alive	T2	NX	MX		G1	1	265.0	Liver	Locoregional Recurrence	Unknown																					Not Available	61	Not Available	Not Available	Not Available	TCGA-MI-A75I	55E53229-C58F-4922-8869-0F5E2F6C2D7D	Not Available	Not Available	3	A	Not Available	Not Available	Not Available	20	-22341	Not Applicable	0	265	Not Available																								1	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-MI-A75I-F62897	A7FDB396-B85C-442F-8E48-8175A607D55A	28	Not Applicable	630	Not Available	NO	7	Unknown	Unknown	Not Available	265	Not Available	Liver	Not Available	Not Applicable	Unknown	Not Available	Not Available	Not Available	YES	Unknown	NO	NO	NO	Alive	2014	MALE	188	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	11	G1	Unknown	Unknown	Not Available	265	Not Available	Liver	Locoregional Recurrence	Not Applicable	Unknown	Unknown	No	Not Available	YES	No	A75I	Unknown	153	150	450	Unknown	Unknown	Not Available	BLACK OR AFRICAN AMERICAN	Unknown																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	NO	YES	MI	Not Available	Liver	Unknown	Unknown	Alive	100	2013	2011
TCGA-DD-AAVX	38	MALE	178	1718	65	20.515086478979928	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	1	393.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					Severe	38	3.3	3.9	5.2	TCGA-DD-AAVX	AFCB9708-92B3-4727-9C0D-63E7FF22D87B	0.2	1.1	2	A	0.7	1.4	1.0	13	-14016	Not Applicable	0	1718	Not Available																								0	NOT HISPANIC OR LATINO	0	15	1	6 - Established Cirrhosis	TCGA-DD-AAVX-F67583	BCD9679F-8241-407F-A83B-F6BBB080A016	30	Not Applicable	1570	Not Available	NO	12	YES;YES	NO;YES	Not Available;Not Available	393;393	Not Available;Not Available	Liver;Bone	Intrahepatic Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable	Yes;No	NO;NO	No;No	Not Available;Not Available	YES	WITH TUMOR	YES	YES	YES	Alive	2014	MALE	178	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	6	G2	NO	NO	Not Available	393	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AAVX	WITH TUMOR	186	130	400	NO	NO	1.0	ASIAN	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	65	2014	2008
TCGA-EP-A2KC	62	MALE	171	19	Not Available		Hepatocellular Carcinoma	Liver	Dead	T1	NX	MX	Stage I	G3	0	19			TUMOR FREE																					Not Available	62	3.6	3.1	4.8	TCGA-EP-A2KC	71681DB9-FA90-4FE1-A497-67D501EB75F0	Not Available	Not Available	Not Available	A	Not Available	Not Available	Not Available	5	-22677	19	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	Not Available	43	Not Available	TCGA-EP-A2KC-F17206	92057F4D-7789-45AA-8EE2-B72634A1973F	5	19	Not Available	Not Available	Not Available	10													NO	TUMOR FREE	NO	NO	NO	Dead	2011	MALE	171	Hepatocellular Carcinoma	Hepatitis C	Liver Cirrhosis, Moderate alcohol use on weekends	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	10	G3													Not Available	No	A2KC	TUMOR FREE	193	140	415	Not Available	Not Available	1.1	BLACK OR AFRICAN AMERICAN	Not Available																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	EP	Not Available	Liver	None	Not Available	Dead	Not Available	2011	2011
TCGA-DD-AADN	59	MALE	160	898	62	24.21875	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G4	0	898			TUMOR FREE																					Unknown	59	3.8	3.5	5.3	TCGA-DD-AADN	32E39C1D-B8E8-4EFE-B451-8EFB112D3518	0.2	1.1	Not Available	A	0.7	1.5	0.8	7	-21632	Not Applicable	0	527	Not Available																								0	NOT HISPANIC OR LATINO	0	8	151367	Unknown	TCGA-DD-AADN-F68400	1423C791-0530-4FBC-A7B1-F2D1092D16F3	17	Not Applicable	898	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	160	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AADN	TUMOR FREE	176	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	62	2014	2012
TCGA-DD-A4NV	61	MALE	179	2398	129	40.26091570175712	Hepatocellular Carcinoma	Liver	Alive	T3	N0	M0	Stage IIIA	G1	0	2398			TUMOR FREE																					None	61	3.5	3.9	5.0	TCGA-DD-A4NV	8E5CE60B-2EDA-482D-B109-210DF1321AFF	0.1	0.5	1	A	0.8	1.3	0.8	11	-22438	Not Applicable	0	2018	Not Available																								1	NOT HISPANIC OR LATINO	0	6	3	0 - No Fibrosis	TCGA-DD-A4NV-F49672;TCGA-DD-A4NV-F59879	11005FB2-2123-4D31-B39F-3E1DAB367DB9;F5CE02EC-9A4D-4024-A8AF-51FE5C6B10AC	7;22	Not Applicable;Not Applicable	2018;2398	Not Available;Not Available	NO;NO	10;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE	NO;NO	NO;NO	NO;NO	Alive;Alive	2013;2014	MALE	179	Hepatocellular Carcinoma	Non-Alcoholic Fatty Liver Disease;Other	morbid obesity, tobacco use	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	2	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A4NV	TUMOR FREE	240	150	450	NO	NO	9.0	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	129	2013	2007
TCGA-T1-A6J8	68	MALE	188	23	65	18.39067451335446	Hepatocellular Carcinoma	Liver	Alive	T1	NX	M0		G2	0	23			TUMOR FREE																					Not Available	68	Not Available	Not Available	Not Available	TCGA-T1-A6J8	59F163D2-6A7C-41B8-B4D6-F07174DAFC6E	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	-24853	Not Applicable	0	23	Not Available																								Unknown	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-T1-A6J8-F68334	AEAD5B2D-FB4A-46F4-8DD3-A1B5B93B5ABD	14	Not Applicable	23	Not Available	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Unknown	Unknown	Unknown	Alive	2014	MALE	188	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	11	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Yes	A6J8	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	WHITE	Unknown																			Unknown	RX	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1	NO	YES	T1	Not Available	Liver	None	Unknown	Alive	65	2014	2013
TCGA-DD-A4NK	80	FEMALE	Not Available	1210	84		Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G2	1	89.0	Liver	Intrahepatic Recurrence	WITH TUMOR		NO						TCGA-DD-A4NK-A43137	1C367DCC-24E5-449B-9392-4AC3076FAA2E	13	YES	917	Not Available	Not Applicable	Chemoembolization	Y-90 Therasphere	Not Applicable	5	2013		None	80	3.5	4.1	5.0	TCGA-DD-A4NK	5B8D04B2-EF40-4216-A3BB-42520EFBE863	0.1	0.5	3	A	0.7	1.2	1.1	5	-29244	1210	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	6	3	0 - No Fibrosis	TCGA-DD-A4NK-F49654	3B07113D-0015-423D-B1AF-4700EA72F6A0	7	1210	Not Available	Not Available	NO	10	NO	NO	Not Available	89	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	YES	NO	NO	Dead	2013	FEMALE	Not Available	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	2	G2	Not Available	Not Available	Not Available	89	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	Not Available	Not Available	Not Available	YES	No	A4NK	WITH TUMOR	372	150	450	YES	NO	8.7	WHITE	NO																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen	Dead	84	2013	2004
TCGA-CC-A7IJ	56	MALE	165	382	54	19.834710743801654	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G3	0	382			TUMOR FREE																					Not Available	56	Not Available	Not Available	Not Available	TCGA-CC-A7IJ	E610A644-0504-445A-BBA1-4BAE360DE4C1	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	22	-20751	Not Applicable	0	0	Not Available																								2	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A7IJ-F69704	3CD2840B-08D2-4DA9-AB68-3DE8F4491CE7	16	Not Applicable	382	Not Available	NO	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2015	MALE	165	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7IJ	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	54	2014	2013
TCGA-DD-AADR	58	MALE	170	2028	75	25.951557093425606	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	1	1700.0	Liver	Intrahepatic Recurrence	TUMOR FREE																					Mild	58	3.8	4.4	5.3	TCGA-DD-AADR	899D8EA5-49DC-4970-8848-EA6EA088A272	0.2	0.9	Not Available	A	0.7	1.5	1.0	7	-21217	Not Applicable	0	1742	Not Available																								0	NOT HISPANIC OR LATINO	0	8	3	6 - Established Cirrhosis	TCGA-DD-AADR-F68404	C4B8CFD0-F32A-46CD-B0C1-96EF0AB38C26	17	Not Applicable	2028	Not Available	NO	11	NO	NO	Not Available	2028	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	170	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	NO	NO	Not Available	1700	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	AADR	TUMOR FREE	75	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	75	2014	2009
TCGA-DD-A4NH	65	FEMALE	157	917	81	32.86137368655929	Hepatocellular Carcinoma	Liver	Alive	T3b	N0	M0	Stage IIIB	G3	1	161.0	Lung	Extrahepatic Recurrence	WITH TUMOR																					None	65	3.5	4.0	5.0	TCGA-DD-A4NH	4012EA90-5768-4ACC-AF3A-BA954F493DB4	0.1	0.6	1	A	0.6	1.1	0.8	29	-23865	Not Applicable	0	433	Not Available	TCGA-DD-A4NH-D43119	46FAF023-C8C4-42D9-9042-5DFA619DA676	Not Available	13	305	162	Sorafenib	Clinical Progressive Disease	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	NOT HISPANIC OR LATINO	0	6	92889	1,2 - Portal Fibrosis	TCGA-DD-A4NH-F49649;TCGA-DD-A4NH-F59474	AB79378E-6DC6-4F2B-A6F3-FF5F52C59424;9122BEBA-FE08-46D3-BD54-0EFD58463A47	7;13	Not Applicable;Not Applicable	690;917	Not Available;Not Available	NO;NO	10;5	YES;YES	NO;NO	Not Available;Not Available	161;161	Not Available;Not Available	Lung;Lung	Extrahepatic Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable	No;No	NO;NO	No;No	Not Available;Not Available	YES;YES	WITH TUMOR;WITH TUMOR	NO;NO	NO;NO	NO;NO	Alive;Alive	2013;2014	FEMALE	157	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.5	13.8	1	G3	YES	NO	Not Available	161	Not Available	Lung	Extrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	A4NH	WITH TUMOR	226	150	450	NO	NO	11.8	WHITE	NO																			YES	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3b	NO	YES	DD	1.0	Liver	Macro	Hepatitis B Surface Antigen	Alive	81	2013	2011
TCGA-BD-A2L6	69	MALE	168	1363	110	38.97392290249433	Hepatocellular Carcinoma	Liver	Alive	T2	NX	MX		G2	1	415.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					None	69	3.4	3.7	5.0	TCGA-BD-A2L6	13A97CEE-76B0-46A1-B728-D87B2248311E	0.3	0.9	Not Available	A	0.5	1.4	1.2	10	-25489	Not Applicable	0	289	Not Available																								1	Not Available	0	20	53	3,4 - Fibrous Speta	TCGA-BD-A2L6-F34562	7100607E-DF74-4EB4-BB49-0BFE00C91360	23	Not Applicable	1363	Not Available	NO	8	YES	NO	Not Available	415	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2012	MALE	168	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	2	G2													Not Available	No	A2L6	WITH TUMOR	222	156	369	Not Available	Not Available	1.0	WHITE	Not Available																			Not Available	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	YES	NO	BD	1.5	Liver	Micro	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	110	2012	2011
TCGA-G3-A3CG	80	MALE	168	673	93	32.95068027210884	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	1	329.0	Liver	Intrahepatic Recurrence	TUMOR FREE																					Severe	80	0.3	0.4	0.5	TCGA-G3-A3CG	8A14D153-BBF7-4512-A067-976EDFB65F91	0.3	0.3	Not Available	A	0.6	1.4	0.9	27	-29432	Not Applicable	0	254	Not Available	TCGA-G3-A3CG-D40229	97F4F766-A4E0-4356-BC34-568E8F1B07D7	Not Available	14	577	367	Sorafenib	Stable Disease	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Targeted Molecular therapy	Not Available	Not Available	Not Available	NO	2013	1	NOT HISPANIC OR LATINO	0	10	67	6 - Established Cirrhosis	TCGA-G3-A3CG-F40228	3C72C48E-6290-4837-8DF2-9B673EC74FAC	14	Not Applicable	673	Not Available	NO	2	YES	NO	Not Available	329	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2013	MALE	168	Hepatocellular Carcinoma	Hepatitis C	Not Available	Yes	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	1	G2													Not Available	Yes	A3CG	TUMOR FREE	131	150	400	Not Available	Not Available	1.1	WHITE	Not Available																			NO	R1	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	G3	1.4	Liver	Micro	Not Available	Alive	93	2012	2011
TCGA-RC-A6M3	24	MALE	175	0	Not Available		Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G3	0	0			Unknown																					Not Available	24	Not Available	Not Available	Not Available	TCGA-RC-A6M3	C6A74DB2-CF97-4C7B-BE8C-557EE27E1D43	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	-8899	Not Applicable	0	0	Not Available																								Not Available	Unknown	Not Available	Not Available	Not Available	Not Available																												MALE	175	Hepatocellular Carcinoma	Unknown	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	No	A6M3	Unknown	Not Available	Not Available	Not Available	NO	Unknown	Not Available	AMERICAN INDIAN OR ALASKA NATIVE	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	RC	Not Available	Liver	Micro	Not Available	Alive	Not Available	2015	2009
TCGA-DD-AACB	74	FEMALE	156	2324	72	29.585798816568047	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	2324			TUMOR FREE																					Mild	74	3.8	4.1	5.3	TCGA-DD-AACB	6D2E8BC2-CA86-41C1-AE49-289E20FCE758	0.2	0.8	Not Available	A	0.7	1.5	1.1	28	-27103	Not Applicable	0	1800	Not Available																								0	NOT HISPANIC OR LATINO	0	8	1902	6 - Established Cirrhosis	TCGA-DD-AACB-F68365	5437BA00-7E54-4436-B301-73586AA43592	17	Not Applicable	2324	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	156	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AACB	TUMOR FREE	179	130	400	NO	NO	0.8	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	72	2014	2008
TCGA-BC-A10Y	76	MALE	175	711	77	25.142857142857142	Hepatocellular Carcinoma	Liver	Dead	T4	NX	MX		G3	1	400.0		Intrahepatic Recurrence	WITH TUMOR		YES	Radiofrequency Ablation	Not Applicable	0	2	1	TCGA-BC-A10Y-A13752	7B52CE23-0D78-4CD7-BE6D-BD49B670EBE2	4	YES	420;470;527	Other;Other;Other	Doxorubicin and Mitomycin C;Doxorubicin and Mitomycin C;Doxorubicin and Mitomycin C	Chemoembolization;Chemoembolization;Chemoembolization	Other, specify;Other, specify;Other, specify	Embosphere/gelfoam;Embosphere/gelfoam;spherical PVA/gelfoam	4	2011		None	76	3.5	4.0	5.0	TCGA-BC-A10Y	6533648f-1353-4253-b65b-d472aacf5751	0.0	0.5	Not Available	Not Available	0.9	1.4	1.0	31	-28049	711	0	Not Available	Not Available																								Not Available	NOT HISPANIC OR LATINO	0	10	10575	Not Available	TCGA-BC-A10Y-F9955;TCGA-BC-A10Y-F9958	EE8054A8-D08C-4CA8-BF70-7527D15F836E;C7790B92-F814-4F48-8753-3C1F7DDCE58F	4;4	711;711	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	4;4	None;NO	None;NO	None;Not Available	None;400	None;Not Available	None;Not Available	None;Intrahepatic Recurrence	None;Not Applicable	None;Yes	None;NO	None;No	None;Not Available	Not Available;YES	WITH TUMOR;WITH TUMOR	YES;YES	NO;NO	NO;NO	Dead;Dead	2011;2011	MALE	175	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G3													Not Available	No	A10Y	WITH TUMOR	239	150	440	Not Available	Not Available	1.0	WHITE	Not Available																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T4	NO	YES	BC	1.2	Liver	Micro	Not Available	Dead	77	2011	2002
TCGA-CC-A9FW	68	MALE	175	248	67	21.877551020408163	Hepatocellular Carcinoma	Liver	Alive	T3	N0	M0	Stage IIIA	G2	1	153.0		Locoregional Recurrence	TUMOR FREE																					Not Available	68	Not Available	Not Available	Not Available	TCGA-CC-A9FW	027322F0-D720-41F8-897C-A10E5C1424C5	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	22	-24891	Not Applicable	0	0	Not Available																								3	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A9FW-F69912	D43EA494-E75D-497A-80EF-1EEBC67128BE	22	Not Applicable	248	Not Available	NO	1	NO	NO	Not Available	153	Not Available	Not Available	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2015	MALE	175	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9FW	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	67	2014	2013
TCGA-DD-A1EL	23	MALE	182	415	54	16.302378939741576	Hepatocellular Carcinoma	Liver	Dead	T2	N0	M0	Stage II	G3	1		Liver	Intrahepatic Recurrence	WITH TUMOR		NO						TCGA-DD-A1EL-A42231	6CA54E88-D6C5-4F67-B456-159E16441697	15	YES	165	Not Available	Not Applicable	Chemoembolization	Other, specify	PVA particles	4	2013		Mild	23	3.5	4.4	5.0	TCGA-DD-A1EL	2854ffe8-1f77-497a-bf49-11e0189fee35	0.1	0.5	Not Available	A	0.8	1.3	1.0	16	-8573	415	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	6	5	0 - No Fibrosis	TCGA-DD-A1EL-F42229	307DC566-5815-4352-96AB-67938D531924	15	415	Not Available	Not Available	NO	4	NO	NO	Not Available	Discrepancy	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	YES	NO	NO	Dead	2013	MALE	182	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	10.8	5	G3													Not Available	No	A1EL	WITH TUMOR	153	150	450	Not Available	Not Available	10.8	BLACK OR AFRICAN AMERICAN	Not Available																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody;HBV DNA	Dead	54	2011	2009
TCGA-DD-AAEE	55	MALE	160	810	58	22.65625	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G4	1	224.0	Liver	Intrahepatic Recurrence	WITH TUMOR		NO						TCGA-DD-AAEE-A68428	824D8AAC-0C3D-40A8-8091-A0704D0DC6DC	3	YES	383;502;551	Other;Other;Other	adriamycin;adriamycin;adriamycin	Chemoembolization;Chemoembolization;Chemoembolization	Gelfoam;Gelfoam;Gelfoam	Not Applicable;Not Applicable;Not Applicable	11	2014		None	55	3.8	4.7	5.3	TCGA-DD-AAEE	3C51FEE0-DA54-40E9-A954-DFE30F6F075C	0.2	0.8	Not Available	A	0.7	1.5	0.9	18	-20396	Not Applicable	0	498	Not Available																								0	NOT HISPANIC OR LATINO	0	8	3	6 - Established Cirrhosis	TCGA-DD-AAEE-F68427	2A9EE485-30AC-497E-B631-E5EB8B8BDA3D	17	Not Applicable	810	Not Available	NO	11	NO;NO	NO;YES	298;Not Available	224;224	Not Available;Not Available	Liver;Bone	Intrahepatic Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable	Yes;No	YES;NO	No;No	RX;Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	MALE	160	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G4	NO;NO	NO;YES	298;Not Available	224;224	Not Available;Not Available	Liver;Bone	Intrahepatic Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable	Yes;No	YES;NO	No;No	RX;Not Available	YES	No	AAEE	WITH TUMOR	221	130	400	NO	NO	1.0	ASIAN	NO	Distant Recurrence	TCGA-DD-AAEE-R68429	F6970A06-9B74-4957-9847-E8385B837BE3	Not Available	17	692	595	Unknown	11	2	14000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	58	2014	2012
TCGA-BC-A10W	50	MALE	Not Available	91	71		Hepatocellular Carcinoma	Liver	Dead	T4	NX	MX		G3	1				WITH TUMOR																					Not Available	50	3.5	2.8	5.0	TCGA-BC-A10W	39baf24a-4032-4c23-b3fe-2c50df1881f6	0.0	1.4	1	Not Available	0.8	1.4	0.8	31	-18562	91	0	Not Available	Not Available	TCGA-BC-A10W-D10105	2234B152-15AA-4827-A697-FDAD95FD6285	Not Available	7	85	82	Not Available	Not Available	4	1	Not Available	Not Available	ADJUVANT	Not Applicable	1	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	79	Not Available	TCGA-BC-A10W-F9925	DFF9929C-73A0-48E4-BE05-674DE1169CFD	4	91	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No New Tumor Event	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	WITH TUMOR	NO	YES	NO	Dead	2011	MALE	Not Available	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G3													Not Available	No	A10W	WITH TUMOR	401	150	440	Not Available	Not Available	0.9	ASIAN	Not Available																			YES	R1	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T4	NO	YES	BC	1.2	Liver	Not Available	Hepatitis B Surface Antigen	Dead	71	2011	2002
TCGA-CC-A8HU	39	FEMALE	163	344	42	15.807896420640596	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G3	1	301.0		Locoregional Recurrence	TUMOR FREE																					Not Available	39	Not Available	Not Available	Not Available	TCGA-CC-A8HU	1943FF2C-CA53-4E3C-ACC1-5AE84F4BA230	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	22	-14367	Not Applicable	0	0	Not Available																								3	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A8HU-F69708	4806E024-8A37-42C5-A3F6-83CB186BAC46	16	344	Not Available	Not Available	NO	1	NO	NO	Not Available	301	Not Available	Not Available	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2015	FEMALE	163	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A8HU	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	42	2014	2013
TCGA-RC-A7SK	59	MALE	169	472	60	21.007667798746542	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	1	312.0	Liver	Intrahepatic Recurrence	TUMOR FREE																					None	59	3.1	4.3	5.2	TCGA-RC-A7SK	ACFD58EB-C546-49C3-A846-684F22428219	0.1	0.6	Not Available	A	0.3	1.20	1	21	-21814	Not Applicable	0	472	Not Available																								0	NOT HISPANIC OR LATINO	0	20	25	1,2 - Portal Fibrosis																												MALE	169	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.30	7	G3	NO	NO	Not Available	312	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	A7SK	TUMOR FREE	138000	150000	400000	NO	NO	1	ASIAN	NO																			Unknown	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	YES	NO	RC	1.3	Liver	Micro	Not Available	Alive	60	2014	2013
TCGA-CC-5258	48	MALE	Not Available	129	55		Hepatocellular Carcinoma	Liver	Dead	T2	N0	M0	Stage II	G2	0	129			TUMOR FREE																					Not Available	48	Not Available	Not Available	Not Available	TCGA-CC-5258	6a93206a-c25c-4e45-b0ba-0a21bd8253b6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	15	-17586	Not Applicable	0	0	Not Available																								3	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-5258-F20327	4CF203F0-49DD-4F68-A2E2-57151703B3AC	9	129	Not Available	Scheduled Follow-up Submission	Not Available	1													NO	TUMOR FREE	NO	NO	NO	Dead	2012	MALE	Not Available	Hepatocellular Carcinoma	Not Available	Not Available	No	Hepatic Resection (right)	C22.0	8170/3	C22.0	YES	Not Available	Not Available	4	G2													Not Available	No	5258	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			NO	RX	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	CC	Not Available	Liver	None	Hepatitis  C Antibody;HBV Surface Antibody	Alive	55	2011	2010
TCGA-UB-A7MF	56	MALE	195	214	95	24.983563445101908	Hepatocellular Carcinoma	Liver	Dead	T3a	NX	MX	Stage IIIA	G2	1	133.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					Unknown	56	3.5	3.6	4.8	TCGA-UB-A7MF	8EEF926B-F316-4FDB-B84A-262010258FEB	0.2	1.1	1	A	0.7	1.2	0.9	16	-20815	214	0	Not Available	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	8	2505	6 - Established Cirrhosis																												MALE	195	Hepatocellular Carcinoma	Hepatitis B;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.2	8	G2	NO	NO	Not Available	133	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	Yes	A7MF	WITH TUMOR	130	140	450	NO	NO	1.0	WHITE	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3a	YES	NO	UB	1.3	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Core Antibody;HBV DNA	Dead	95	2014	2013
TCGA-DD-AACL	66	FEMALE	150	107	69	30.666666666666668	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G3	0	107			Unknown																					Unknown	66	3.8	3.3	5.3	TCGA-DD-AACL	3DA3CFEC-5464-4DD8-9757-A0CDFE3536F8	0.2	0.7	Not Available	A	0.7	1.5	1.0	29	-24355	Not Applicable	0	58	Not Available																								1	NOT HISPANIC OR LATINO	0	8	1368	Unknown	TCGA-DD-AACL-F68370	DDC6F1BE-4920-42A4-9EAB-45DDCC991F75	17	107	Not Available	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	NO	NO	NO	Dead	2014	FEMALE	150	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	No	AACL	Unknown	99	130	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	69	2014	2008
TCGA-BC-A10T	76	MALE	Not Available	837	86		Hepatocellular Carcinoma	Liver	Dead	T4	NX	MX		G1	1	598.0	Pulmonary	Extrahepatic Recurrence	WITH TUMOR																					Not Available	76	Not Available	3.0	Not Available	TCGA-BC-A10T	8a9cde9a-c38c-423e-bc14-354ee26468c9	Not Available	0.7	Not Available	Not Available	Not Available	Not Available	1.2	23	-27944	837	0	Not Available	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	1,2 - Portal Fibrosis	TCGA-BC-A10T-F9882	CE05DEED-067F-44DD-B929-EA2968614815	1	837	Not Available	Not Available	Not Available	4	NO	NO	Not Available	598	Not Available	Pulmonary	Extrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2011	MALE	Not Available	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	R hepatic lobectomy w/ resection of L segment	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G1													Not Available	No	A10T	WITH TUMOR	450000	150	440	Not Available	Not Available	1.1	WHITE	Not Available																			NO	R1	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T4	NO	YES	BC	Not Available	Liver	None	Not Available	Dead	86	2011	2000
TCGA-DD-AACE	62	MALE	162	2184	62	23.62444749276025	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	1	1279.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					Mild	62	3.8	4.4	5.3	TCGA-DD-AACE	ABBCF6BD-4683-45AC-947A-51AE6EF0A244	0.2	0.9	Not Available	A	0.7	1.5	1.2	28	-22727	Not Applicable	0	1931	Not Available																								0	NOT HISPANIC OR LATINO	0	8	2	6 - Established Cirrhosis	TCGA-DD-AACE-F68366	5CD068FD-2D86-42B9-9B45-F3FE2A75EC9A	30	Not Applicable	2184	Not Available	NO	12	NO	NO	Not Available	1279	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	TUMOR FREE	Discrepancy	NO	NO	Alive	2014	MALE	162	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	NO	NO	Not Available	1279	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AACE	WITH TUMOR	175	130	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	62	2014	2008
TCGA-BC-A110	51	FEMALE	155	2116	91	37.87721123829344	Hepatocellular Carcinoma	Liver	Dead	T1	NX	MX		G1	1	2057.0	Other, specify	Extrahepatic Recurrence	WITH TUMOR																					Not Available	51	3.5	3.7	5.0	TCGA-BC-A110	cf028bce-d20d-42b8-8507-1ec94a391e85	0.0	0.3	2	Not Available	0.7	1.1	3.5	1	-18951	2116	0	Not Available	Not Available																								Not Available	NOT HISPANIC OR LATINO	0	10	Not Available	Not Available	TCGA-BC-A110-F9979	3A7218B7-6E57-4E9E-8905-C34485B9461F	4	2116	Not Available	Not Available	Not Available	4	NO	NO	Not Available	2057	Not Available	Other, specify	Extrahepatic Recurrence	spleen	No	NO	No	Not Available	YES	WITH TUMOR	NO	YES	NO	Dead	2011	FEMALE	155	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	4	G1													Not Available	Yes	A110	WITH TUMOR	288	150	440	Not Available	Not Available	0.9	BLACK OR AFRICAN AMERICAN	Not Available																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	BC	1.2	Liver	None	Not Available	Dead	91	2011	2003
TCGA-ED-A7PY	20	FEMALE	156	390	40	16.43655489809336	Hepatocellular Carcinoma	Liver	Alive	T2	NX	M0	Stage II	G3	0	390			TUMOR FREE		YES	Ethanol Injection;Ethanol Injection;Ethanol Injection	Not Applicable;Not Applicable;Not Applicable	20;53;82	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	TCGA-ED-A7PY-A64278	867D2F96-7949-4978-8BF0-0176298728EF	28	NO	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	8	2014		Mild	20	Not Available	Not Available	Not Available	TCGA-ED-A7PY	A396E048-5AA0-4D71-96BD-7F4FDF6934AA	0.1	0.6	Not Available	Unknown	4.0	5.8	3.9	7	-7556	Not Applicable	0	6	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	20	2	Not Available	TCGA-ED-A7PY-F62651	179AF171-BB74-4E36-94BD-CF78404AEBE3	23	Not Applicable	390	Not Available	NO	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	YES	NO	NO	Alive	2014	FEMALE	156	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.3	1.3	1	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7PY	TUMOR FREE	282	150	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2	YES	NO	ED	1.3	Liver	Micro	Hepatitis B Surface Antigen	Alive	40	2014	2013
TCGA-DD-A4NR	85	FEMALE	64	9	54	131.8359375	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G3	0	9			Unknown																					Unknown	85	3.5	3.1	5.0	TCGA-DD-A4NR	52A7F734-DA07-49C5-861D-C70DA37FF959	0.1	0.8	1	A	0.7	1.2	1.0	11	-31386	9	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	6	40250	6 - Established Cirrhosis	TCGA-DD-A4NR-F49670	08BD39FD-EC68-4463-BA07-501E827F5A14	7	9	Not Available	Not Available	NO	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Dead	2013	FEMALE	64	Hepatocellular Carcinoma	Other	primary biliary cirrhosis	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	2	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A4NR	Unknown	239	150	450	NO	NO	9.3	WHITE	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Dead	54	2013	2005
TCGA-BC-A8YO	66	FEMALE	170	562	74	25.60553633217993	Hepatocellular Carcinoma	Liver	Alive	T4	N0	M0	Stage IIIC	G3	1	220.0	Liver	Locoregional Recurrence	WITH TUMOR																					None	66	3.5	4.3	5.0	TCGA-BC-A8YO	F53A70D9-A774-4969-896E-2DCDD4D02A7A	0.0	0.3	3	Unknown	0.6	1.0	0.8	10	-24189	Not Applicable	0	227	Not Available	TCGA-BC-A8YO-D57375	B8B6D701-E9E5-44C2-9D90-692659730A0A	Not Available	10	186	54	Nexavar	Partial Response	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Unknown	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Unknown	TCGA-BC-A8YO-F70635	6F05AE56-1310-43AC-8B34-40752A94CFC7	26	Not Applicable	562	Not Available	NO	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	YES	WITH TUMOR	NO	YES	NO	Alive	2015	FEMALE	170	Hepatocellular Carcinoma	Alcohol consumption;Other	Chronic hepatitis, either viral or autoimmune	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G3	Not Available	Not Available	Not Available	220	Not Available	Liver	Locoregional Recurrence	Not Applicable	Not Available	Not Available	No	Not Available	YES	No	A8YO	WITH TUMOR	441000	150000	440000	NO	YES	1.0	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4	YES	NO	BC	1.2	Liver	Macro	Not Available	Alive	74	2014	2013
TCGA-DD-AADU	60	MALE	166	554	73	26.49150820148062	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G3	0	554			TUMOR FREE																					None	60	3.8	4.3	5.3	TCGA-DD-AADU	CF358FB8-866C-4780-A550-D6C1C30B8C63	0.2	1.8	Not Available	A	0.7	1.5	0.8	14	-21940	Not Applicable	0	252	Not Available																								0	NOT HISPANIC OR LATINO	0	8	52	3,4 - Fibrous Speta	TCGA-DD-AADU-F68406	4E0DAF1D-F01D-4C87-ACA6-D1EE2C3B01A2	17	Not Applicable	554	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	166	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AADU	TUMOR FREE	223	130	400	NO	NO	1.0	ASIAN	NO																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	73	2014	2013
TCGA-BC-A10Z	62	FEMALE	Not Available	34	79		Hepatocellular Carcinoma	Liver	Dead	T1	N0	MX	Stage I	G2	0	34			TUMOR FREE																					None	62	3.5	3.1	5.0	TCGA-BC-A10Z	709f1e4d-f5e8-4a0b-8254-23f037f4bae7	0.0	0.6	1	Not Available	0.7	1.1	1.2	1	-22913	34	0	Not Available	Not Available																								Not Available	NOT HISPANIC OR LATINO	0	10	779	Not Available	TCGA-BC-A10Z-F9962	D5A4C022-45D6-4F96-BE1E-2BD1D7DDE1AC	4	34	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No New Tumor Event	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Dead	2011	FEMALE	Not Available	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	4	G2													Not Available	No	A10Z	TUMOR FREE	260	150	440	Not Available	Not Available	0.9	WHITE	Not Available																			YES	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	NO	YES	BC	1.2	Liver	None	Unknown	Dead	79	2011	2003
TCGA-DD-AACK	70	MALE	172	9	68	22.98539751216874	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	9			TUMOR FREE																					None	70	3.8	4.6	5.3	TCGA-DD-AACK	D7CD045A-0BE2-4B6D-AEFD-5D75E57BC6F6	0.2	0.9	Not Available	A	0.7	1.5	1.3	15	-25796	Not Applicable	0	9	Not Available																								2	NOT HISPANIC OR LATINO	0	8	5	6 - Established Cirrhosis	TCGA-DD-AACK-F68369	DE4295DC-7303-4BB1-94DC-23749B83A5C4	17	Not Applicable	9	Not Available	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	Unknown	Unknown	Unknown	Alive	2014	MALE	172	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AACK	TUMOR FREE	98	130	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	68	2014	2008
TCGA-DD-AAEK	51	MALE	169	1067	64	22.408178985329645	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G3	0	1067			TUMOR FREE																					None	51	3.8	4.1	5.3	TCGA-DD-AAEK	6EA0EF82-694D-492D-95DA-A3BC8DE99149	0.2	1.0	Not Available	A	0.7	1.5	0.7	15	-18757	Not Applicable	0	1067	Not Available																								0	NOT HISPANIC OR LATINO	0	8	5166	6 - Established Cirrhosis	TCGA-DD-AAEK-F68434	21288B18-1DDC-4368-867A-028AED3E53F7	17	Not Applicable	1067	Not Available	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Unknown	NO	NO	NO	Alive	2014	MALE	169	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAEK	TUMOR FREE	202	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.2	Liver	None	Unknown	Alive	64	2014	2010
TCGA-DD-AAW3	69	MALE	162	1633	64	24.386526444139612	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	1633			TUMOR FREE																					None	69	3.3	4.1	5.2	TCGA-DD-AAW3	564B4F4D-3C18-40D5-9D95-916774DF600C	0.2	0.6	1	Not Available	0.0	1.4	1.0	13	-25254	Not Applicable	0	1451	Not Available																								0	NOT HISPANIC OR LATINO	0	15	3	0 - No Fibrosis	TCGA-DD-AAW3-F67593	90D2EC6B-1B72-43EB-8AA1-D62CB19CC869	6	Not Applicable	1633	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	162	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	6	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAW3	TUMOR FREE	241	130	400	NO	NO	Not Available	ASIAN	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	64	2014	2009
TCGA-2Y-A9GZ	82	FEMALE	153	848	51	21.78649237472767	Hepatocellular Carcinoma	Liver	Dead	T2	NX	MX	Stage II	G2	1	719.0	Liver	Locoregional Recurrence	WITH TUMOR																					None	82	3.5	4.5	5	TCGA-2Y-A9GZ	0E8C3831-DEF9-4EFA-9F93-8942072D6A77	0.2	0.7	4	A	0.8	1.5	1.1	3	-30082	848	0	Not Available	Not Available	TCGA-2Y-A9GZ-D66953	858BC16D-D48D-46AE-8C07-FBD8A5DF9D01	Not Available	3	842	719	Naxavar	Unknown	11	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Unknown	NOT HISPANIC OR LATINO	0	7	7	Unknown																												FEMALE	153	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G2	YES	NO	Not Available	719	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	A9GZ	WITH TUMOR	318	143	382	NO	YES	9.9	WHITE	NO																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	NO	YES	2Y	1.3	Liver	Unknown	Hepatitis  C Antibody;HBV Core Antibody	Dead	51	2014	2007
TCGA-DD-A73F	77	FEMALE	164	1085	69	25.65437239738251	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G1	0	1085			TUMOR FREE																					None	77	3.5	4.6	5.0	TCGA-DD-A73F	870C86E7-D6E1-4F9D-BB0B-BD1C66D6BCDE	0.1	0.5	1	A	0.6	1.1	1.0	30	-28234	Not Applicable	0	843	Not Available																								1	NOT HISPANIC OR LATINO	0	6	283	0 - No Fibrosis	TCGA-DD-A73F-F66599;TCGA-DD-A73F-F71152	2A3085AF-9EEA-40EA-88A2-6486BD8E1740;83CD7205-69C2-4149-BC55-1EE28B6EA079	21;18	Not Applicable;Not Applicable	1085;1085	Not Available;Not Available	NO;YES	10;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;Unknown	TUMOR FREE;Not Available	NO;Unknown	NO;Unknown	NO;Unknown	Alive;Alive	2014;2015	FEMALE	164	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.5	13.8	9	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A73F	TUMOR FREE	243	150	450	NO	NO	10.9	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Unknown	Alive	69	2013	2010
TCGA-DD-AACS	39	MALE	172	1804	80	27.041644131963224	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	1804			TUMOR FREE																					Unknown	39	3.8	4.3	5.3	TCGA-DD-AACS	82D6268A-DE59-4A14-ABD2-7492178FA5BD	0.2	1.0	Not Available	A	0.7	1.5	1.1	29	-14473	Not Applicable	0	1475	Not Available																								0	NOT HISPANIC OR LATINO	0	8	1	Unknown	TCGA-DD-AACS-F68376	DD36E59D-5E09-4B52-B472-BFB0FD9166E6	17	Not Applicable	1804	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	172	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AACS	TUMOR FREE	223	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	80	2014	2009
TCGA-ED-A66Y	51	FEMALE	160	296	59	23.046875	Hepatocellular Carcinoma	Liver	Dead	T3a	N0	M0	Stage IIIA	G3	0	296			TUMOR FREE																					Mild	51	3.8	6	5.1	TCGA-ED-A66Y	34303CDD-C31C-4B95-9965-2A5513DC322D	0.1	1	Not Available	Unknown	4.1	5.9	4.4	3	-18797	Not Applicable	0	7	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	20	12100	Not Available	TCGA-ED-A66Y-F56839	93D0CCCE-6B24-4723-9D0A-1044968CE3FB	24	296	Not Available	Not Available	NO	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	NO	NO	NO	Dead	2014	FEMALE	160	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.3	1.3	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A66Y	TUMOR FREE	289	150	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3a	YES	NO	ED	1.3	Liver	Micro	Hepatitis B Surface Antigen	Alive	59	2013	2013
TCGA-G3-A3CJ	52	MALE	174	594	72	23.781212841854934	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	1	296.0	Lung	Extrahepatic Recurrence	TUMOR FREE																					Severe	52	0.3	0.4	0.5	TCGA-G3-A3CJ	CB8F3C76-DA86-4A1D-977C-44AB399B342A	0	1.0	Not Available	A	0.5	1.4	0.8	17	-19305	Not Applicable	0	136	Not Available	TCGA-G3-A3CJ-D40237	2579D68E-1CDC-4AB5-8F3B-E366F68B5152	Not Available	14	367	346	Sorafenib	Clinical Progressive Disease	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Targeted Molecular therapy	Not Available	Not Available	Not Available	NO	2013	0	NOT HISPANIC OR LATINO	0	10	3	5 - Nodular Formation and Incomplete Cirrhosis	TCGA-G3-A3CJ-F40234	ACE37AC4-FA90-4FAA-80CD-DB0ABAAA35C0	14	Not Applicable	594	Not Available	NO	2	YES;YES	NO;YES	Not Available;Not Available	296;296	Not Available;Not Available	Lung;Bone	Extrahepatic Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable	No;No	NO;NO	No;No	Not Available;Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2013	MALE	174	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	1	G2													Not Available	No	A3CJ	TUMOR FREE	185	150	400	Not Available	Not Available	1.0	AMERICAN INDIAN OR ALASKA NATIVE	Not Available	Distant site	TCGA-G3-A3CJ-R40238	12767A64-5DF8-480E-A1D5-54FDFE1F1EDD	Not Available	14	Not Available	559	Not Applicable	2	Not Available	Not Available	YES	External	Not Applicable	Not Available	Not Available	Not Available	2013	NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	G3	1.4	Liver	Micro	Not Available	Alive	72	2012	2011
TCGA-2Y-A9H2	64	FEMALE	176	1731	55	17.755681818181817	Hepatocellular Carcinoma	Liver	Alive	T1	N0	MX	Stage I	G3	0	1731			TUMOR FREE																					None	64	3.5	4.5	5	TCGA-2Y-A9H2	CF7F0473-EAF3-4259-A68E-475A782FC84C	0.2	0.4	Not Available	Unknown	0.8	1.5	1.4	3	-23653	Not Applicable	0	1582	Not Available																								0	NOT HISPANIC OR LATINO	0	7	2	Unknown	TCGA-2Y-A9H2-F69173	6B216173-3374-4246-9636-5FAA0C0B1683	30	Not Applicable	1731	Not Available	NO	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	176	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9H2	TUMOR FREE	386	143	382	NO	NO	10.8	WHITE	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	NO	YES	2Y	1.3	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Core Antibody	Alive	55	2014	2010
TCGA-ED-A7PZ	61	MALE	159	6	50	19.77769866698311	Hepatocellular Carcinoma	Liver	Alive	T2	NX	M0	Stage II	G2	0	6			TUMOR FREE																					Mild	61	3.8	4.2	5.1	TCGA-ED-A7PZ	87750E70-3AF7-452A-9AA5-375ACD3843EA	0.1	0.9	Not Available	Unknown	4.0	5.8	7.0	7	-22601	Not Applicable	0	6	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	20	2	Not Available	TCGA-ED-A7PZ-F62652	159B662E-4A38-4712-AF7F-DF219D242D9B	30	Not Applicable	Not Available	Not Available	YES	9													Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2014	MALE	159	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.3	1.3	1	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7PZ	TUMOR FREE	289	150	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2	YES	NO	ED	1.3	Liver	Micro	Hepatitis B Surface Antigen	Alive	50	2014	2013
TCGA-DD-AACI	69	MALE	155	1618	48	19.979188345473464	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G3	1	1432.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					Mild	69	3.8	3.6	5.3	TCGA-DD-AACI	E6FA354E-ADA7-41E0-8C8B-38520A5E6601	0.2	0.5	Not Available	A	0.7	1.5	1.0	28	-25236	Not Applicable	0	1618	Not Available																								1	NOT HISPANIC OR LATINO	0	8	1	5 - Nodular Formation and Incomplete Cirrhosis	TCGA-DD-AACI-F68367	9FF3066C-E605-445F-ADE2-3C0E8A050511	17	Not Applicable	1618	Not Available	NO	11	NO	NO	Not Available	1432	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	MALE	155	Hepatocellular Carcinoma	Unknown	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	NO	NO	Not Available	1432	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	AACI	WITH TUMOR	106	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.2	Liver	None	Unknown	Alive	48	2014	2008
TCGA-DD-A116	68	MALE	175	1622	73	23.836734693877553	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G3	1	828.0	Other, specify	Extrahepatic Recurrence	TUMOR FREE																					Not Available	68	3.5	4.1	5.0	TCGA-DD-A116	994347ba-3045-4ade-926f-06420fbd906c	0.1	1.1	0	A	0.8	1.4	1.1	29	-24934	1622	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	6	24	3,4 - Fibrous Speta	TCGA-DD-A116-F38781	01D5AC9B-C9B0-4E53-81ED-A6D15C578596	21	1622	Not Available	Not Available	NO	12	NO	YES	1023	828	Not Available	Other, specify	Extrahepatic Recurrence	sternum	No	YES	No	R0	YES	Unknown	NO	NO	YES	Dead	2012	MALE	175	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	12	G3													Not Available	No	A116	TUMOR FREE	157	150	450	Not Available	Not Available	1.0	ASIAN	Not Available	Regional site	TCGA-DD-A116-R43737	4D4874E2-723B-4C89-9D42-AFEB0D026AAC	Not Available	2	755	755	Radiographic Progressive Disease	6	1	5500	NO	Systemic	Not Applicable	Not Available	Not Available	cGy	2013	NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	DD	1.0	Liver	Not Available	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Dead	73	2010	2002
TCGA-DD-AAEG	59	FEMALE	149	719	40	18.017206432142697	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	719			TUMOR FREE																					None	59	3.8	3.0	5.3	TCGA-DD-AAEG	BD627786-31A8-46D9-B3E2-7F489D50F608	0.2	0.6	Not Available	A	0.7	1.5	0.6	15	-21853	Not Applicable	0	476	Not Available																								0	NOT HISPANIC OR LATINO	0	8	1	6 - Established Cirrhosis	TCGA-DD-AAEG-F68430	6F4227E6-BD6F-4F25-9855-02C80D5934E4	17	Not Applicable	719	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	149	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Yes	AAEG	TUMOR FREE	69	130	400	NO	NO	1.3	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	40	2014	2012
TCGA-DD-A114	42	MALE	173	1149	74	24.725182932941294	Hepatocellular Carcinoma	Liver	Dead	T2		M0	Stage II	G3	0	1149			Not Available																					Mild	42	3.5	3.5	5.0	TCGA-DD-A114	02931491-f56b-4233-a079-812e08bc0c59	0.1	2.5	Not Available	A	0.9	1.4	1.2	29	-15410	1149	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	6	21	5 - Nodular Formation and Incomplete Cirrhosis	TCGA-DD-A114-F38779	DCA31E33-F1CB-4598-A63E-9AE8C8BDCD62	21	1149	Not Available	Not Available	NO	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Dead	2012	MALE	173	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.2	12	G3													Not Available	No	A114	Not Available	185	150	450	Not Available	Not Available	1.0	BLACK OR AFRICAN AMERICAN	Not Available																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	Not Available	T2	NO	YES	DD	1.0	Liver	Micro	Hepatitis C Virus RNA;HCV Genotype;Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Dead	74	2010	2005
TCGA-ZS-A9CF	64	MALE	Not Available	2412	Not Available		Hepatocellular Carcinoma	Liver	Alive	T2	NX	MX	Stage II	G2	1	636.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					None	64	36	51	50	TCGA-ZS-A9CF	7FE5E2D9-C514-47BC-8387-3F940F7A822D	0	19	Not Available	Unknown	62	106	89	1	-23510	Not Applicable	0	2258	Not Available																								0	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	0 - No Fibrosis	TCGA-ZS-A9CF-F68445	18FD980A-9AE2-4BE1-9C2C-A8C27CE468C5	18	Not Applicable	2412	Not Available	NO	11	NO	NO	700	636	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	YES	No	RX	YES	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	Not Available	Hepatocellular Carcinoma	Hemochromatosis	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9	12	5	G2	NO	NO	700	636	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	YES	No	RX	YES	No	A9CF	WITH TUMOR	259	150	400	NO	NO	10.2	WHITE	NO																			Unknown	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	NO	YES	ZS	17	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	Not Available	2014	2008
TCGA-RC-A6M6	75	MALE	Not Available	9	Not Available		Hepatocellular Carcinoma	Liver	Alive	T2	NX	M0	Stage II	G3	0	9			Unknown																					Not Available	75	3.5	2.8	4.8	TCGA-RC-A6M6	A62F065E-7491-493A-87B3-D213CD87091D	0.2	2.3	Not Available	B	0.8	1.3	0.8	9	-27649	Not Applicable	0	9	Not Available																								Not Available	NOT HISPANIC OR LATINO	0	44	12986	Not Available																												MALE	Not Available	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.2	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	No	A6M6	Unknown	235000	150000	400000	NO	Unknown	1.3	WHITE	Unknown																			Unknown	R1	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2	NO	YES	RC	1.3	Liver	None	Not Available	Alive	Not Available	2015	2011
TCGA-5R-AA1C	57	MALE	174	520	90	29.72651605231867	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	0	520			TUMOR FREE																					None	57	3.2	3.0	4.6	TCGA-5R-AA1C	290890EB-321C-45DC-9CD1-45676C6E5E96	0	1.8	Not Available	B	0.5	1.3	1.0	14	-21073	Not Applicable	0	63	Not Available																								1	NOT HISPANIC OR LATINO	0	15	2	1,2 - Portal Fibrosis	TCGA-5R-AA1C-F68309;TCGA-5R-AA1C-F72055	D321735C-BA0F-4FF9-84AD-AFFEC06248AA;4617D528-C984-4971-A6B3-F54E515F554F	14;6	Not Applicable;Not Applicable	364;520	Not Available;Not Available	NO;NO	11;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;Unknown	NO;NO	NO;NO	NO;NO	Alive;Alive	2014;2015	MALE	174	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	11	15	11	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AA1C	TUMOR FREE	223000	150000	450000	NO	NO	18	WHITE	NO																			NO	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	5R	1.2	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	90	2014	2013
TCGA-CC-5262	67	MALE	170	103	62	21.453287197231834	Hepatocellular Carcinoma	Liver	Dead	T4	N0	M0	Stage IIIC	G1	0	103			TUMOR FREE																					Not Available	67	Not Available	Not Available	Not Available	TCGA-CC-5262	1b428ada-eb3f-40c2-b4bf-1bbf6b61729d	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	-24787	Not Applicable	0	0	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-5262-F20334	D35836E4-6F7B-42D5-808C-68F97FD9C549	9	103	Not Available	Scheduled Follow-up Submission	Not Available	1													NO	TUMOR FREE	NO	NO	NO	Dead	2012	MALE	170	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Hepatic Resection	C22.0	8170/3	C22.0	YES	Not Available	Not Available	6	G1													Not Available	No	5262	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			NO	Not Available	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4	YES	NO	CC	Not Available	Liver	Not Available	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	62	2011	2010
TCGA-DD-AACO	40	MALE	164	1876	43	15.98750743604997	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	1	479.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					Mild	40	3.8	3.7	5.3	TCGA-DD-AACO	34413807-07BE-4204-B095-5E1DD1ED87DC	0.2	0.6	Not Available	A	0.7	1.5	1.4	29	-14796	Not Applicable	0	1485	Not Available																								0	NOT HISPANIC OR LATINO	0	9	5	6 - Established Cirrhosis	TCGA-DD-AACO-F68373	D95C7449-122B-4F6E-8E43-9A84FA14E6A5	17	Not Applicable	1876	Not Available	NO	11	NO	NO	Not Available	479	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	MALE	164	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	NO	NO	Not Available	479	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	AACO	WITH TUMOR	88	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	43	2014	2009
TCGA-ZP-A9CY	66	FEMALE	152	782	83	35.924515235457065	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX		G1	0	782			TUMOR FREE																					Mild	66	3.5	3.9	5.2	TCGA-ZP-A9CY	34FD27CE-930A-4F29-8A6E-DAE4949D92EB	0.2	0.9	1	A	Not Available	Not Available	Not Available	28	-24223	Not Applicable	0	782	Not Available																								1	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	6 - Established Cirrhosis	TCGA-ZP-A9CY-F57752	C5AEB5CB-B0E6-4272-96EC-869137784990	28	Not Applicable	782	Not Available	NO	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	152	Hepatocellular Carcinoma	Non-Alcoholic Fatty Liver Disease	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.6	12.6	3	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9CY	TUMOR FREE	93000	163000	369000	NO	NO	11	WHITE	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	ZP	1.2	Liver	None	Unknown	Alive	83	2014	2011
TCGA-ZP-A9D4	64	FEMALE	155	395	55	22.892819979188346	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX		G1	0	395			TUMOR FREE																					Mild	64	3.5	4.3	5.2	TCGA-ZP-A9D4	4244912D-8527-410C-A084-A56C55EB1F82	0.2	0.4	Not Available	A	0.5	1.1	0.6	28	-23656	Not Applicable	0	395	Not Available																								0	NOT HISPANIC OR LATINO	0	8	2	0 - No Fibrosis	TCGA-ZP-A9D4-F57750	843F963C-B2B8-4895-95AE-EB00092EB118	28	Not Applicable	395	Not Available	NO	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	155	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9D4	TUMOR FREE	292000	163000	369000	NO	NO	Not Available	WHITE	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	ZP	1.2	Liver	None	Unknown	Alive	55	2014	2012
TCGA-ZS-A9CE	79	FEMALE	Not Available	1241	Not Available		Hepatocellular Carcinoma	Liver	Alive	T2	NX	MX	Stage II	G1	1	892.0	Other, specify	New Primary Tumor	Unknown																					None	79	36	44	50	TCGA-ZS-A9CE	7BDC5F86-4D7D-4F1F-BC23-AB51FA9FB947	0	5	Not Available	A	44	80	78	30	-29051	Not Applicable	0	1066	Not Available																								0	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	0 - No Fibrosis	TCGA-ZS-A9CE-F68444	740B3E4A-10D4-452B-8930-41BAF579F2BC	18	Not Applicable	1241	Not Available	NO	11	NO	NO	892	892	Not Available	Other, specify	New Primary Tumor	Right Temple	No	YES	No	R0	YES	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	Not Available	Hepatocellular Carcinoma	Unknown	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9	12	4	G1	NO	NO	892	892	Not Available	Other, specify	New Primary Tumor	Right temple	No	YES	No	R0	YES	Yes	A9CE	Unknown	310	150	400	NO	NO	36.4	WHITE	NO																			Unknown	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	NO	YES	ZS	15	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	Not Available	2014	2011
TCGA-DD-AAVS	56	MALE	169	1823	72	25.20920135849585	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	1823			TUMOR FREE																					Mild	56	3.3	3.0	5.2	TCGA-DD-AAVS	9FC30C21-2C78-4843-A658-FE84A64B8FAD	0.2	1.0	Not Available	A	0	1.4	1.0	13	-20586	Not Applicable	0	1823	Not Available																								1	NOT HISPANIC OR LATINO	0	15	50149	3,4 - Fibrous Speta	TCGA-DD-AAVS-F67576	47A718BE-2D98-4C9E-974C-1DEDDD810F0C	6	Not Applicable	1823	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	169	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	6	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAVS	TUMOR FREE	281	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	72	2014	2007
TCGA-XR-A8TC	43	FEMALE	155	1339	52	21.644120707596255	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G2	1				WITH TUMOR																					Mild	43	3.5	3.9	4.8	TCGA-XR-A8TC	4DB9DE75-9297-46E5-ACC5-9275F52A642A	0.2	0.2	Not Available	A	0.7	1.5	0.7	20	-15817	Not Applicable	0	1339	Not Available																								0	HISPANIC OR LATINO	6	6	47	6 - Established Cirrhosis	TCGA-XR-A8TC-F72317	13D95172-1742-45F3-A508-E1A05C213FB5	20	Not Applicable	1339	Not Available	NO	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	WITH TUMOR	YES	NO	NO	Alive	2015	FEMALE	155	Hepatocellular Carcinoma	Hepatitis B	Not Available	Yes	Not Applicable	C22.0	8170/3	C22.0	YES	1.3	1.3	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Yes	A8TC	WITH TUMOR	318000	150000	450000	YES	NO	1.0	WHITE	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	XR	1.2	Liver	None	Not Available	Alive	52	2015	2011
TCGA-DD-A39W	29	FEMALE	177	827	74	23.620287912158066	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage III	G2	0	827			Not Available																					Not Available	29	Not Available	Not Available	Not Available	TCGA-DD-A39W	48D33449-B969-423A-B4E7-541809109617	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	-10699	827	0	Not Available	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-DD-A39W-F42705	BD24B76F-33CC-4657-B6A1-01A82DCCC156	8	827	Not Available	Not Available	NO	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	Unknown	Unknown	Unknown	Dead	2013	FEMALE	177	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	1	G2													Not Available	No	A39W	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage III	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	DD	Not Available	Liver	None	Unknown	Dead	74	2012	1995
TCGA-BC-A69H	64	MALE	173	444	70	23.38868655818771	Hepatocellular Carcinoma	Liver	Alive	T2	NX	M0	Stage II	G3	0	444			TUMOR FREE																					None	64	3.6	4.3	4.8	TCGA-BC-A69H	79DF037C-7D37-4E6C-A654-57708A4F87AA	0.0	0.4	Not Available	A	0.8	1.3	0.8	18	-23380	Not Applicable	0	120	Not Available																								1	NOT HISPANIC OR LATINO	0	Not Available	103900	Not Available	TCGA-BC-A69H-F59404	9F638109-2F93-4056-8FD8-373F89A86E0C	12	Not Applicable	444	Not Available	NO	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	173	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.1	12.0	6	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A69H	TUMOR FREE	194000	140000	440000	NO	NO	10.7	WHITE	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2	YES	NO	BC	1.2	Liver	Micro	Not Available	Alive	70	2013	2013
TCGA-DD-A4NA	67	FEMALE	166	1008	93	33.74945565394106	Hepatocellular Carcinoma	Liver	Alive	T2	N1	M0	Stage IIIC	G3	0	1008			TUMOR FREE																					None	67	Not Available	Not Available	Not Available	TCGA-DD-A4NA	BEE9D6C8-948F-4B76-97CA-B985064249EF	Not Available	Not Available	2	Unknown	0.6	1.1	0.8	21	-24603	Not Applicable	0	1008	Not Available																								0	NOT HISPANIC OR LATINO	0	6	3	5 - Nodular Formation and Incomplete Cirrhosis	TCGA-DD-A4NA-F49640	7A528F0A-12F2-413B-99E5-BCDEF8D66562	7	Not Applicable	1008	Not Available	YES	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2013	FEMALE	166	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	10.8	12	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A4NA	TUMOR FREE	332	150	450	Unknown	Unknown	9.6	WHITE	Unknown																			YES	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	NO	YES	DD	Not Available	Liver	Not Available	Hepatitis B Surface Antigen;HBV Surface Antibody	Alive	93	2012	2009
TCGA-MI-A75E	61	MALE	175	507	103	33.63265306122449	Hepatocellular Carcinoma	Liver	Alive	T4	N0	M0	Stage IIIC	G2	0	507			TUMOR FREE																					Not Available	61	3.5	3.0	4.9	TCGA-MI-A75E	010D5817-9A3F-4A06-8643-653116C044FF	0.2	1.1	1	A	0.6	1.3	Not Available	19	-22457	Not Applicable	0	155	Not Available																								1	NOT HISPANIC OR LATINO	0	9	5	1,2 - Portal Fibrosis	TCGA-MI-A75E-F62895	5711E872-2337-467D-AFBB-922115802C46	28	Not Applicable	507	Not Available	NO	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	175	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	11	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A75E	TUMOR FREE	158	150	450	NO	NO	Not Available	WHITE	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4	NO	YES	MI	1.2	Liver	Micro	HCV Genotype	Alive	103	2013	2013
TCGA-DD-AAVZ	38	MALE	171	1900	62	21.203105228959338	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	1900			TUMOR FREE																					None	38	3.3	3.8	5.2	TCGA-DD-AAVZ	11F69D9F-A67D-41FA-95A9-BAA194B3FCFB	0.2	1.0	1	A	0.7	1.4	1.2	13	-14005	Not Applicable	0	1699	Not Available																								0	NOT HISPANIC OR LATINO	0	15	945	6 - Established Cirrhosis	TCGA-DD-AAVZ-F67588	5F5B673A-177D-4A10-BF3A-27C3CA39CB11	6	Not Applicable	1900	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	171	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	6	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAVZ	TUMOR FREE	98	130	400	NO	NO	1.2	ASIAN	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	62	2014	2009
TCGA-G3-A5SL	70	MALE	180	621	88	27.160493827160494	Hepatocellular Carcinoma	Liver	Alive	T2	NX	M0	Stage II	G2	0	621			TUMOR FREE																					None	70	3.1	4.2	4.7	TCGA-G3-A5SL	9A56D8A8-DADD-442E-BC09-732CD619AEF7	0	0.8	Not Available	Unknown	0.6	1.4	1	15	-25671	Not Applicable	0	243	Not Available																								0	NOT HISPANIC OR LATINO	0	10	4	0 - No Fibrosis	TCGA-G3-A5SL-F62747	171BE770-D995-4E6C-B3EB-C2F07D3E26E0	24	Not Applicable	621	Not Available	NO	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	180	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Right Hepatectomy Cholecystectomy	C22.0	8170/3	C22.0	YES	0.9	1.3	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A5SL	TUMOR FREE	295	150	400	NO	NO	1	WHITE	NO																			NO	R0	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2	YES	NO	G3	1.40	Liver	Micro	Not Available	Alive	88	2013	2012
TCGA-ED-A7XP	53	FEMALE	157	400	54	21.907582457706194	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G3	1	187.0	Liver	Locoregional Recurrence	TUMOR FREE		YES	Ethanol Injection	Not Applicable	193	3	Not Available	TCGA-ED-A7XP-A65356	DC5CC86A-6960-47BF-9A87-B47CD01EC180	22	NO	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	9	2014		Mild	53	3.8	6.9	5.1	TCGA-ED-A7XP	CCA827CA-0066-497D-83DC-477F3B08EA6D	0.1	0.1	Not Available	Unknown	4.1	5.9	4.8	5	-19504	Not Applicable	0	6	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	20	18	Not Available	TCGA-ED-A7XP-F65353	AAFBABFB-C294-463D-AEDC-DA3212EB9795	22	Not Applicable	400	Not Available	NO	9	NO	NO	Not Available	187	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	Unknown	Unknown	NO	Alive	2014	FEMALE	157	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.3	1.3	12	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7XP	TUMOR FREE	108	150	400	NO	NO	1	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	ED	1.3	Liver	Micro	Hepatitis B Surface Antigen	Alive	54	2013	2013
TCGA-EP-A2KB	46	FEMALE	165	596	81	29.75206611570248	Hepatocellular Carcinoma	Liver	Dead	T1	NX	MX	Stage I	G2	1	161.0	Liver	Locoregional Recurrence	TUMOR FREE		NO						TCGA-EP-A2KB-A33377	950DA764-8CFA-48C1-8ADC-A39018424BE9	28	YES	334	Doxorubicin	Not Applicable	Chemoembolization	Other, specify	Micron Microspheres	6	2012		Not Available	46	3.8	3.8	5.1	TCGA-EP-A2KB	18C08546-BED3-4ED9-B223-479AFE633C8E	0.2	1.4	Not Available	A	Not Available	1.0	Not Available	26	-16835	Not Applicable	0	60	Not Available																								1	NOT HISPANIC OR LATINO	0	9	2128	Not Available	TCGA-EP-A2KB-F33135;TCGA-EP-A2KB-F41390	B6FD7C06-6322-48AC-B5CB-012003D05B3E;B141D7BD-ECA2-459F-A234-BD284B194C04	21;18	Not Applicable;596	334;Not Available	Scheduled Follow-up Submission;Not Available	Not Available;NO	6;3	NO;NO	NO;NO	Not Available;Not Available	161;161	Not Available;Not Available	Liver;Liver	Intrahepatic Recurrence;Locoregional Recurrence	Not Applicable;Not Applicable	Yes;Yes	NO;NO	No;No	Not Available;Not Available	YES;YES	WITH TUMOR;WITH TUMOR	NO;NO	NO;NO	NO;NO	Alive;Dead	2012;2013	FEMALE	165	Hepatocellular Carcinoma	Hepatitis C	Cirrhosis, Alcohol abuse	No	Right Hepatectomy (Segment 6)	C22.0	8170/3	C22.0	YES	Not Available	Not Available	9	G2													Not Available	No	A2KB	TUMOR FREE	133	140	415	Not Available	Not Available	1.4	WHITE	Not Available																			NO	R0	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	EP	1.0	Liver	None	Not Available	Alive	81	2011	2011
TCGA-DD-A4NI	67	MALE	172	816	99	33.46403461330449	Hepatocellular Carcinoma	Liver	Alive	T2	NX	M0	Stage II	G2	0	816			TUMOR FREE																					Unknown	67	3.5	4.4	5.0	TCGA-DD-A4NI	518AA9CC-71CF-4734-9D55-B435DA99D300	0.1	0.6	6	A	0.8	1.3	1.1	29	-24516	Not Applicable	0	328	Not Available																								0	NOT HISPANIC OR LATINO	0	6	6	0 - No Fibrosis	TCGA-DD-A4NI-F49650;TCGA-DD-A4NI-F59476	B2385095-16B5-453E-9FA2-8C8BADB46F91;C8B81494-E953-4665-AC7A-A1E744B51ED8	7;13	Not Applicable;Not Applicable	561;816	Not Available;Not Available	NO;YES	10;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE	NO;NO	NO;NO	NO;NO	Alive;Alive	2013;2014	MALE	172	Hepatocellular Carcinoma	Alcohol consumption;Non-Alcoholic Fatty Liver Disease	tobacco	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.5	13.8	1	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Yes	A4NI	TUMOR FREE	187	150	450	NO	NO	12.4	WHITE	NO																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	99	2013	2011
TCGA-CC-A9FV	57	MALE	165	0	59	21.6712580348944	Hepatocellular Carcinoma	Liver	Alive	T3	N0	M0	Stage IIIA	G2	0	0			TUMOR FREE																					Not Available	57	Not Available	Not Available	Not Available	TCGA-CC-A9FV	C4E6527A-8F58-4F6B-93B1-04ABB5680ED0	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	22	-21044	Not Applicable	0	0	Not Available																								Unknown	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available																												MALE	165	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9FV	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	59	2014	2013
TCGA-WQ-AB4B	62	MALE	175	395	122	39.83673469387755	Hepatocellular Carcinoma	Liver	Alive	T2	NX	M0	Stage II	G2	1	273.0		Intrahepatic Recurrence	TUMOR FREE																					Not Available	62	3.5	3.3	5	TCGA-WQ-AB4B	D5471A2B-F14C-44DE-9142-5A5FB07B6FC2	0.3	1.7	Not Available	A	0.4	1.2	1.1	18	-22769	Not Applicable	0	122	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	15	5	Not Available	TCGA-WQ-AB4B-F66633	E6953DE1-6DD3-4BBE-A231-CCD1B9162E32	21	Not Applicable	395	Not Available	NO	10	NO	NO	Not Available	273	Not Available	Not Available	Intrahepatic Recurrence	Not Applicable	No	Not Available	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	MALE	175	Hepatocellular Carcinoma	Alcohol consumption;Non-Alcoholic Fatty Liver Disease;Other	Hepatic Encephalopathy	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	6	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AB4B	TUMOR FREE	Not Available	Not Available	Not Available	NO	NO	1.3	WHITE	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2	NO	YES	WQ	1.2	Liver	Micro	Unknown	Alive	122	2014	2013
TCGA-G3-AAV1	51	MALE	181	359	99	30.218857788223804	Hepatocellular Carcinoma	Liver	Dead	T4	N0	M0	Stage IIIC	G3	1	49.0	Liver	Locoregional Recurrence	WITH TUMOR		NO						TCGA-G3-AAV1-A62195	5D3B3242-0A08-41DA-BE37-6C1E9D3BE0AE	14	YES	75;231	Doxorubicin;Not Available	Not Applicable;Not Applicable	Chemoembolization;Radioembolization	Gelfoam;Y-90 Therasphere	Not Applicable;Not Applicable	7	2014		Severe	51	3.3	3.2	4.8	TCGA-G3-AAV1	EE6D81BF-0470-4652-AFF0-D85F6AB67626	0	0.7	Not Available	B	0.6	1.4	0.7	14	-18973	359	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	10	8	6 - Established Cirrhosis	TCGA-G3-AAV1-F65936	A6E14844-331A-473A-A0C8-D0BE38686E18	1	359	Not Available	Not Available	NO	10	NO;NO;NO;NO	NO;NO;NO;NO	Not Available;Not Available;Not Available;Not Available	49;49;98;239	Not Available;Not Available;Not Available;Not Available	Liver;Liver;Liver;Liver	Locoregional Recurrence;Intrahepatic Recurrence;Intrahepatic Recurrence;Intrahepatic Recurrence	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Yes;Yes;Yes;Yes	NO;NO;NO;NO	No;No;No;No	Not Available;Not Available;Not Available;Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2014	MALE	181	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	7	G3	NO;NO;NO;NO	NO;NO;NO;NO	Not Available;Not Available;Not Available;Not Available	49;49;98;239	Not Available;Not Available;Not Available;Not Available	Liver;Liver;Liver;Liver	Locoregional Recurrence;Intrahepatic Recurrence;Intrahepatic Recurrence;Intrahepatic Recurrence	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Yes;Yes;Yes;Yes	NO;NO;NO;NO	No;No;No;No	Not Available;Not Available;Not Available;Not Available	YES	No	AAV1	WITH TUMOR	115	150	400	NO	NO	1.2	ASIAN	NO																			Unknown	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4	YES	NO	G3	1.4	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Surface Antibody;HBV DNA	Dead	99	2014	2013
TCGA-CC-A3MC	54	MALE	163	363	52	19.57168128269788	Hepatocellular Carcinoma	Liver	Alive	T3	N0	M0	Stage IIIA	G2	1	297.0	Liver	Locoregional Recurrence	TUMOR FREE																					Not Available	54	Not Available	Not Available	Not Available	TCGA-CC-A3MC	0277F393-3743-47D6-A96F-155BAEC9EB49	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	-20067	Not Applicable	0	4	Not Available																								3	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A3MC-F70912	21CD825B-9E19-49CB-945E-B463832650CD	10	Not Applicable	363	Not Available	NO	3	NO	NO	Not Available	297	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2015	MALE	163	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G2													Not Available	No	A3MC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	Not Available	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	52	2012	2011
TCGA-G3-AAUZ	48	MALE	160	480	77	30.078125	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	480			TUMOR FREE																					Severe	48	3.3	3.8	4.8	TCGA-G3-AAUZ	D74DDBE2-5860-40B1-9BD8-99CC50F3392D	0	0.3	Not Available	A	0.6	1.4	0.8	14	-17760	Not Applicable	0	342	Not Available																								0	HISPANIC OR LATINO	0	10	3	1,2 - Portal Fibrosis	TCGA-G3-AAUZ-F67244	B54FFF1B-E90C-4B00-AC6A-70B868D99FEF	3	Not Applicable	480	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	160	Hepatocellular Carcinoma	Hepatitis B;Non-Alcoholic Fatty Liver Disease	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAUZ	TUMOR FREE	214	150	400	NO	NO	1	Unknown	NO																			Unknown	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	YES	NO	G3	1.4	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Surface Antibody;HBV DNA	Alive	77	2014	2013
TCGA-DD-AACM	48	MALE	177	1769	68	21.705129432793896	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G3	1	1097.0	Lung	Extrahepatic Recurrence	WITH TUMOR																					Mild	48	3.8	4.2	5.3	TCGA-DD-AACM	173088ED-6BC0-4CCF-80E7-C647028CCCD6	0.2	1.6	Not Available	A	0.7	1.5	1.2	29	-17590	Not Applicable	0	1769	Not Available																								0	NOT HISPANIC OR LATINO	0	8	2	3,4 - Fibrous Speta	TCGA-DD-AACM-F68371	4567DFE4-6E86-4B3F-8AB1-0B6EAFA8E29E	17	Not Applicable	1769	Not Available	NO	11	NO	NO	1126	1097	Not Available	Lung	Extrahepatic Recurrence	Not Applicable	No	YES	No	R0	YES	WITH TUMOR	NO	NO	NO	Alive	2014	MALE	177	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	NO	NO	1126	1097	Not Available	Lung	Extrahepatic Recurrence	Not Applicable	No	YES	No	R0	YES	No	AACM	WITH TUMOR	113	130	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.2	Liver	None	Unknown	Alive	68	2014	2009
TCGA-DD-A11D	57	FEMALE	163	1560	73	27.47562949301818	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G2	1	498.0	Liver	Intrahepatic Recurrence	WITH TUMOR		NO						TCGA-DD-A11D-A43743	1BD30F5B-B70D-4E68-8C90-E6658939E2A4	2	YES	1506	Other	Y90 Theraspheres	Radioembolization	Y-90 Therasphere	Not Applicable	6	2013		None	57	3.5	4.5	5.0	TCGA-DD-A11D	0ef95351-0133-4f34-a59c-90934fb161f8	0.1	0.5	2	A	0.6	1.1	1.1	29	-21003	1560	0	Not Available	Not Available	TCGA-DD-A11D-D43740;TCGA-DD-A11D-D43741;TCGA-DD-A11D-D43742	2DB8D5F3-1FDA-4725-86C3-2549F8DD8D73;4BBDB795-AA63-453D-88B3-677EB922902E;D511991F-BE5E-4BF0-BD66-6448564DE07C	Not Available;Not Available;Not Available	2;2;2	641;1105;1474	586;709;1408	Sorafenib;ABT-888 and temozolomide;Temozolomide	Clinical Progressive Disease;Partial Response;Stable Disease	6;6;6	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;YES;NO	2013;2013;2013	1	NOT HISPANIC OR LATINO	0	6	8	6 - Established Cirrhosis	TCGA-DD-A11D-F38787	52047B14-703B-43D5-BA06-2FA783E14E20	21	1560	Not Available	Not Available	NO	12	YES;YES;YES	NO;NO;NO	Not Available;Not Available;Not Available	498;498;498	Not Available;Not Available;Not Available	Liver;Other, specify;Lung	Intrahepatic Recurrence;Extrahepatic Recurrence;Extrahepatic Recurrence	Not Applicable;anterior abdominal wall;Not Applicable	Yes;No;Yes	NO;NO;NO	No;No;No	Not Available;Not Available;Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2012	FEMALE	163	Hepatocellular Carcinoma	Non-Alcoholic Fatty Liver Disease	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.2	12	G2													Not Available	No	A11D	WITH TUMOR	249	150	450	Not Available	Not Available	0.9	WHITE	Not Available																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Unknown	Dead	73	2010	2006
TCGA-DD-AACF	68	MALE	168	365	60	21.258503401360546	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G3	1	119.0	Liver	Locoregional Recurrence	WITH TUMOR																					Mild	68	3.8	3.5	5.3	TCGA-DD-AACF	635AAD0B-9C47-4564-821F-C00DDB280D53	0.2	0.5	Not Available	A	0.7	1.5	1.1	28	-25172	365	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	8	16	6 - Established Cirrhosis																												MALE	168	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	NO	NO	Not Available	119	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AACF	WITH TUMOR	99	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Dead	60	2014	2008
TCGA-BD-A3EP	75	FEMALE	168	409	71	25.155895691609977	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	409			TUMOR FREE																					Mild	75	3.4	3.8	5.0	TCGA-BD-A3EP	DE302B98-250D-42FE-9945-11E1B2BBD3C6	0.3	0.6	0	A	0.5	1.4	1.1	21	-27756	Not Applicable	0	409	Not Available																								1	NOT HISPANIC OR LATINO	0	20	17	1,2 - Portal Fibrosis	TCGA-BD-A3EP-F68680	57BB3CF4-9602-4E0D-B75A-8FB7C4E4FAD6	10	Not Applicable	409	Not Available	YES	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	168	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	3	G2													Not Available	No	A3EP	TUMOR FREE	333	156	369	Not Available	Not Available	1.0	BLACK OR AFRICAN AMERICAN	Not Available																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	YES	NO	BD	1.5	Liver	None	Not Available	Alive	71	2012	2010
TCGA-ED-A4XI	58	MALE	170	819	55	19.031141868512112	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G3	0	819			TUMOR FREE																					None	58	3.8	2.9	5.1	TCGA-ED-A4XI	C52ABAC9-07DA-4B3D-BF8A-2161CACF9682	0.1	1.3	Not Available	Unknown	4.1	5.9	54	22	-21497	Not Applicable	0	6	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	20	573	Not Available	TCGA-ED-A4XI-F49352;TCGA-ED-A4XI-F68085	528AB9BE-1822-426E-8270-DC7086676CFB;85C4313F-62B7-414E-A215-C9C7B597F514	7;13	Not Applicable;Not Applicable	386;819	Not Available;Not Available	NO;NO	10;11	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE	NO;NO	Unknown;NO	NO;NO	Alive;Alive	2013;2014	MALE	170	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.3	1.3	3	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A4XI	TUMOR FREE	276	150	400	NO	Unknown	0.9	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	ED	1.3	Liver	Micro	Hepatitis B Surface Antigen	Alive	55	2013	2012
TCGA-DD-A11A	67	MALE	156	79	67	27.531229454306377	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	79			Not Available																					None	67	Not Available	Not Available	Not Available	TCGA-DD-A11A	609c82fd-eb3a-46d7-8c09-0cde281a50b3	0.1	3.6	Not Available	Not Available	0.9	1.4	1.1	29	-24646	Not Applicable	0	79	Not Available																								0	NOT HISPANIC OR LATINO	0	6	223	0 - No Fibrosis	TCGA-DD-A11A-F38784	B2EE0E18-7BB7-499A-8924-D97A6C24850E	21	Not Applicable	79	Not Available	YES	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	Unknown	Unknown	Unknown	Not Available	2012	MALE	156	Hepatocellular Carcinoma	Other	HBcAB total (+), HBsAg (-), HBcIgm Ab (-)	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	12	G3													Not Available	No	A11A	Not Available	513	150	450	Not Available	Not Available	1.0	BLACK OR AFRICAN AMERICAN	Not Available																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Core Antibody	Alive	67	2010	2004
TCGA-QA-A7B7	48	MALE	180	94	108	33.333333333333336	Hepatocellular Carcinoma	Liver	Alive	T2	NX	MX	Stage II	G2	1	88.0	Liver	Locoregional Recurrence	TUMOR FREE																					Mild	48	3.5	4.2	4.8	TCGA-QA-A7B7	B0952FD6-62EE-44EF-9A2A-E5262ED4721A	0.3	1.0	Not Available	A	0.7	1.2	1	23	-17636	Not Applicable	0	62	Not Available																								1	NOT HISPANIC OR LATINO	0	8	1751	0 - No Fibrosis	TCGA-QA-A7B7-F65031	8E4D0410-E042-4138-97DE-E79AC66A6BC7	30	Not Applicable	94	Not Available	NO	10	Unknown;Unknown	NO;NO	Not Available;Not Available	88;88	Not Available;Not Available	Liver;Liver	Locoregional Recurrence;Intrahepatic Recurrence	Not Applicable;Not Applicable	No;No	NO;NO	No;No	Not Available;Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	MALE	180	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	LIVER AND DIAPHRAGM, RIGHT LOBE, PARTIAL HEPATECTOMY	C22.0	8170/3	C22.0	YES	10.4	13.1	12	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7B7	TUMOR FREE	218	150	400	NO	NO	11.5	BLACK OR AFRICAN AMERICAN	NO																			NO	RX	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	YES	NO	QA	1.2	Liver	Micro	Unknown	Alive	108	2013	2013
TCGA-DD-AADL	58	MALE	159	636	53	20.964360587002098	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G4	0	636			TUMOR FREE																					Unknown	58	3.8	3.5	5.3	TCGA-DD-AADL	A7F7E313-4636-4C54-B2B7-F5928A8368E4	0.2	0.5	2	A	0.7	1.5	0.5	7	-21512	Not Applicable	0	636	Not Available																								0	NOT HISPANIC OR LATINO	0	8	14	Unknown	TCGA-DD-AADL-F68398	BD8161ED-CF15-4F78-83CF-BD03A2D95A90	17	Not Applicable	636	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	159	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AADL	TUMOR FREE	204	130	400	NO	NO	0.9	ASIAN	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	53	2014	2012
TCGA-2Y-A9H6	68	FEMALE	156	357	99	40.680473372781066	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G2	0	357			Unknown																					None	68	3.5	4	5	TCGA-2Y-A9H6	BC3502BC-BBF6-44F2-A1F4-D1567819AEFB	0.3	0.3	1	Unknown	0.8	1.5	1.8	3	-24982	Not Applicable	0	357	Not Available																								0	NOT HISPANIC OR LATINO	0	7	114	Unknown	TCGA-2Y-A9H6-F69088	3761694C-88B1-42BD-B2B5-3FF86FC9641D	29	Not Applicable	357	Not Available	YES	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	Unknown	Unknown	Unknown	Alive	2014	FEMALE	156	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Yes	A9H6	Unknown	224	143	382	NO	NO	10.5	WHITE	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	2Y	1.3	Liver	Macro	Unknown	Alive	99	2014	2011
TCGA-2Y-A9GY	64	FEMALE	161	757	92	35.4924578527063	Hepatocellular Carcinoma	Liver	Dead	T2	NX	MX	Stage II	G3	1	637.0	Lung	Extrahepatic Recurrence	WITH TUMOR																					None	64	3.5	4.2	5	TCGA-2Y-A9GY	75030B63-59AF-4705-86E7-3A431B7CF65A	0.2	0.4	2	Unknown	0.8	1.5	0.6	3	-23435	757	0	Not Available	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	7	27600	Unknown																												FEMALE	161	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G3	NO	NO	698	637	Not Available	Lung	Extrahepatic Recurrence	Not Applicable	No	YES	No	R0	YES	No	A9GY	WITH TUMOR	207	143	382	NO	NO	9.5	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	NO	YES	2Y	1.3	Liver	Unknown	Unknown	Dead	92	2014	2007
TCGA-DD-A73E	66	MALE	172	44	108	36.50621957815035	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G1	0	44			TUMOR FREE																					Mild	66	3.5	4.7	5.0	TCGA-DD-A73E	E0863874-F7B8-49B6-A88B-5AE5F1EC2B15	0.1	0.4	2	A	0.8	1.3	1.2	30	-24377	Not Applicable	0	44	Not Available																								0	NOT HISPANIC OR LATINO	0	6	1	0 - No Fibrosis	TCGA-DD-A73E-F66598	FDB54AF8-2B1A-4773-9793-0580F2B42055	21	Not Applicable	44	Not Available	YES	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	NO	NO	NO	Alive	2014	MALE	172	Hepatocellular Carcinoma	Alcohol consumption;Non-Alcoholic Fatty Liver Disease	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.5	13.8	9	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A73E	TUMOR FREE	190	150	450	NO	NO	11.5	WHITE	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody	Alive	108	2013	2012
TCGA-RC-A7SF	66	MALE	170	579	76	26.29757785467128	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	1	502.0	Liver	Locoregional Recurrence	WITH TUMOR																					None	66	3.1	4.4	5.2	TCGA-RC-A7SF	714A6878-ED2A-47F3-9755-B705AC144D68	0.1	0.8	Not Available	A	0.3	1.20	1.0	21	-24432	Not Applicable	0	579	Not Available																								0	NOT HISPANIC OR LATINO	0	20	87	3,4 - Fibrous Speta																												MALE	170	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.30	7	G2	NO	NO	Not Available	502	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	A7SF	WITH TUMOR	209000	150000	400000	NO	NO	0.9	ASIAN	NO																			Unknown	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	YES	NO	RC	1.3	Liver	None	Not Available	Alive	76	2014	2012
TCGA-BC-A3KG	68	FEMALE	159	680	64	25.31545429373838	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G3	1	209.0	Lung	Extrahepatic Recurrence	WITH TUMOR																					Not Available	68	3.5	3.6	5.0	TCGA-BC-A3KG	75F43FCA-200A-48B0-BB67-0693D7B91119	0.0	0.5	Not Available	Not Available	0.6	1.0	0.7	19	-25061	Not Applicable	0	252	Not Available																								Not Available	NOT HISPANIC OR LATINO	0	10	618	Not Available	TCGA-BC-A3KG-F38205;TCGA-BC-A3KG-F44817	59B40341-161E-4C90-A8CE-1E662C079D82;EC75CF4B-6877-46DD-97E3-AA03D92B0378	11;27	Not Applicable;Not Applicable	498;680	Not Available;Not Available	NO;NO	12;6	YES;YES;YES;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	209;209;209;Not Available	Not Available;Not Available;Not Available;Not Available	Liver;Lung;Other, specify;Not Available	Intrahepatic Recurrence;Extrahepatic Recurrence;Extrahepatic Recurrence;Not Available	Not Applicable;Not Applicable;Spleen;Not Applicable	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;Not Available	No;No;No;Not Available	Not Available;Not Available;Not Available;Not Available	YES;YES	WITH TUMOR;WITH TUMOR	NO;NO	NO;NO	NO;NO	Alive;Alive	2012;2013	FEMALE	159	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	4	G3													Not Available	No	A3KG	WITH TUMOR	499000	150000	440000	Not Available	Not Available	1.1	WHITE	Not Available																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	BC	1.2	Liver	Micro	Not Available	Alive	64	2012	2011
TCGA-DD-AAVP	48	MALE	167	2752	62	22.230987127541326	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G1	1	903.0	Liver	Intrahepatic Recurrence	TUMOR FREE																					Severe	48	3.3	4.3	5.0	TCGA-DD-AAVP	0004D251-3F70-4395-B175-C94C2F5B1B81	0.2	1.1	1	A	0.7	1.4	1.2	13	-17833	Not Applicable	0	2405	Not Available																								0	NOT HISPANIC OR LATINO	0	15	2	6 - Established Cirrhosis	TCGA-DD-AAVP-F67571	327361EE-AD1A-4ECC-8819-78FD8943F5C7	6	Not Applicable	2752	Not Available	NO	11	NO;NO	NO;NO	Not Available;2088	903;903	1211;Not Available	Liver;Lung	Locoregional Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable	Yes;No	NO;YES	Yes;No	RX;RX	YES	TUMOR FREE	YES	NO	NO	Alive	2014	MALE	167	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	6	G1	NO	NO	Not Available	903	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AAVP	TUMOR FREE	189	130	400	NO	NO	1	ASIAN	NO																			YES	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	62	2014	2007
TCGA-ED-A459	47	MALE	167	910	51	18.286779733945284	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	0	910			TUMOR FREE																					Not Available	47	3800	5200	5100	TCGA-ED-A459	56403463-1727-4C23-A709-DE5F168C4073	.3	1.4	Not Available	Unknown	.7	1.1	1.1	15	-17402	Not Applicable	0	7	Not Available	TCGA-ED-A459-D48393	F463B232-BE1D-4F17-B6D6-9755593A0B3C	Not Available	14	103	38	Alvesin	Complete Response	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Ancillary	Not Available	Not Available	Not Available	NO	2013	Unknown	NOT HISPANIC OR LATINO	0	20	267	Not Available	TCGA-ED-A459-F45970;TCGA-ED-A459-F68559	DFA39EE4-A425-4A78-8E06-F44E256DA704;3C1E3539-1032-4FB7-9211-307A78AC80C4	26;26	Not Applicable;Not Applicable	408;910	Not Available;Not Available	NO;NO	7;11	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE	NO;NO	YES;YES	YES;YES	Alive;Alive	2013;2014	MALE	167	Hepatocellular Carcinoma	Unknown	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	.9	1.3	1	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A459	TUMOR FREE	200	150	400	Unknown	NO	.9	ASIAN	NO	Primary Tumor Field	TCGA-ED-A459-R48394	11ED1612-851A-4E04-9298-256AB29DBED0	Not Available	7	37	18	Complete Response	10	Not Available	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	ED	1.2	Liver	Micro	Hepatitis B Surface Antigen	Alive	51	2013	2012
TCGA-DD-AACW	43	MALE	166	1424	65	23.588329220496444	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	1424			TUMOR FREE																					Unknown	43	3.8	4.0	5.3	TCGA-DD-AACW	67A00F5F-C753-48F9-BC24-8287F50EC776	0.2	0.6	Not Available	A	0.7	1.5	1.0	29	-15872	Not Applicable	0	1157	Not Available																								0	NOT HISPANIC OR LATINO	0	8	1726	Unknown	TCGA-DD-AACW-F68380	73DD7355-E20B-47C3-AD45-B10226B0C64F	17	Not Applicable	1424	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	166	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AACW	TUMOR FREE	137	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	65	2014	2010
TCGA-3K-AAZ8	65	MALE	172	396	84	28.393726338561386	Hepatocellular Carcinoma	Liver	Alive	T3b	NX	MX	Stage IIIB	G1	1	151.0	Liver	Locoregional Recurrence	WITH TUMOR																					Not Available	65	Not Available	Not Available	Not Available	TCGA-3K-AAZ8	94E387AE-B641-4E9F-BB53-22C7B2A9CCCB	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	25	-24046	Not Applicable	0	243	Not Available	TCGA-3K-AAZ8-D64051;TCGA-3K-AAZ8-D69331	53F09997-1A79-41DE-A307-66747EA290B2;4B86947A-374F-4EC2-8181-4C1BFBE93662	Not Available;Not Available	25;5	304;Not Available	212;304	Sarafenib;Regorafenib	Clinical Progressive Disease;Not Applicable	8;1	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2015	Unknown	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	5 - Nodular Formation and Incomplete Cirrhosis	TCGA-3K-AAZ8-F69330	00DE20A5-53ED-419B-945A-1460F560942C	5	Not Applicable	396	Not Available	NO	1	NO	NO	Not Available	304	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	YES	NO	Alive	2015	MALE	172	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G1	NO	Not Available	Not Available	151	Not Available	Liver	Locoregional Recurrence	Not Applicable	Not Available	NO	No	Not Available	YES	No	AAZ8	WITH TUMOR	Not Available	Not Available	Not Available	NO	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			NO	RX	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3b	YES	NO	3K	Not Available	Liver	Not Available	Unknown	Alive	84	2014	2013
TCGA-G3-A7M5	76	MALE	164	447	68	25.28256989886972	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G2	0	447			TUMOR FREE																					None	76	3.3	4.1	4.8	TCGA-G3-A7M5	869F8A17-BCED-4002-BD60-99DF84A03B93	0	0.5	Not Available	A	0.6	1.4	1.9	5	-27963	Not Applicable	0	0	Not Available																								0	NOT HISPANIC OR LATINO	0	10	6	0 - No Fibrosis	TCGA-G3-A7M5-F65810	630910C8-FFF6-433D-BD1A-F68F7400FC7C	30	Not Applicable	447	Not Available	NO	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	164	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	2	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7M5	TUMOR FREE	181	150	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	G3	1.4	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Surface Antibody	Alive	68	2014	2013
TCGA-FV-A3R2	75	MALE	Not Available	194	75		Hepatocellular Carcinoma	Liver	Dead	T1	NX	MX	Stage I	Not Available	0	194			TUMOR FREE																					Not Available	75	Not Available	Not Available	Not Available	TCGA-FV-A3R2	17833039-0D7E-47F0-90E6-8CABAE94C124	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	24	-27530	194	0	Not Available	Not Available	TCGA-FV-A3R2-D35314;TCGA-FV-A3R2-D35315	97BF9DCB-DCA9-47B9-BB10-006D47608DAC;B4669B2E-E16D-482F-A73B-C4BDF8EB5278	Not Available;Not Available	16;16	Not Available;Not Available	25;25	Cisplatin;Gemcitabine	Unknown;Unknown	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-FV-A3R2-F47054	64D72F30-249A-4476-B0D3-4F6E215B3872	21	194	Not Available	Not Available	NO	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	YES	NO	Dead	2013	MALE	Not Available	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Yes	A3R2	TUMOR FREE	Not Available	Not Available	Not Available	NO	YES	Not Available	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	FV	Not Available	Liver	Not Available	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Surface Antibody	Dead	75	2012	2005
TCGA-BD-A3ER	62	MALE	188	1115	111	31.405613399728384	Hepatocellular Carcinoma	Liver	Alive	T2	NX	MX	Stage II	G2	1	226.0	Liver	Locoregional Recurrence	TUMOR FREE																					Mild	62	3.4	3.9	5.0	TCGA-BD-A3ER	9457A9A1-3DD1-4D88-B1E1-D20AAE4491DD	0.3	0.7	0	A	0.5	1.4	0.9	21	-22657	Not Applicable	0	146	Not Available																								0	NOT HISPANIC OR LATINO	0	20	5	6 - Established Cirrhosis	TCGA-BD-A3ER-F68681	33F6553F-51F4-47A2-8C2C-613FE356F3AF	10	Not Applicable	1115	Not Available	NO	12	NO	NO	Not Available	226	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	MALE	188	Hepatocellular Carcinoma	Hemochromatosis	Alcohol Consumption	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	3	G2													Not Available	Yes	A3ER	TUMOR FREE	208	156	369	Not Available	Not Available	1.2	WHITE	Not Available																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	YES	NO	BD	1.5	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	111	2012	2011
TCGA-DD-AADY	55	FEMALE	161	555	55	21.21831719455268	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	555			TUMOR FREE																					None	55	3.8	3.5	5.3	TCGA-DD-AADY	E42E4244-DCE8-453A-B5E0-7593A9B5AF61	0.2	0.8	Not Available	A	0.7	1.5	0.6	14	-20233	Not Applicable	0	294	Not Available																								0	NOT HISPANIC OR LATINO	0	8	9	6 - Established Cirrhosis	TCGA-DD-AADY-F68409	D2180F12-72F8-4C7E-A3E5-A4FE2AB9CE29	17	Not Applicable	555	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	161	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AADY	TUMOR FREE	159	130	400	NO	NO	1.3	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	55	2014	2013
TCGA-DD-AACY	61	MALE	162	1450	62	23.62444749276025	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	1	776.0	Liver	Intrahepatic Recurrence	WITH TUMOR		YES	Radiofrequency Ablation;Radiofrequency Ablation	Not Applicable;Not Applicable	845;1161	2;1	2;1	TCGA-DD-AACY-A66127	0745DCEF-5CAE-438E-8619-E0D0820BDD76	2	YES	407;Not Available	Other;Not Available	adriamycin;Not Applicable	Chemoembolization;Not Available	Other, specify;Not Available	lipidol;Not Applicable	10	2014		Mild	61	3.8	3.1	5.3	TCGA-DD-AACY	D884561B-5828-4C47-ACD7-3F02E181B596	0.2	1.3	Not Available	A	0.7	1.5	0.6	29	-22332	Not Applicable	0	1140	Not Available																								0	NOT HISPANIC OR LATINO	0	8	290	3,4 - Fibrous Speta	TCGA-DD-AACY-F68382	18A7024E-2E3F-4CFA-9501-2D52737859D6	17	Not Applicable	1450	Not Available	NO	11	NO	NO	Not Available	776	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	YES	NO	NO	Alive	2014	MALE	162	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	NO	NO	Not Available	776	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	AACY	WITH TUMOR	114	130	400	YES	NO	1.1	ASIAN	NO																			NO	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	62	2014	2010
TCGA-DD-A1EI	46	MALE	175	183	69	22.53061224489796	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	183			TUMOR FREE																					Mild	46	3.5	5.1	5.0	TCGA-DD-A1EI	3acf7438-fd65-442c-8a30-68b6714537f3	0.1	0.7	0	B	0.8	1.3	0.9	10	-17097	Not Applicable	0	183	Not Available																								2	NOT HISPANIC OR LATINO	0	6	24	6 - Established Cirrhosis	TCGA-DD-A1EI-F42222	94B7ECA9-3FBF-41E0-B938-1DF33B9A9857	15	Not Applicable	183	Not Available	YES	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Unknown	Unknown	Unknown	Unknown	Alive	2013	MALE	175	Hepatocellular Carcinoma	Hepatitis B	cirrhosis	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	10.8	5	G2													Not Available	No	A1EI	TUMOR FREE	148	150	450	Not Available	Not Available	10.9	ASIAN	Not Available																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV DNA	Alive	69	2011	2008
TCGA-2Y-A9HB	66	MALE	167	260	74	26.533758829646096	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G2	0	260			TUMOR FREE																					None	66	3.5	3.9	5	TCGA-2Y-A9HB	B181B591-269C-4E48-B681-243D28772025	0.2	0.6	Not Available	Unknown	0.8	1.5	0.8	3	-24359	Not Applicable	0	158	Not Available																								0	HISPANIC OR LATINO	0	7	21	Unknown	TCGA-2Y-A9HB-F69098	7AD365DD-2B80-40C7-906A-04C2487C4847	29	Not Applicable	260	Not Available	YES	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	Unknown	Unknown	Unknown	Alive	2014	MALE	167	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9HB	TUMOR FREE	124	143	382	NO	NO	11.1	Not Evaluated	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	2Y	1.3	Liver	None	Hepatitis C Virus RNA;HCV Genotype	Alive	74	2014	2012
TCGA-CC-A123	24	FEMALE	Not Available	219	Not Available		Hepatocellular Carcinoma	Liver	Alive	T3	N0	M0	Stage IIIA	G1	1	145.0	Lung	New Primary Tumor	TUMOR FREE																					Not Available	24	Not Available	Not Available	Not Available	TCGA-CC-A123	e2f6d3aa-b817-4193-a550-8e53265aa336	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	18	-9107	Not Applicable	0	-8	Not Available																								3	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A123-F70913	15697E27-B54A-4577-9D7E-EE7BFDD1C8F5	10	Not Applicable	219	Not Available	NO	3	NO	NO	Not Available	145	Not Available	Lung	New Primary Tumor	Not Applicable	No	NO	Not Available	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2015	FEMALE	Not Available	Hepatocellular Carcinoma	Not Available	Not Available	No	Hepatic Resection	C22.0	8170/3	C22.0	YES	Not Available	Not Available	4	G1													Not Available	No	A123	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			Not Available	RX	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	Not Available	2011	2010
TCGA-XR-A8TE	16	MALE	157	925	43	17.444926771877157	Hepatocellular Carcinoma	Liver	Alive	T3	N0	MX	Stage IIIA	G1	1	210.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					None	16	3.2	3.9	4.5	TCGA-XR-A8TE	EC4B4D34-2576-4412-B036-7460E64F4398	Not Available	Not Available	Not Available	Not Available	0.7	1.5	0.4	20	-5862	Not Applicable	0	925	Not Available																								0	HISPANIC OR LATINO	6	6	809	0 - No Fibrosis	TCGA-XR-A8TE-F72321	5624D223-57B0-4A1A-98F3-B671AE83DE88	20	Not Applicable	925	Not Available	NO	5	YES	NO	244	210	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	YES	No	R0	YES	WITH TUMOR	NO	YES	NO	Alive	2015	MALE	157	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.3	1.3	5	G1	YES	NO	244	210	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	YES	No	R0	YES	No	A8TE	WITH TUMOR	206000	150000	450000	NO	YES	1.0	WHITE	NO																			NO	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	NO	YES	XR	Not Available	Liver	None	Not Available	Alive	43	2015	2012
TCGA-CC-A8HT	74	MALE	159	140	48	18.986590720303784	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G2	1	83.0		Locoregional Recurrence	TUMOR FREE																					Not Available	74	Not Available	Not Available	Not Available	TCGA-CC-A8HT	95408571-9D4E-412B-8EE8-7992E0270B0F	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	22	-27334	Not Applicable	0	0	Not Available																								4	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A8HT-F69842	E4BB6675-F20C-4C0A-8D54-C9C46F8CE00C	21	140	Not Available	Not Available	NO	1	NO	NO	Not Available	83	Not Available	Not Available	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2015	MALE	159	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A8HT	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	48	2014	2013
TCGA-G3-A5SM	58	MALE	184	520	106	31.30907372400756	Hepatocellular Carcinoma	Liver	Alive	T2	NX	M0	Stage II	G3	1	252.0	Liver	Intrahepatic Recurrence	TUMOR FREE		YES	Radiofrequency Ablation;Radiofrequency Ablation	Not Applicable;Not Applicable	302;365	1;1	1;1	TCGA-G3-A5SM-A62750	1796E529-FEBB-4E24-96C2-D4B5ACD824D7	24	NO	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	7	2014		Unknown	58	3.3	3.2	4.8	TCGA-G3-A5SM	D397E70F-C174-4656-9B7E-5E4C00754410	0	0.6	Not Available	A	0.5	1.4	0.5	15	-21236	Not Applicable	0	133	Not Available																								1	NOT HISPANIC OR LATINO	0	10	12	6 - Established Cirrhosis	TCGA-G3-A5SM-F62748	2941AE94-5DE5-42B8-ADB7-2E2A7953EF27	24	Not Applicable	520	Not Available	NO	7	NO;NO	NO;NO	Not Available;Not Available	252;252	Not Available;Not Available	Liver;Liver	Intrahepatic Recurrence;Intrahepatic Recurrence	Not Applicable;Not Applicable	Yes;Yes	NO;NO	No;No	Not Available;Not Available	YES	TUMOR FREE	YES	NO	NO	Alive	2014	MALE	184	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis C	Not Available	No	Partial left hepatectomy	C22.0	8170/3	C22.0	YES	0.9	1.1	5	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A5SM	TUMOR FREE	260	150	400	NO	NO	0.9	WHITE	NO																			NO	R0	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2	YES	NO	G3	1.4	Liver	None	Not Available	Alive	106	2013	2012
TCGA-ES-A2HS	80	MALE	180	688	97	29.938271604938272	Hepatocellular Carcinoma	Liver	Dead	T1	NX	MX	Stage I	G2	0	688			TUMOR FREE																					Mild	80	3.5	3.8	5.0	TCGA-ES-A2HS	728AEDB3-551A-4C16-9BE3-7733A9539E9E	0	1.9	0	A	0.8	1.2	0.6	28	-29268	688	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	8	1	0 - No Fibrosis																												MALE	180	Hepatocellular Carcinoma	No History of Primary Risk Factors	No	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	9	G2													Not Available	Yes	A2HS	TUMOR FREE	119	150	450	Not Available	Not Available	1.3	WHITE	Not Available																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	ES	1.0	Liver	None	Not Available	Dead	97	2011	2008
TCGA-FV-A2QQ	80	MALE	Not Available	729	Not Available		Hepatocellular Carcinoma	Liver	Alive	T1	N0	MX	Stage I	G2	0	729			TUMOR FREE																					Not Available	80	Not Available	Not Available	Not Available	TCGA-FV-A2QQ	D680DF09-368E-42B5-B540-45C41ED31042	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	1	-29354	Not Applicable	0	0	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-FV-A2QQ-F57856	3936A779-EA07-4091-AEC1-C2631C512D8E	27	Not Applicable	729	Not Available	NO	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	Not Available	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	10	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A2QQ	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	WHITE	Unknown																			Unknown	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	YES	NO	FV	Not Available	Liver	None	Not Available	Alive	Not Available	2012	2011
TCGA-DD-AACU	59	MALE	166	1567	67	24.31412396574249	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	1567			TUMOR FREE																					Unknown	59	3.8	4.4	5.3	TCGA-DD-AACU	88B6181C-1086-42DF-8BB9-1069EC2DC675	0.2	0.3	Not Available	A	0.7	1.5	1.1	29	-21606	Not Applicable	0	1240	Not Available																								0	NOT HISPANIC OR LATINO	0	8	22	Unknown	TCGA-DD-AACU-F68378	1CDADA23-0C16-4764-9519-936E974CB097	17	Not Applicable	1567	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	166	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AACU	TUMOR FREE	166	130	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	67	2014	2010
TCGA-RC-A7SH	42	MALE	174	468	68	22.460034350640772	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G3	1	91.0	Lung	Extrahepatic Recurrence	WITH TUMOR																					None	42	3.1	4.1	5.2	TCGA-RC-A7SH	32A98B3D-4CBD-4DCC-AC71-428FAFC5E1C3	0.1	0.5	Not Available	A	0.3	1.20	0.8	21	-15560	Not Applicable	0	468	Not Available																								1	NOT HISPANIC OR LATINO	0	20	2466	3,4 - Fibrous Speta																												MALE	174	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8174/3	C22.0	YES	0.8	1.30	7	G3	YES	NO	Not Available	91	Not Available	Lung	Extrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	A7SH	WITH TUMOR	225	150000	400000	NO	NO	1.0	ASIAN	NO																			Unknown	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	RC	1.3	Liver	Micro	Not Available	Alive	68	2014	2012
TCGA-ZP-A9D2	51	MALE	172	765	74	25.01352082206598	Hepatocellular Carcinoma	Liver	Dead	T2	NX	MX		G2	1	315.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					Mild	51	Not Available	Not Available	Not Available	TCGA-ZP-A9D2	CBB89556-D783-4E70-8DB4-EF53E9A45922	Not Available	Not Available	1	A	Not Available	Not Available	Not Available	28	-18717	Not Applicable	0	743	Not Available																								0	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	1,2 - Portal Fibrosis	TCGA-ZP-A9D2-F57748;TCGA-ZP-A9D2-F65766	EE2F0D09-A089-4ACA-8EEE-0402B56F2003;ED61A21A-0067-4107-A53B-B3F816EA1B06	28;16	Not Applicable;765	743;Not Available	Not Available;Not Available	NO;NO	3;1	NO;Not Available	NO;Not Available	Not Available;Not Available	315;Not Available	Not Available;Not Available	Liver;Not Available	Intrahepatic Recurrence;Not Available	Not Applicable;Not Applicable	Yes;Not Available	NO;Not Available	No;Not Available	Not Available;Not Available	YES;NO	WITH TUMOR;WITH TUMOR	NO;YES	NO;NO	NO;NO	Alive;Dead	2014;2015	MALE	172	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G2	NO	NO	Not Available	315	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	A9D2	WITH TUMOR	Not Available	Not Available	Not Available	NO	NO	Not Available	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	NO	YES	ZP	Not Available	Liver	Micro	Hepatitis C Virus RNA	Alive	74	2014	2012
TCGA-DD-AACT	69	FEMALE	158	1562	62	24.835763499439192	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	1562			TUMOR FREE																					Mild	69	3.8	4.4	5.3	TCGA-DD-AACT	3EA084C5-3783-4FDE-B341-5914D2EDB977	0.2	0.8	Not Available	A	0.7	1.5	0.7	29	-25292	Not Applicable	0	1291	Not Available																								0	NOT HISPANIC OR LATINO	0	8	4	Unknown	TCGA-DD-AACT-F68377	280C17EA-2604-4506-A284-D851D4CE23B8	17	Not Applicable	1562	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	158	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AACT	TUMOR FREE	213	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	62	2014	2010
TCGA-DD-AADG	70	MALE	160	1145	61	23.828125	Hepatocellular Carcinoma	Liver	Alive	T3a	N0	M0	Stage IIIA	G3	1	270.0	Liver	Intrahepatic Recurrence	TUMOR FREE																					Mild	70	3.8	4.2	5.3	TCGA-DD-AADG	89D1261C-6D93-4298-A2AF-B5FF52BE0CB6	0.2	0.9	Not Available	A	0.7	1.5	1.0	7	-25887	Not Applicable	0	808	Not Available																								0	NOT HISPANIC OR LATINO	0	8	2256	3,4 - Fibrous Speta	TCGA-DD-AADG-F68394	D08A9A86-D952-4585-9825-58A863D8075B	17	Not Applicable	1145	Not Available	NO	11	NO	NO	386	270	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	YES	No	R0	YES	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	160	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	NO	NO	386	270	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	YES	No	R0	YES	No	AADG	TUMOR FREE	170	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3a	NO	YES	DD	1.2	Liver	None	Unknown	Alive	61	2014	2011
TCGA-2Y-A9H0	49	MALE	180	3675	89	27.469135802469136	Hepatocellular Carcinoma	Liver	Alive	T3	N0	M0	Stage IIIA	G1	0	3675			TUMOR FREE																					None	49	3.5	2	5	TCGA-2Y-A9H0	492FF93F-432B-4B73-8706-632FB2C83EB4	0.2	0.8	Not Available	Unknown	0.8	1.5	0.8	3	-18109	Not Applicable	0	3675	Not Available																								0	HISPANIC OR LATINO	0	8	7598	Unknown	TCGA-2Y-A9H0-F69171	D0AC41D4-7565-41E7-8F26-896CE512B5E3	30	Not Applicable	3675	Not Available	NO	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	180	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9H0	TUMOR FREE	207	143	382	NO	NO	12.2	WHITE	NO																			Not Available	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	2Y	1.3	Liver	Unknown	Unknown	Alive	89	2014	2004
TCGA-G3-AAV6	53	FEMALE	165	65	78	28.650137741046834	Hepatocellular Carcinoma	Liver	Dead	T3a	N0	M0	Stage IIIA	G3	1	44.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					Severe	53	3.4	3.9	5.2	TCGA-G3-AAV6	A6733FA1-030A-45ED-9C24-0E64164D4998	0	1.6	Not Available	A	0.6	1.4	0.9	16	-19556	65	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	10	57875	0 - No Fibrosis	TCGA-G3-AAV6-F65959	C38EC073-1A6B-4191-9EFD-1CBFB2A494DF	1	65	Not Available	Not Available	NO	10	NO	NO	Not Available	44	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2014	FEMALE	165	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	7	G3	NO	NO	Not Available	44	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	AAV6	WITH TUMOR	303	150	400	NO	NO	1	WHITE	NO																			Unknown	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3a	YES	NO	G3	1.2	Liver	Micro	Hepatitis B Surface Antigen	Dead	78	2014	2013
TCGA-DD-A73D	68	FEMALE	170	693	102	35.294117647058826	Hepatocellular Carcinoma	Liver	Alive	T2	NX	MX	Stage II	G1	1	592.0	Liver	Intrahepatic Recurrence	TUMOR FREE																					Mild	68	3.5	4.5	5.0	TCGA-DD-A73D	24170A77-94E0-4002-9D3E-A46C84E84FCA	0.1	0.3	1	A	0.6	1.1	0.8	30	-24941	Not Applicable	0	334	Not Available																								0	NOT HISPANIC OR LATINO	0	6	4	6 - Established Cirrhosis	TCGA-DD-A73D-F66596	A05916AF-AFC8-4386-AAA3-4B5E6EE35219	21	Not Applicable	693	Not Available	NO	10	NO	NO	Not Available	592	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	Not Available	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	FEMALE	170	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.5	13.8	9	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A73D	TUMOR FREE	214	150	450	NO	NO	12.5	WHITE	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	NO	YES	DD	1.0	Liver	Micro	Hepatitis C Virus RNA;Hepatitis B Surface Antigen	Alive	102	2013	2012
TCGA-FV-A2QR	75	MALE	Not Available	581	Not Available		Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G1	1	561.0		Extrahepatic Recurrence	WITH TUMOR																					Not Available	75	Not Available	Not Available	Not Available	TCGA-FV-A2QR	D3A03F7A-3482-4548-957E-05C692B20101	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	9	Not Available	581	0	Not Available	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-FV-A2QR-F42770	3D08E08E-0E37-42A3-8C3E-2BA6CAC05414	30	581	Not Available	Not Available	NO	4	NO	NO	Not Available	561	Not Available	Unknown	Extrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2013	MALE	Not Available	Hepatocellular Carcinoma	Other	Male, IDDM for 30+years	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	2	G1													Not Available	No	A2QR	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			YES	RX	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	FV	Not Available	Liver	Not Available	Not Available	Dead	Not Available	2012	2006
TCGA-DD-AADK	68	FEMALE	150	1049	51	22.666666666666668	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G3	0	1049			TUMOR FREE																					None	68	3.8	4.4	5.3	TCGA-DD-AADK	40F30FFB-51DE-4786-A88F-16C170AAC207	0.2	0.5	Not Available	A	0.7	1.5	1.2	14	-25046	Not Applicable	0	734	Not Available																								0	NOT HISPANIC OR LATINO	0	8	236	6 - Established Cirrhosis	TCGA-DD-AADK-F68397	3763CF87-1E9B-47CB-AD17-334E1998BBA8	17	Not Applicable	1049	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	150	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AADK	TUMOR FREE	197	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	51	2014	2011
TCGA-DD-A4NE	75	FEMALE	170	660	79	27.335640138408305	Hepatocellular Carcinoma	Liver	Dead	T3a	N0	M0	Stage IIIA	G3	1	190.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					None	75	3.5	4.2	5.0	TCGA-DD-A4NE	BCE25281-502E-4599-9679-32DC8462FFB1	0.1	0.9	3	A	0.6	1.0	0.8	21	-27549	660	0	Not Available	Not Available	TCGA-DD-A4NE-D43115	8B7A43C8-CAD9-4752-846A-109156C0512A	Not Available	13	Not Available	225	Sorafenib	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	HISPANIC OR LATINO	0	6	28	0 - No Fibrosis	TCGA-DD-A4NE-F49644	AA54969A-CF78-42D8-850A-A3F91AFDA161	7	660	Not Available	Not Available	NO	10	NO;NO	NO;NO	Not Available;Not Available	190;190	Not Available;Not Available	Liver;Liver	Locoregional Recurrence;Intrahepatic Recurrence	Not Applicable;Not Applicable	No;No	NO;NO	No;No	Not Available;Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2013	FEMALE	170	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	10.8	12	G3	NO;NO	NO;NO	Not Available;Not Available	190;190	Not Available;Not Available	Liver;Liver	Intrahepatic Recurrence;Locoregional Recurrence	Not Applicable;Not Applicable	No;No	NO;NO	No;No	Not Available;Not Available	YES	No	A4NE	WITH TUMOR	348	150	450	NO	NO	10.2	WHITE	NO																			YES	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3a	NO	YES	DD	1.0	Liver	None	Hepatitis C Virus RNA;Hepatitis B Surface Antigen;HBV Core Antibody	Dead	79	2012	2011
TCGA-CC-A7IG	47	MALE	174	299	62	20.478266613819528	Hepatocellular Carcinoma	Liver	Dead	T2	N0	M0	Stage II	G2	1	195.0		Locoregional Recurrence	TUMOR FREE																					Not Available	47	Not Available	Not Available	Not Available	TCGA-CC-A7IG	534A7B11-3ABD-4581-A9C9-D984D6AA33A0	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	22	-17453	Not Applicable	0	0	Not Available																								2	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A7IG-F69702	CD45DE16-E733-4C3E-B138-FF98E3BE77F2	16	299	Not Available	Not Available	NO	1	NO	NO	Not Available	195	Not Available	Not Available	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2015	MALE	174	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7IG	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	62	2014	2013
TCGA-DD-A1EB	72	FEMALE	164	2017	57	21.19274241522903	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	1	505.0	Liver	Intrahepatic Recurrence	Discrepancy		YES	Ethanol Injection;Ethanol Injection	Not Applicable;Not Applicable	506;731	Not Available;Not Available	Not Available;Not Available	TCGA-DD-A1EB-A42227	59CA7EF7-652C-416A-82B8-14E666059859	15	NO	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	5	2013		None	72	3.5	3.7	5.0	TCGA-DD-A1EB	68015cc7-d3a1-4c90-b8fb-5d14143d9960	0.1	0.3	1	B	0.6	1.1	1.3	9	-26471	Not Applicable	0	2017	Not Available																								1	Not Available	0	6	7	0 - No Fibrosis	TCGA-DD-A1EB-F42225	2FF823AA-7C05-434E-B6E7-8F7462BEF223	15	Not Applicable	2017	Not Available	YES	4	NO;NO	NO;NO	Not Available;Not Available	505;729	Not Available;Not Available	Liver;Liver	Intrahepatic Recurrence;Locoregional Recurrence	Not Applicable;Not Applicable	Yes;Yes	NO;NO	No;Not Available	Not Available;Not Available	YES	Discrepancy	NO	NO	NO	Alive	2013	FEMALE	164	Hepatocellular Carcinoma	Other	smoking	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	5	G2													Not Available	No	A1EB	Discrepancy	204	150	450	Not Available	Not Available	8.7	Not Available	Not Available																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	57	2011	2001
TCGA-DD-A118	77	FEMALE	169	3437	75	26.259584748433177	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	1	658.0	Other, specify	Extrahepatic Recurrence	Not Available																					None	77	3.4	3.4	4.8	TCGA-DD-A118	7d914d07-f250-4c7a-8fa2-df14e708936e	0.1	0.5	Not Available	A	0.7	1.2	0.9	29	-28406	Not Applicable	0	693	Not Available																								1	NOT HISPANIC OR LATINO	0	6	85150	0 - No Fibrosis	TCGA-DD-A118-F38782	0D3A8B0E-063C-4E95-B302-6ED5A25821E1	21	Not Applicable	3437	Not Available	NO	12	NO	NO	659	658	Not Available	Other, specify	Extrahepatic Recurrence	lateral to the C-loop of the duodenum, anterior to the right  kidney	No	YES	No	R0	YES	Unknown	NO	NO	NO	Alive	2012	FEMALE	169	Hepatocellular Carcinoma	Not Available	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	12	G2													Not Available	No	A118	Not Available	381	150	450	Not Available	Not Available	1.0	WHITE	Not Available																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	75	2010	2003
TCGA-5R-AAAM	65	FEMALE	163	46	80	30.11027889645828	Hepatocellular Carcinoma	Liver	Dead	T2	N0	M0	Stage II	G2	0	46			TUMOR FREE																					Severe	65	3.2	3.0	4.6	TCGA-5R-AAAM	477AFFB9-7C8B-4895-A4F3-6CC6EF8EC5E4	0	0.6	Not Available	A	0.5	1.3	0.7	14	-24020	46	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	15	32	6 - Established Cirrhosis																												FEMALE	163	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	11	15	11	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAAM	TUMOR FREE	68000	150000	450000	NO	NO	Not Available	WHITE	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	5R	1.2	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Dead	80	2014	2013
TCGA-DD-AAVQ	38	MALE	171	2728	72	24.622960911049553	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	1	1509.0	Liver	Locoregional Recurrence	TUMOR FREE																					Severe	38	3.3	3.0	5.2	TCGA-DD-AAVQ	80E7742F-ABBE-4F11-B4E4-C999DC1BD459	0.2	1.0	Not Available	A	0.7	1.4	1.1	13	-13911	Not Applicable	0	2406	Not Available																								1	NOT HISPANIC OR LATINO	0	15	1456	6 - Established Cirrhosis	TCGA-DD-AAVQ-F67572	27C888AC-4FAB-429B-8506-739A833E4122	6	Not Applicable	2728	Not Available	NO	11	NO;NO	NO;NO	Not Available;1525	1509;1523	1875;1875	Liver;Liver	Locoregional Recurrence;Intrahepatic Recurrence	Not Applicable;Not Applicable	Yes;No	NO;YES	Yes;Yes	RX;R0	YES	TUMOR FREE	YES	NO	NO	Alive	2014	MALE	171	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	6	G2	NO	NO	1525	1523	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	YES	No	R0	YES	No	AAVQ	TUMOR FREE	128	130	400	NO	NO	1.2	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	72	2014	2007
TCGA-G3-A25U	63	FEMALE	153	1636	47	20.07774787474903	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	1636			TUMOR FREE																					Mild	63	0.3	0.3	0.5	TCGA-G3-A25U	B9835DC5-BF31-4541-A973-E8CA802D80BA	0	0.3	Not Available	A	0.4	1.1	0.5	27	-23207	Not Applicable	0	1231	Not Available																								0	NOT HISPANIC OR LATINO	0	10	10	0 - No Fibrosis	TCGA-G3-A25U-F33636	CD1E18AC-08A4-48BC-B59E-55FC9B25B246	11	Not Applicable	1636	Scheduled Follow-up Submission	Not Available	7													NO	TUMOR FREE	NO	NO	NO	Alive	2012	FEMALE	153	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	7	G3													Not Available	No	A25U	TUMOR FREE	113	150	400	Not Available	Not Available	1.0	ASIAN	Not Available																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	G3	1.2	Liver	None	Not Available	Alive	47	2011	2007
TCGA-G3-A7M8	31	MALE	Not Available	430	Not Available		Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G1	0	430			TUMOR FREE																					Unknown	31	3.3	3.5	4.8	TCGA-G3-A7M8	01CC571C-A47C-4548-9C14-5E51C79B095B	0	1.8	Not Available	A	0.6	1.4	0.7	5	-11527	Not Applicable	0	0	Not Available																								0	NOT HISPANIC OR LATINO	0	10	5	6 - Established Cirrhosis	TCGA-G3-A7M8-F65814	1CE75E8D-FE04-4CDB-884D-066042F151E6	30	Not Applicable	430	Not Available	NO	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	Not Available	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	2	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7M8	TUMOR FREE	136	150	400	NO	NO	1.1	ASIAN	NO																			Unknown	RX	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	G3	1.2	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Surface Antibody	Alive	Not Available	2014	2013
TCGA-DD-A3A5	66	FEMALE	170	3125	58	20.069204152249135	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage III	G2	1	84.0	Liver	Intrahepatic Recurrence	WITH TUMOR		NO						TCGA-DD-A3A5-A42572	DE62BB09-B68C-42AB-B933-D4B5995B733C	23	YES	260	Not Available	Not Applicable	Chemoembolization	Not Available	Not Applicable	4	2013		None	66	3.5	4.2	5.0	TCGA-DD-A3A5	D8549D23-37D4-42BD-B472-F49BBEBD09B0	0.1	0.8	Not Available	A	0.6	0.9	0.7	5	-24288	3125	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	6	55	0 - No Fibrosis	TCGA-DD-A3A5-F42571	08790D34-FCCB-4E11-AFEB-B47475A1C3E8	24	3125	Not Available	Not Available	NO	4	NO	NO	Not Available	84	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2013	FEMALE	170	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	1	G2													Not Available	No	A3A5	WITH TUMOR	312	150	450	Not Available	Not Available	8.7	WHITE	Not Available																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage III	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	DD	1.1	Liver	None	Unknown	Dead	58	2012	1996
TCGA-DD-AACZ	63	FEMALE	149	171	52	23.422368361785505	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G4	1	88.0	Liver	Locoregional Recurrence	TUMOR FREE																					Unknown	63	3.8	4.5	5.3	TCGA-DD-AACZ	CCE2BB32-84CB-4991-9628-1EA408A9B11A	0.2	0.4	Not Available	A	0.7	1.5	0.6	29	-23230	171	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	8	25	Unknown																												FEMALE	149	Hepatocellular Carcinoma	Unknown	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G4	NO	NO	Not Available	88	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AACZ	TUMOR FREE	412	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	Macro	Unknown	Dead	52	2014	2010
TCGA-BC-A217	75	FEMALE	163	1397	81	30.486657382664006	Hepatocellular Carcinoma	Liver	Dead	T2	NX	M0	Stage II	G3	0	1397			TUMOR FREE																					None	75	3.5	4.4	5.0	TCGA-BC-A217	6dcfc418-ab28-4365-95ea-c1ae254f2341	0.0	0.2	Not Available	Not Available	0.6	1.0	0.8	8	-27411	Not Applicable	0	421	Not Available																								Not Available	Not Available	0	10	28	0 - No Fibrosis	TCGA-BC-A217-F22059;TCGA-BC-A217-F70242	1936F4F7-51AA-4F78-B97E-368DDF318A4A;C9E5E467-4B36-466D-9FD2-60C0FB0C4EFD	23;2	Not Applicable;1397	421;Not Available	Scheduled Follow-up Submission;Not Available	Not Available;NO	2;2	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	NO;NO	TUMOR FREE;TUMOR FREE	NO;NO	NO;NO	NO;NO	Alive;Dead	2012;2015	FEMALE	163	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	7	G3													Not Available	No	A217	TUMOR FREE	243000	150000	440000	Not Available	Not Available	1.0	WHITE	Not Available																			NO	R0	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2	YES	NO	BC	1.2	Liver	Micro	Not Available	Alive	81	2011	2010
TCGA-ED-A7XO	29	MALE	175	427	64	20.897959183673468	Hepatocellular Carcinoma	Liver	Alive	T3a	N0	M0	Stage IIIA	G2	1	262.0	Liver	Locoregional Recurrence	TUMOR FREE																					Mild	29	3.8	4.2	5.1	TCGA-ED-A7XO	20BB3855-66E2-46D4-B189-006B4B254C2E	0.1	0.6	Not Available	Unknown	4.1	5.9	4.9	5	-10828	Not Applicable	0	6	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	Not Available	4	Not Available	TCGA-ED-A7XO-F65727	7FB7AF17-2C67-4456-89C5-83A72AEA5E6A	8	Not Applicable	427	Not Available	NO	10	Unknown	NO	Not Available	262	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	Unknown	NO	Alive	2014	MALE	175	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	12	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7XO	TUMOR FREE	Not Available	Not Available	Not Available	NO	NO	Not Available	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3a	YES	NO	ED	1.3	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	64	2013	2013
TCGA-FV-A495	51	FEMALE	172	1	70	23.66143861546782	Hepatocellular Carcinoma	Liver	Alive	T2	NX	M0	Stage II	G2	0	1			TUMOR FREE																					Mild	51	3.8	4.0	5.0	TCGA-FV-A495	BD48FA5E-0152-46F0-A4FA-8CF723FF2DCD	0.3	1.0	1	Unknown	0.6	1.1	1.0	21	-18740	Not Applicable	0	1	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	8	39	3,4 - Fibrous Speta																												FEMALE	172	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	2	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A495	TUMOR FREE	258	140	440	Unknown	Unknown	Not Available	WHITE	Unknown																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2	YES	NO	FV	1.9	Liver	None	Not Available	Alive	70	2013	2012
TCGA-DD-A1EH	23	MALE	179	1495	70	21.847008520333322	Hepatocellular Carcinoma	Liver	Alive	T3	N0	M0	Stage III	G3	1	120.0	Liver	Intrahepatic Recurrence	WITH TUMOR		YES	Radiofrequency Ablation	Not Applicable	126	Not Available	1	TCGA-DD-A1EH-A45785	5BD6AA35-352F-459E-BFCB-FDD1929F1153	22	NO	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	7	2013		None	23	3.5	4.7	5.0	TCGA-DD-A1EH	cab5b264-abab-4bdb-816e-9d2c0ac30629	0.1	1.0	1	B	0.8	1.3	1.0	16	-8499	Not Applicable	0	1036	Not Available	TCGA-DD-A1EH-D45786;TCGA-DD-A1EH-D45810;TCGA-DD-A1EH-D45811	3A35F09B-03D7-48FA-9823-F28D51834CD4;7F848383-13AF-41E4-890D-56CDCC89F3F2;2F99B152-0487-4404-BD4E-57B8429496BD	Not Available;Not Available;Not Available	22;22;22	863;721;975	358;553;862	Sorafenib;doxorubicin;Everolimus, Gemcitabine, and Cisplatin	Partial Response;Partial Response;Clinical Progressive Disease	7;7;7	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	2013;2013;2013	1	NOT HISPANIC OR LATINO	0	6	94340	3,4 - Fibrous Speta	TCGA-DD-A1EH-F42567	343DEC20-1DC4-4B49-802D-86E849463D82	24	Not Applicable	1495	Not Available	NO	4	YES;YES	NO;NO	Not Available;Not Available	120;120	Not Available;Not Available	Liver;Lung	Intrahepatic Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable	Yes;Yes	NO;NO	No;No	Not Available;Not Available	YES	WITH TUMOR	YES	YES	NO	Alive	2013	MALE	179	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.5	13.8	5	G3													Not Available	No	A1EH	WITH TUMOR	212	150	450	Not Available	Not Available	10.4	WHITE	Not Available																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage III	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	DD	1.0	Liver	Macro	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody;HBV DNA	Alive	70	2011	2008
TCGA-FV-A23B	70	FEMALE	Not Available	1852	Not Available		Hepatocellular Carcinoma	Liver	Dead	T2	N0	M0	Stage II	Not Available	1	1453.0	Liver	Locoregional Recurrence	TUMOR FREE		YES	Radiofrequency Ablation	Not Applicable	1501	1	4	TCGA-FV-A23B-A56106	90DB9C36-2FC9-4029-B149-5FB11F680DB6	28	NO	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	1	2014		Not Available	70	Not Available	Not Available	Not Available	TCGA-FV-A23B	C95ED407-BCC2-44AA-BC59-BF7549F2D665	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	18	-25788	Not Applicable	0	987	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-FV-A23B-F45565	502CD80A-EC04-4DAC-8062-F8E1EBA58C23	17	1852	Not Available	Not Available	NO	7	NO	NO	Not Available	1453	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2013	FEMALE	Not Available	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Surgical Resection	C22.0	8170/3	C22.0	YES	Not Available	Not Available	7	Not Available													Not Available	No	A23B	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	R0	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	FV	Not Available	Liver	Not Available	Not Available	Alive	Not Available	2011	2005
TCGA-MI-A75C	64	MALE	175	291	84	27.428571428571427	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	291			TUMOR FREE																					Not Available	64	3.5	4.0	4.9	TCGA-MI-A75C	A6C0DEF6-7649-485A-A679-50DAFB5EADE5	0.2	1.1	Not Available	A	0.6	1.3	1.0	19	-23441	Not Applicable	0	291	Not Available																								1	NOT HISPANIC OR LATINO	0	9	4	Not Available	TCGA-MI-A75C-F62894	AC9F7997-0678-4880-B23C-70E15517EE92	28	Not Applicable	291	Not Available	YES	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	175	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	11	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A75C	TUMOR FREE	243	150	450	NO	NO	Not Available	WHITE	NO																			Unknown	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	MI	1.2	Liver	None	HBV Surface Antibody	Alive	84	2013	2012
TCGA-DD-A4NP	32	MALE	177	3308	79	25.216253311628204	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	1	1286.0	Liver	Intrahepatic Recurrence	WITH TUMOR		YES	Radiofrequency Ablation;Radiofrequency Ablation	Not Applicable;Not Applicable	1309;2807	1;1	1;1	TCGA-DD-A4NP-A49668	06609191-6ABF-403E-B125-A194B805FD89	7	NO	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	10	2013		None	32	3.5	2.4	5.0	TCGA-DD-A4NP	001887AA-36D0-463F-8BCA-DEC7043B4F2E	0.1	0.7	Not Available	B	0.9	1.4	1.9	5	-11838	Not Applicable	0	2849	Not Available																								0	NOT HISPANIC OR LATINO	0	6	2	0 - No Fibrosis	TCGA-DD-A4NP-F49666;TCGA-DD-A4NP-F59646	649F6B5A-D02F-4C66-A53E-895842E0D95E;60E9D29E-9C36-41D2-AE6C-C10E66ECE9BC	7;17	Not Applicable;Not Applicable	3104;3308	Not Available;Not Available	NO;NO	10;5	NO;NO;NO;NO	NO;NO;NO;NO	Not Available;Not Available;Not Available;Not Available	1286;2742;1286;2742	Not Available;Not Available;Not Available;Not Available	Liver;Liver;Liver;Liver	Intrahepatic Recurrence;Locoregional Recurrence;Intrahepatic Recurrence;Locoregional Recurrence	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Yes;Yes;Yes;Yes	NO;NO;NO;NO	No;No;No;No	Not Available;Not Available;Not Available;Not Available	YES;YES	TUMOR FREE;TUMOR FREE	NO;NO	NO;NO	NO;NO	Alive;Alive	2013;2014	MALE	177	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	2	G3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	1286;2742	Not Available;Not Available	Liver;Liver	Intrahepatic Recurrence;Locoregional Recurrence	Not Applicable;Not Applicable	Yes;Yes	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES	No	A4NP	WITH TUMOR	348	150	450	NO	NO	8.9	WHITE	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	79	2013	2005
TCGA-DD-AADF	64	FEMALE	145	115	55	26.159334126040427	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G4	0	115			TUMOR FREE																					Unknown	64	3.8	3.5	5.3	TCGA-DD-AADF	70BB26B8-B38B-4E79-90E7-033A38405B00	0.2	1.1	Not Available	A	0.7	1.5	0.6	7	-23614	115	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	8	725	Unknown																												FEMALE	145	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AADF	TUMOR FREE	174	130	400	NO	NO	1.2	ASIAN	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Dead	55	2014	2011
TCGA-DD-AAEA	65	MALE	163	575	66	24.84098008957808	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	575			TUMOR FREE																					Unknown	65	3.8	4.5	5.3	TCGA-DD-AAEA	AD9657AA-34E9-48B1-BA63-916FE7BD14BB	0.2	0.6	Not Available	A	0.7	1.5	0.9	14	-24027	Not Applicable	0	450	Not Available																								0	NOT HISPANIC OR LATINO	0	8	2	1,2 - Portal Fibrosis	TCGA-DD-AAEA-F68421	DF940455-4932-4CBC-A571-AFC84A509901	17	Not Applicable	575	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	163	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Yes	AAEA	TUMOR FREE	255	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	66	2014	2012
TCGA-EP-A3RK	73	MALE	178	363	101	31.877288221184195	Hepatocellular Carcinoma	Liver	Alive	T3a	NX	MX	Stage IIIA	G2	1	320.0	Liver	Locoregional Recurrence	TUMOR FREE																					Not Available	73	3.5	4.3	4.8	TCGA-EP-A3RK	F15279DD-5D12-460B-9BD1-B4F95681CA65	0.0	0.6	Not Available	A	Not Available	Not Available	Not Available	15	-26985	Not Applicable	0	13	Not Available																								0	NOT HISPANIC OR LATINO	0	Not Available	7	1,2 - Portal Fibrosis	TCGA-EP-A3RK-F40454	6DF49976-00D4-4E6D-936F-D3101F557BF7	20	Not Applicable	363	Not Available	NO	2	YES	Not Available	Not Available	320	Not Available	Liver	Locoregional Recurrence	Not Applicable	Unknown	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2013	MALE	178	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	left hepatic lobectomy	C22.0	8170/3	C22.0	YES	0.9	1.2	5	G2													Not Available	No	A3RK	TUMOR FREE	234	140	415	Not Available	Not Available	1.1	WHITE	Not Available																			NO	Not Available	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3a	YES	NO	EP	1.2	Liver	Not Available	Not Available	Alive	101	2012	2012
TCGA-BC-4072	74	FEMALE	Not Available	1490	Not Available		Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G3	1	475.0	Lymph Node(s)	Extrahepatic Recurrence	WITH TUMOR																					Not Available	74	3.5	4.4	5.0	TCGA-BC-4072	5c9a21a3-d471-401a-9568-59dc84245d28	0	.5	7	Not Available	.7	1.1	1	20	-27162	1490	0	Not Available	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-BC-4072-F6875	470EA447-F596-4924-A26A-5406CE179E7E	20	1490	Not Available	Not Available	Not Available	12	NO	NO	Not Available	475	Not Available	Lymph Node(s)	Extrahepatic Recurrence	Not Applicable	No	NO	Not Available	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2010	FEMALE	Not Available	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	12	G3													Not Available	No	4072	WITH TUMOR	268	150	440	Not Available	Not Available	1	WHITE	Not Available																			YES	R1	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	BC	1.2	Liver	Macro	Not Available	Dead	Not Available	2010	2005
TCGA-FV-A3I0	76	FEMALE	Not Available	848	Not Available		Hepatocholangiocarcinoma (Mixed)	Liver	Alive	T2	NX	M0	Stage II	G2	1	159.0	Liver	Intrahepatic Recurrence	TUMOR FREE																					Not Available	76	Not Available	4.40	Not Available	TCGA-FV-A3I0	A8C2AA08-9156-4845-AD77-5E060858C757	Not Available	0.4	Not Available	Not Available	Not Available	Not Available	Not Available	16	-28101	Not Applicable	0	6	Not Available	TCGA-FV-A3I0-D57855	CE83DB6D-029E-4406-84CE-771A43CC490D	Not Available	27	586	166	Gemcitabine	Clinical Progressive Disease	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-FV-A3I0-F57854	D8CBBFD6-88E3-477D-914A-7CF67093DC68	27	Not Applicable	848	Not Available	NO	3	YES	NO	Not Available	159	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	FEMALE	Not Available	Hepatocholangiocarcinoma (Mixed)	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8171/3	C22.0	YES	Not Available	Not Available	4	G2													Not Available	No	A3I0	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2	YES	NO	FV	Not Available	Liver	Micro	Not Available	Alive	Not Available	2012	2011
TCGA-UB-A7MB	24	MALE	180	601	62	19.135802469135804	Hepatocellular Carcinoma	Liver	Alive	T2	NX	MX	Stage II	G3	1	48.0	Liver	Intrahepatic Recurrence	WITH TUMOR		NO;YES	Radiofrequency Ablation	Not Applicable	365	1	1	TCGA-UB-A7MB-A69955;TCGA-UB-A7MB-A63685	3A2D60D6-5CD4-43E6-957D-F2B0EF1EC49F;0F7DA27F-5C06-479C-B6BD-1CD6AA8A6B65	22;15	YES;YES	390;428;85;112;390;417	Mitomycin C;Doxorubicin;Doxorubicin;Doxorubicin;Doxorubicin;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Chemoembolization;Chemoembolization;Chemoembolization;Chemoembolization;Chemoembolization;Radioembolization	Other, specify;Plastic Beads;Plastic Beads;Plastic Beads;Other, specify;Y-90 Therasphere	Ethiodol;Not Applicable;Not Applicable;Not Applicable;Ethiodol;Not Applicable	1;8	2014;2014		None	24	3.5	3.1	4.8	TCGA-UB-A7MB	AF1E56AF-410C-4CAD-A4E8-1C6937F1A350	0.2	0.4	Not Available	A	0.7	1.2	0.4	15	-8951	Not Applicable	0	526	Not Available	TCGA-UB-A7MB-D63686;TCGA-UB-A7MB-D63687;TCGA-UB-A7MB-D63688;TCGA-UB-A7MB-D63689;TCGA-UB-A7MB-D63690	B5DB5B04-A285-4B4F-9677-5EF63DC2CC7A;12487060-F921-47CB-B022-758C8911EEB3;E1751217-035E-4A98-9E0D-0A4B84DF6C7A;008CFE07-942D-4EAD-B4F7-D21BA4F9BF5D;0A33C84D-D75A-4EA7-9ABD-8EF3BB748571	Not Available;TORC1/2 inhibitor;Not Available;Not Available;IMID	15;15;15;15;15	168;382;510;510;Not Available	123;187;480;480;525	sorafenib;Not Available;5-fluorouracil;oxaliplatin;Not Available	Clinical Progressive Disease;Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease;Not Applicable	8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES	Targeted Molecular therapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;YES;NO;NO;YES	2014;2014;2014;2014;2014	0	NOT HISPANIC OR LATINO	0	8	1865	0 - No Fibrosis	TCGA-UB-A7MB-F67159	7220B0CF-105F-4956-A9AC-E0C7CB09C928	31	Not Applicable	601	Not Available	NO	10	YES	NO	Not Available	48	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	MALE	180	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.2	8	G3	YES	NO	Not Available	48	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	A7MB	WITH TUMOR	583	140	450	NO	NO	1.0	WHITE	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	YES	NO	UB	1.3	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Core Antibody	Alive	62	2014	2013
TCGA-ZP-A9CZ	72	MALE	167	706	73	26.175194521137367	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX		G1	0	706			TUMOR FREE																					Not Available	72	3.5	4.4	5.2	TCGA-ZP-A9CZ	22077056-067D-4DB5-98E5-106778CECA56	0.2	0.5	2	A	Not Available	Not Available	Not Available	28	-26403	Not Applicable	0	706	Not Available																								0	NOT HISPANIC OR LATINO	0	8	8	3,4 - Fibrous Speta	TCGA-ZP-A9CZ-F57754	12DFA8BD-8EB7-4676-ABC2-F1B2CF93CA73	28	Not Applicable	706	Not Available	NO	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	167	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.6	12.6	3	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9CZ	TUMOR FREE	Not Available	Not Available	Not Available	NO	NO	11.5	ASIAN	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	ZP	1.2	Liver	None	Hepatitis B Surface Antigen	Alive	73	2014	2011
TCGA-MI-A75H	77	MALE	173	747	84	28.066423869825254	Hepatocellular Carcinoma	Liver	Alive		NX	MX		Not Available	1	301.0	Liver	Locoregional Recurrence	TUMOR FREE		YES	Radiofrequency Ablation	Not Applicable	350	1	1	TCGA-MI-A75H-A51546	DF17533C-CE9B-483C-8C88-23C6240447E1	20	YES	746	Doxorubicin	Not Applicable	Chemoembolization	Plastic Beads	Not Applicable	11	2013		Not Available	77	3.5	3.3	4.9	TCGA-MI-A75H	F3F6BA92-C68F-4313-99F4-0281272E02B6	0.2	2.3	Not Available	B	0.6	1.3	Not Available	20	-28371	Not Applicable	0	391	Not Available																								1	NOT HISPANIC OR LATINO	0	9	11	6 - Established Cirrhosis	TCGA-MI-A75H-F68684	5E2776B3-6D43-4039-9D24-D33D3C428D66	9	Not Applicable	747	Not Available	NO	1	NO	NO	Not Available	307	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	R0	YES	WITH TUMOR	YES	NO	NO	Alive	2015	MALE	173	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	11	Not Available	NO	NO	Not Available	301	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	R0	YES	Yes	A75H	TUMOR FREE	138	150	450	NO	NO	1.1	WHITE	NO																			Unknown	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	Not Available	NO	YES	MI	1.2	Liver	Micro	HCV Genotype	Alive	84	2013	2012
TCGA-G3-A5SJ	59	MALE	171	698	87	29.752744434184876	Hepatocellular Carcinoma	Liver	Alive	T1	NX	M0	Stage I	G2	1	308.0	Liver	Intrahepatic Recurrence	WITH TUMOR		YES	Radiofrequency Ablation	Not Applicable	364	1	1	TCGA-G3-A5SJ-A42748	743F0876-028E-4792-9D8B-F8673D375F17	30	NO	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	4	2013		Mild	59	3.3	4.1	4.8	TCGA-G3-A5SJ	2C8A1E74-33DE-453F-8D1E-E226185E52FC	0	0.5	Not Available	B	0.6	1.4	1.3	15	-21848	Not Applicable	0	364	Not Available																								0	NOT HISPANIC OR LATINO	0	10	3	6 - Established Cirrhosis	TCGA-G3-A5SJ-F62744	C9F56CA2-0397-4A20-AF57-196F2E22301A	24	Not Applicable	698	Not Available	NO	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	171	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	5	G2	NO	NO	Not Available	308	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	A5SJ	WITH TUMOR	136	150	400	NO	NO	1	WHITE	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1	NO	YES	G3	1.4	Liver	None	Not Available	Alive	87	2013	2012
TCGA-DD-AAD0	73	FEMALE	150	137	54	24.0	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	1	47.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					Mild	73	3.8	3.4	5.3	TCGA-DD-AAD0	09790A9B-CC2F-4D7E-A971-8FB4ECD9F791	0.2	0.8	Not Available	A	0.7	1.5	0.5	29	-26781	Not Applicable	0	137	Not Available																								0	NOT HISPANIC OR LATINO	0	8	4	Unknown	TCGA-DD-AAD0-F68383	627DD116-40F6-4F89-A4FF-BC7718D8897A	17	Not Applicable	137	Not Available	YES	11	NO	NO	Not Available	47	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	FEMALE	150	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G2	NO	NO	Not Available	47	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AAD0	WITH TUMOR	86	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	54	2014	2010
TCGA-ED-A82E	60	FEMALE	150	408	44	19.555555555555557	Hepatocellular Carcinoma	Liver	Alive	T3a	N0	M0	Stage IIIA	G2	0	408			TUMOR FREE																					Mild	60	3.8	4.3	5.1	TCGA-ED-A82E	A96B67BA-6180-4B80-8792-877860421CA0	0.1	0.4	Not Available	Unknown	4.1	5.8	2.8	7	-22234	Not Applicable	0	6	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	20	4	Not Available	TCGA-ED-A82E-F65333	E6E29D52-CCA7-4BF8-8CDE-F2DBA532947D	22	Not Applicable	408	Not Available	NO	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	150	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.3	1.3	1	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A82E	TUMOR FREE	261	150	400	NO	Unknown	0.9	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3a	YES	NO	ED	1.3	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	44	2014	2013
TCGA-BC-A5W4	69	MALE	183	547	106	31.652184299322165	Hepatocellular Carcinoma	Liver	Dead	T3a	NX	M0	Stage IIIA	G3	1	384.0		Locoregional Recurrence	TUMOR FREE																					None	69	3.5	4.2	5.0	TCGA-BC-A5W4	6BB5D506-8FCA-43F3-90A6-03C915D7EDE2	0.0	0.6	Not Available	A	0.70	1.30	Not Available	20	-25503	Not Applicable	0	289	Not Available																								Unknown	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-BC-A5W4-F57584	40257579-8EA1-49F9-A0EC-3BF236327CBF	17	547	Not Available	Not Available	NO	3	NO	NO	Not Available	384	Not Available	Not Available	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	TUMOR FREE	NO	NO	NO	Dead	2014	MALE	183	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.9	13.0	5	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Yes	A5W4	TUMOR FREE	102000	150000	440000	NO	NO	12.9	WHITE	NO																			NO	R1	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T3a	YES	NO	BC	1.2	Liver	Micro	Not Available	Alive	106	2013	2012
TCGA-DD-AAEI	72	MALE	166	1531	79	28.668892437218755	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	1	491.0	Bone	Extrahepatic Recurrence	WITH TUMOR		YES	Radiofrequency Ablation	Not Applicable	1352	1	1	TCGA-DD-AAEI-A66239	CA6D87A8-4CDC-47EC-80E3-E3F46B605C09	6	NO	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	10	2014		None	72	3.8	3.6	5.3	TCGA-DD-AAEI	34416BE6-B6D6-4029-B899-9BA685E39590	0.2	0.5	Not Available	A	0.7	1.5	0.9	15	-26465	Not Applicable	0	1233	Not Available																								0	NOT HISPANIC OR LATINO	0	8	24	6 - Established Cirrhosis	TCGA-DD-AAEI-F68433	51D1C7ED-6183-44EC-B047-826C67803FEB	17	Not Applicable	1531	Not Available	NO	11	NO	YES	Not Available	491	Not Available	Bone	Extrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	YES	NO	NO	Alive	2014	MALE	166	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G2	NO	YES	Not Available	491	Not Available	Bone	Extrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	AAEI	WITH TUMOR	161	130	400	YES	NO	1.1	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	79	2014	2010
TCGA-2Y-A9GT	51	MALE	182	1624	122	36.831300567564305	Hepatocellular Carcinoma	Liver	Dead	T1	NX	MX	Stage I	G2	1	1083.0	Liver	Locoregional Recurrence	WITH TUMOR		NO						TCGA-2Y-A9GT-A66917	2D8CCE67-5CA1-4B90-AAFD-04B8C2CF2B5D	27	YES	Not Available;1547	Doxorubicin;Not Available	Not Applicable;Not Applicable	Chemoembolization;Radioembolization	Other, specify;Y-90 Therasphere	LC beads;Not Applicable	10	2014		None	51	3.5	3.7	5	TCGA-2Y-A9GT	31A2ECC5-2D45-4823-8187-DC701DD412A8	0.2	0.4	1	C	0.8	1.5	0.8	3	-18768	1624	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	Not Available	7	17	Unknown																												MALE	182	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G2	NO	NO	Not Available	1083	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	A9GT	WITH TUMOR	187	143	382	Unknown	NO	9.8	WHITE	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	2Y	1.3	Liver	None	Hepatitis C Virus RNA;Hepatitis B Surface Antigen;HBV Core Antibody;HBV DNA	Dead	122	2014	2006
TCGA-XR-A8TD	49	FEMALE	156	1030	69	28.353057199211044	Hepatocellular Carcinoma	Liver	Alive	T3	N0	M0	Stage IIIB	G3	0	1030			TUMOR FREE																					None	49	3.5	3.8	4.8	TCGA-XR-A8TD	574BA00B-FEE6-4AAB-AC01-6FFAF8FDC0C5	0.2	0.7	Not Available	A	0.7	1.5	0.5	20	-17908	Not Applicable	0	1030	Not Available																								1	HISPANIC OR LATINO	6	6	188	0 - No Fibrosis	TCGA-XR-A8TD-F72319	F83276E2-B648-4A1A-AAFC-50812CC5BB54	20	Not Applicable	1030	Not Available	NO	5	NO	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	NO	No	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2015	FEMALE	156	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8174/3	C22.0	YES	0	1.3	5	G3	NO	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	NO	No	Not Available	NO	No	A8TD	TUMOR FREE	334000	150000	450000	NO	NO	1.1	WHITE	NO																			Unknown	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	XR	1.2	Liver	None	Not Available	Alive	69	2015	2012
TCGA-2Y-A9H4	68	MALE	167	1452	61	21.872422819032593	Hepatocellular Carcinoma	Liver	Alive	T1	N0	MX	Stage I	G2	0	1452			TUMOR FREE																					Unknown	68	3.5	4.6	5	TCGA-2Y-A9H4	801B1D2C-EB6F-4EEF-A00B-83DA939D755A	0.2	0.3	2	A	0.8	1.5	1.2	3	-25096	Not Applicable	0	1270	Not Available																								0	NOT HISPANIC OR LATINO	0	7	11	Unknown	TCGA-2Y-A9H4-F69087	33D613BC-FC38-46C3-8CE3-3D4C67EDAF6E	29	Not Applicable	1452	Not Available	NO	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	167	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9H4	TUMOR FREE	223	143	382	NO	NO	11	BLACK OR AFRICAN AMERICAN	NO																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	NO	YES	2Y	1.3	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	61	2014	2010
TCGA-DD-AACD	48	MALE	182	381	66	19.925129815239707	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G4	1	151.0	Lung	Locoregional Recurrence	WITH TUMOR																					Mild	48	3.8	3.9	5.3	TCGA-DD-AACD	41FB30AA-63B4-4CC6-A275-B77048612FA0	0.2	0.3	3	A	0.7	1.5	1.0	28	-17828	381	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	8	2	1,2 - Portal Fibrosis																												MALE	182	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G4	NO	YES	Not Available	151	Not Available	Lung	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AACD	WITH TUMOR	268	130	400	NO	NO	6.9	ASIAN	NO																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	Micro	Unknown	Dead	66	2014	2008
TCGA-BC-A112	80	MALE	165	153	97	35.62901744719927	Hepatocellular Carcinoma	Liver	Dead	T3	NX	MX		G2	0	153			TUMOR FREE																					Not Available	80	3.5	4.1	5.0	TCGA-BC-A112	a2c17e87-d8bc-4160-88ae-e3e894d013e4	0.0	0.3	Not Available	Not Available	0.7	1.3	2.1	1	-29511	153	0	Not Available	Not Available																								Not Available	NOT HISPANIC OR LATINO	0	10	233	0 - No Fibrosis	TCGA-BC-A112-F9980	C082991E-EF98-40D7-9AC1-84134B7D51BA	4	153	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No New Tumor Event	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Dead	2011	MALE	165	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	4	G2													Not Available	Yes	A112	TUMOR FREE	218	150	440	Not Available	Not Available	1.1	WHITE	Not Available																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3	NO	YES	BC	1.2	Liver	None	Not Available	Dead	97	2011	2009
TCGA-2Y-A9GV	54	FEMALE	167	2532	85	30.477966223242138	Hepatocellular Carcinoma	Liver	Dead	T1	NX	MX	Stage I	G1	1	2189.0	Other, specify	Extrahepatic Recurrence	WITH TUMOR																					Unknown	54	3.5	4.2	5	TCGA-2Y-A9GV	D1AA9C1A-D732-48C0-B669-8A14E0397344	0.2	0.3	Not Available	Unknown	0.8	1.5	0.6	3	-20011	2532	0	Not Available	Not Available	TCGA-2Y-A9GV-D66920	2ED70472-0453-4F85-9A75-C8A9A6BDD3A9	Not Available	3	2304	2233	Naxavar	Clinical Progressive Disease	11	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	2	NOT HISPANIC OR LATINO	Not Available	7	6	Unknown																												FEMALE	167	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G1	YES;YES	NO;NO	2190;Not Available	2189;1745	Not Available;Not Available	Other, specify;Other, specify	Extrahepatic Recurrence;New Primary Tumor	Soft Tissue;Renal met from prior lung primary	No;No	YES;NO	No;No	RX;Not Available	YES	Yes	A9GV	WITH TUMOR	370	143	382	NO	YES	9.5	WHITE	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	2Y	1.3	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Core Antibody	Dead	85	2014	2007
TCGA-DD-AADJ	70	FEMALE	154	1066	59	24.87771968291449	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	1066			TUMOR FREE																					Unknown	70	3.8	4.2	5.3	TCGA-DD-AADJ	1D880AEA-9EFE-4A43-8A6A-6A81801DA9E0	0.2	0.6	Not Available	A	0.7	1.5	0.6	7	-25863	Not Applicable	0	730	Not Available																								0	NOT HISPANIC OR LATINO	0	8	708	Unknown	TCGA-DD-AADJ-F68396	2C587B55-F5B0-4F85-8476-293287824E1C	17	Not Applicable	1066	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	154	Hepatocellular Carcinoma	Unknown	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AADJ	TUMOR FREE	203	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	59	2014	2011
TCGA-CC-5260	61	FEMALE	153	87	46	19.650561749754367	Hepatocellular Carcinoma	Liver	Dead	T4	N0	M0	Stage IIIC	G1	0	87			TUMOR FREE																					Not Available	61	Not Available	Not Available	Not Available	TCGA-CC-5260	ca8afb2c-be3d-41e8-8dbc-19fe7ab6154b	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	15	-22345	Not Applicable	0	0	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-5260-F20330	633C1A41-D9D6-454B-812F-A85A512E54E0	9	87	Not Available	Scheduled Follow-up Submission	Not Available	1													NO	TUMOR FREE	NO	NO	NO	Dead	2012	FEMALE	153	Hepatocellular Carcinoma	Not Available	Not Available	No	Hepatic Resection	C22.0	8170/3	C22.0	YES	Not Available	Not Available	4	G1													Not Available	No	5260	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			NO	RX	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4	YES	NO	CC	Not Available	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	46	2011	2010
TCGA-LG-A6GG	79	FEMALE	158	387	65	26.03749399134754	Hepatocellular Carcinoma	Liver	Alive	T2	NX	M0	Stage II	G2	0	387			TUMOR FREE																					None	79	3.4	3.7	4.8	TCGA-LG-A6GG	C618DA6D-3C66-4A6A-8832-3526A3B75410	0.2	0.8	Not Available	A	0.4	1.1	0.6	25	-28871	Not Applicable	0	15	Not Available																								0	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Unknown	TCGA-LG-A6GG-F59890	D62DCB6F-5C02-4774-A5E3-EF271BCD6EA8	22	Not Applicable	387	Not Available	NO	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	158	Hepatocellular Carcinoma	Other	Cryptogenic Cirrhosis	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.4	12.2	9	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Yes	A6GG	TUMOR FREE	93	150	450	NO	NO	12.2	WHITE	NO																			Unknown	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2	YES	NO	LG	1.0	Liver	Micro	Not Available	Alive	65	2013	2013
TCGA-G3-AAV0	58	MALE	158	476	58	23.233456176894727	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	476			TUMOR FREE																					None	58	3.3	4.2	4.8	TCGA-G3-AAV0	6E657705-8579-433B-AF7A-B6155B599518	0	0.6	Not Available	A	0.6	1.4	0.9	14	-21249	Not Applicable	0	260	Not Available																								0	NOT HISPANIC OR LATINO	0	10	4	0 - No Fibrosis	TCGA-G3-AAV0-F67245	5239FD45-92AF-485F-8DE2-64A0F242F9B9	3	Not Applicable	476	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	158	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAV0	TUMOR FREE	193	150	400	NO	NO	0.9	ASIAN	NO																			Unknown	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	YES	NO	G3	1.4	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Surface Antibody	Alive	58	2014	2013
TCGA-DD-AACQ	50	MALE	169	432	64	22.408178985329645	Hepatocellular Carcinoma	Liver	Dead	T2	N0	M0	Stage II	G3	1	105.0	Liver	Locoregional Recurrence	WITH TUMOR																					Unknown	50	3.8	4.2	5.3	TCGA-DD-AACQ	0F34D654-8984-4B8B-B345-67066D611513	0.2	0.8	Not Available	A	0.7	1.5	1.3	29	-18429	Not Applicable	0	429	Not Available																								0	NOT HISPANIC OR LATINO	0	8	7	Unknown	TCGA-DD-AACQ-F68375	10BFD5A1-1B34-48E9-B8B3-9D71D8EAED29	17	432	Not Available	Not Available	NO	11	NO;NO	NO;YES	Not Available;Not Available	105;105	Not Available;Not Available	Liver;Bone	Locoregional Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable	Yes;No	NO;NO	No;No	Not Available;Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2014	MALE	169	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	NO;NO	NO;YES	Not Available;Not Available	105;105	Not Available;Not Available	Liver;Bone	Locoregional Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable	Yes;No	NO;NO	No;No	Not Available;Not Available	YES	No	AACQ	WITH TUMOR	157	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.2	Liver	None	Unknown	Alive	64	2014	2009
TCGA-KR-A7K7	61	FEMALE	168	951	125	44.288548752834465	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G1	1	239.0	Other, specify	Extrahepatic Recurrence	WITH TUMOR																					Not Available	61	3.5	3.4	4.9	TCGA-KR-A7K7	7BA3D8F1-0C26-4C49-8D6B-0F2875B58DAF	0.2	1.4	Not Available	Unknown	0.5	1.0	0.8	27	-22587	Not Applicable	0	407	Not Available																								Unknown	Not Evaluated	0	8	308836	Not Available	TCGA-KR-A7K7-F61860;TCGA-KR-A7K7-F71440	83047A44-C79C-4E44-96C9-F91EE1C0B21A;45F7341B-DEFA-4F8B-946B-207FA381D8D1	9;25	Not Applicable;Not Applicable	407;951	Not Available;Not Available	NO;NO	7;3	YES;YES	NO;NO	Not Available;Not Available	239;239	Not Available;Not Available	Other, specify;Other, specify	Extrahepatic Recurrence;Extrahepatic Recurrence	Adrenal bilateral;Adrenal	No;No	NO;NO	No;No	Not Available;Not Available	YES;YES	WITH TUMOR;WITH TUMOR	NO;NO	NO;NO	NO;NO	Alive;Alive	2014;2015	FEMALE	168	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	5	G1	NO	NO	Not Available	239	Not Available	Other, specify	Extrahepatic Recurrence	Bilateral Adrenal	No	NO	No	Not Available	YES	Yes	A7K7	WITH TUMOR	130	150	400	NO	NO	1.0	WHITE	NO																			Unknown	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	KR	1.2	Liver	Micro	Unknown	Alive	125	2014	2012
TCGA-DD-A4NJ	54	FEMALE	164	928	88	32.71861986912552	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	1	549.0	Liver	Intrahepatic Recurrence	TUMOR FREE		YES	Radiofrequency Ablation	Not Applicable	577	Not Available	1	TCGA-DD-A4NJ-A49652	138B9C68-C27D-4F7F-9EA2-D034888BDB34	7	NO	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	10	2013		Mild	54	3.5	4.7	5.0	TCGA-DD-A4NJ	815DFFB0-0C22-4E05-868C-26E6C553980A	0.1	0.4	1	A	0.6	1.1	0.7	5	-19964	Not Applicable	0	458	Not Available																								0	NOT HISPANIC OR LATINO	0	6	5	1,2 - Portal Fibrosis	TCGA-DD-A4NJ-F49651;TCGA-DD-A4NJ-F59477	AADA9289-F661-4045-BF22-309A78F40ED6;42CB47E5-0ECF-49E7-B6AD-3142BDCCB277	7;13	Not Applicable;Not Applicable	760;928	Not Available;Not Available	NO;NO	10;5	NO;NO	NO;NO	Not Available;Not Available	553;549	Not Available;Not Available	Liver;Liver	Intrahepatic Recurrence;Intrahepatic Recurrence	Not Applicable;Not Applicable	Yes;Yes	NO;NO	Not Available;No	Not Available;Not Available	YES;YES	WITH TUMOR;WITH TUMOR	NO;NO	NO;NO	NO;NO	Alive;Alive	2013;2014	FEMALE	164	Hepatocellular Carcinoma	Non-Alcoholic Fatty Liver Disease	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.5	13.8	2	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A4NJ	TUMOR FREE	303	150	450	NO	NO	11.5	WHITE	NO																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	88	2013	2011
TCGA-DD-AAVV	56	MALE	158	2455	71	28.440954975164235	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G3	0	2455			TUMOR FREE																					Mild	56	3.3	4.6	5.2	TCGA-DD-AAVV	915F531B-8448-41C7-9DFB-9C83062B906E	0.2	0.9	Not Available	A	0	1.4	1.3	1	-20751	Not Applicable	0	2455	Not Available																								1	NOT HISPANIC OR LATINO	0	15	7	3,4 - Fibrous Speta	TCGA-DD-AAVV-F68858	3437BB9C-1DDE-4156-8F36-C95D51454D73	21	Not Applicable	2455	Not Available	YES	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	158	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	10	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	NO	No	Not Available	NO	No	AAVV	TUMOR FREE	244	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	71	2014	2007
TCGA-DD-AAC8	72	MALE	156	16	57	23.422090729783037	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G3	0	16			TUMOR FREE																					Mild	72	3.8	4.3	5.3	TCGA-DD-AAC8	496BEEF9-80D9-4734-A23D-334AE1B6AAAB	0.2	0.6	Not Available	A	0.7	1.5	1.1	28	-26322	16	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	8	1	1,2 - Portal Fibrosis																												MALE	156	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAC8	TUMOR FREE	177	130	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	Micro	Unknown	Dead	57	2014	2008
TCGA-G3-A25W	79	FEMALE	157	935	48	19.473406629072173	Hepatocellular Carcinoma	Liver	Alive	T3b	N0	M0	Stage IIIB	G2	0	935			TUMOR FREE																					None	79	0.3	0.4	0.5	TCGA-G3-A25W	06AC44E9-1226-4202-828B-6F224766D7AC	0	0.3	3	A	0.4	1.1	1.5	27	-29018	Not Applicable	0	391	Not Available																								0	NOT HISPANIC OR LATINO	0	9	6	0 - No Fibrosis	TCGA-G3-A25W-F40230	60EB4239-581C-40E6-97EF-DEB40EE4702F	14	Not Applicable	935	Not Available	NO	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2013	FEMALE	157	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	7	G2													Not Available	Yes	A25W	TUMOR FREE	308	150	400	Not Available	Not Available	0.9	WHITE	Not Available																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3b	NO	YES	G3	1.2	Liver	Macro	Not Available	Alive	48	2011	2010
TCGA-WJ-A86L	68	FEMALE	159	345	56	22.151022507021082	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G2	0	345			Unknown																					None	68	3.4	4.2	4.8	TCGA-WJ-A86L	63D475EF-8F26-45ED-AE80-CFA87E68B2F5	0.1	0.5	Not Available	A	0.5	1.1	0.9	29	-25018	Not Applicable	0	31	Not Available																								1	NOT HISPANIC OR LATINO	Not Available	6	16	0 - No Fibrosis	TCGA-WJ-A86L-F65568	12FDF77B-672C-44DD-A092-DEAD092E0C7E	26	Not Applicable	345	Not Available	NO	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	159	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8310/3	C22.0	YES	2.0	3.0	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A86L	Unknown	257000	125000	415000	NO	NO	0.9	WHITE	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	WJ	1.2	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Surface Antibody	Alive	56	2014	2013
TCGA-CC-A3MB	36	MALE	176	315	58	18.72417355371901	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G1	1	260.0	Lung	New Primary Tumor	TUMOR FREE																					Not Available	36	Not Available	Not Available	Not Available	TCGA-CC-A3MB	2C53D48D-E3BC-49F3-BBE0-2EEE24252B4C	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	-13255	Not Applicable	0	3	Not Available																								3	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A3MB-F70908	486DE01F-7DD3-4300-926B-A14DD98666CB	10	315	Not Available	Not Available	NO	3	NO	NO	Not Available	260	Not Available	Lung	New Primary Tumor	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2015	MALE	176	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G1													Not Available	No	A3MB	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	Not Available	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	58	2012	2011
TCGA-G3-A7M7	65	MALE	181	361	77	23.503556057507403	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G1	0	361			TUMOR FREE																					Severe	65	3.2	3.5	4.6	TCGA-G3-A7M7	3D048A45-3D5D-4563-ACC8-3C662861F18A	0	0.5	Not Available	A	0.7	1.2	0.6	5	-24002	Not Applicable	0	182	Not Available																								0	NOT HISPANIC OR LATINO	0	7	4	3,4 - Fibrous Speta	TCGA-G3-A7M7-F67243	2394BC71-9ED7-43E0-84DD-BE17F84C0A77	3	Not Applicable	361	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	181	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	2	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7M7	TUMOR FREE	145	150	450	NO	NO	1.1	WHITE	NO																			Unknown	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	G3	1.2	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	77	2014	2013
TCGA-DD-AADC	53	MALE	176	425	81	26.14927685950413	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G3	1	101.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					Unknown	53	3.8	3.8	5.3	TCGA-DD-AADC	4100FD8B-CF37-4E63-A73D-95C9C392D606	0.2	0.7	Not Available	A	0.7	1.5	0.8	7	-19527	425	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	8	36	Unknown																												MALE	176	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	NO	NO	Not Available	101	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AADC	WITH TUMOR	212	130	400	NO	NO	1.2	ASIAN	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	Macro	Unknown	Dead	81	2014	2011
TCGA-DD-AACC	61	MALE	165	1685	61	22.405876951331496	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G2	1	537.0	Liver	Locoregional Recurrence	WITH TUMOR																					Mild	61	3.8	3.9	5.3	TCGA-DD-AACC	ED8C0D53-5DB0-4B77-95EC-15971926E313	0.2	0.5	Not Available	A	0.7	1.5	1.3	28	-22499	1685	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	8	24	6 - Established Cirrhosis																												MALE	165	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8180/3	C22.0	YES	1.0	1.0	6	G2	NO	NO	Not Available	537	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AACC	WITH TUMOR	208	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Dead	61	2014	2008
TCGA-G3-A25T	45	FEMALE	167	1553	64	22.948115744558788	Hepatocellular Carcinoma	Liver	Alive	T3	N0	M0	Stage IIIA	G2	1	452.0	Liver	Intrahepatic Recurrence	TUMOR FREE																					None	45	0.3	0.4	0.5	TCGA-G3-A25T	F6E5979D-D6A9-4408-BD1B-1B37D1064E83	0	2.0	Not Available	A	0.4	1.4	0.7	27	-16461	Not Applicable	0	1175	Not Available																								0	NOT HISPANIC OR LATINO	0	10	7	0 - No Fibrosis	TCGA-G3-A25T-F33639	8015C982-808B-4C1E-80B0-CB7F0B75BBA7	11	Not Applicable	1553	Scheduled Follow-up Submission	Not Available	7	NO	NO	452	452	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	YES	No	R0	YES	WITH TUMOR	NO	NO	NO	Alive	2012	FEMALE	167	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	7	G2													Not Available	No	A25T	TUMOR FREE	306	150	400	Not Available	Not Available	1.1	WHITE	Not Available																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	G3	1.4	Liver	None	Not Available	Alive	64	2011	2007
TCGA-G3-A3CH	53	MALE	178	780	74	23.355636914530994	Hepatocellular Carcinoma	Liver	Alive	T3a	N0	M0	Stage IIIA	G2	1	116.0	Liver	Intrahepatic Recurrence	TUMOR FREE																					Severe	53	0.3	0.3	0.5	TCGA-G3-A3CH	3A2D7482-C246-411E-841F-71D96E353328	0	0.7	Not Available	A	0.6	1.4	0.9	11	-19473	Not Applicable	0	193	Not Available	TCGA-G3-A3CH-D40096	DC72364F-DDFD-4B54-9477-F29E3142536B	Not Available	12	Not Available	717	Sorafenib	Not Applicable	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	NOT HISPANIC OR LATINO	0	10	41	6 - Established Cirrhosis	TCGA-G3-A3CH-F40093	70FB1925-4E06-4CD1-B9D5-A1E3001732B5	12	Not Applicable	780	Not Available	NO	2	NO;NO;NO;YES	NO;NO;NO;NO	180;359;431;Not Available	116;316;406;558	Not Available;Not Available;Not Available;Not Available	Liver;Liver;Liver;Other, specify	Intrahepatic Recurrence;Intrahepatic Recurrence;Intrahepatic Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable;Not Applicable;Spleen	No;No;No;No	YES;YES;YES;NO	No;No;No;No	Not Available;Not Available;Not Available;Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2013	MALE	178	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	1	G2													Not Available	No	A3CH	TUMOR FREE	142	150	400	Not Available	Not Available	1.2	ASIAN	Not Available																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3a	NO	YES	G3	1.4	Liver	None	Not Available	Alive	74	2012	2010
TCGA-HP-A5N0	90	FEMALE	156	752	65	26.70940170940171	Hepatocellular Carcinoma	Liver	Dead	TX	NX	M0		Not Available	1	179.0	Liver	Locoregional Recurrence	WITH TUMOR																					None	90	3.5	2.6	4.8	TCGA-HP-A5N0	7F8E25D4-6021-4327-96AB-79B6FCC97A24	Not Available	Not Available	3	Unknown	0	0.9	0.5	30	-32120	752	0	Not Available	Not Available																								0	Not Evaluated	Not Available	Not Available	Not Available	0 - No Fibrosis	TCGA-HP-A5N0-F70727	5BF63BAF-32F5-472F-8435-8889581D9286	2	752	Not Available	Not Available	NO	3	NO	NO	Not Available	179	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2015	FEMALE	156	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8174/3	C22.0	YES	0.9	1.2	5	Not Available	NO	NO	Not Available	185	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	A5N0	WITH TUMOR	Not Available	Not Available	Not Available	NO	NO	1.2	Not Evaluated	NO																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	NX	TX	NO	YES	HP	Not Available	Liver	Unknown	Unknown	Dead	65	2014	Not Available
TCGA-DD-A3A7	67	MALE	188	419	80	22.634676324128566	Hepatocellular Carcinoma	Liver	Dead	T3b	N0	M0	Stage IIIB	G3	1	144.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					Mild	67	Not Available	Not Available	Not Available	TCGA-DD-A3A7	614C0ECF-6A84-4C86-8706-79BE5BB00991	0.1	0.8	4	Unknown	0.8	1.2	1.4	9	-24599	419	0	Not Available	Not Available	TCGA-DD-A3A7-D42005	30C072AE-2E51-4A99-82A1-9F7734A11DC5	Phase II	9	192	146	Not Available	Clinical Progressive Disease	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	YES	2013	1	Unknown	0	6	120	0 - No Fibrosis	TCGA-DD-A3A7-F42004	E21AE0B6-1747-43F4-86F6-8426E00ED875	9	419	Not Available	Not Available	NO	4	YES	NO	Not Available	144	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2013	MALE	188	Hepatocellular Carcinoma	Alcohol consumption;Other	tobacco	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	4	G3	YES	NO	Not Available	144	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	A3A7	WITH TUMOR	562	150	450	NO	NO	10.6	Unknown	NO																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3b	NO	YES	DD	1.1	Liver	Micro	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Dead	80	2013	1998
TCGA-BC-4073	73	MALE	Not Available	849	Not Available		Hepatocellular Carcinoma	Liver	Alive	T3	N0	MX	Stage IIIA	G3	0	849			WITH TUMOR																					Not Available	73	Not Available	Not Available	Not Available	TCGA-BC-4073	00f209c3-041a-4c6e-8b0f-6383eb3c85fc	0.0	0.7	3	Not Available	0.7	1.3	1.5	20	-26795	Not Applicable	0	352	Not Available	TCGA-BC-4073-D6868;TCGA-BC-4073-D30830	9E049E94-1D4F-49C4-9689-A93EF69D5B9D;63E0D664-0D86-4265-8609-3CA1E342E63B	Not Available;Not Available	21;17	Not Available;Not Available	81;166	Sorafenib;Sorafenib	Not Available;Not Available	12;4	Not Available;Not Available	400;200	mg;mg	PROGRESSION;OTHER, SPECIFY IN NOTES	Not Applicable;dose reduction	1;2	PO;PO	YES;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	800;400	mg/day;mg/day	Not Available;Not Available	2010;2012	0	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-BC-4073-F6829;TCGA-BC-4073-F30829	2CD7C266-0039-4E43-98B0-8364233C1F62;11AD6B07-A384-43A0-A6B7-8973B910FFD0	21;17	Not Applicable;Not Applicable	352;849	Not Available;Scheduled Follow-up Submission	Not Available;Not Available	12;4													NO;NO	WITH TUMOR;WITH TUMOR	NO;NO	NO;NO	NO;NO	Alive;Alive	2010;2012	MALE	Not Available	Hepatocellular Carcinoma	Hemochromatosis	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	12	G3													Not Available	No	4073	WITH TUMOR	253	150	440	Not Available	Not Available	1.0	WHITE	Not Available																			YES	R1	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3	NO	YES	BC	1.2	Liver	Macro	Not Available	Alive	Not Available	2010	2009
TCGA-2Y-A9HA	70	MALE	169	36	69	24.158817968558523	Hepatocellular Carcinoma	Liver	Dead	T2	NX	MX	Stage II	G2	0	36			WITH TUMOR		NO						TCGA-2Y-A9HA-A67272	52861D38-28FF-4D51-989C-88D2270EF75C	3	YES	0	Not Available	Not Applicable	Radioembolization	Other, specify	Habib	11	2014		None	70	3.5	3.5	5	TCGA-2Y-A9HA	A25A714E-C142-482B-91C8-4FEA763E0254	0.2	0.6	Not Available	A	0.8	1.5	0.8	3	-25892	36	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	7	114	3,4 - Fibrous Speta																												MALE	169	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9HA	WITH TUMOR	153	143	382	YES	NO	10.6	WHITE	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	NO	YES	2Y	1.3	Liver	Unknown	Hepatitis  C Antibody	Dead	69	2014	2012
TCGA-WX-AA44	64	FEMALE	152	615	61	26.40235457063712	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G3	1	246.0	Liver	Intrahepatic Recurrence	WITH TUMOR		NO						TCGA-WX-AA44-A70655	895DE754-2102-438F-9A1D-E4A8443D0344	2	YES	274	Not Available	Not Applicable	Radioembolization	Y-90 Sirsphere	Not Applicable	3	2012		None	64	3.5	4.4	5.0	TCGA-WX-AA44	5436FAFB-BC16-4450-AC8B-568E1E5EE5FE	0	0.5	Not Available	A	0.5	1.2	0.6	21	-23654	Not Applicable	0	473	Not Available	TCGA-WX-AA44-D70641	CF571D27-7579-40DA-8545-E2A600A0CDA1	Not Available	27	375	306	SORAFENIB	Partial Response	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Targeted Molecular therapy	Not Available	Not Available	Not Available	NO	2015	1	HISPANIC OR LATINO	0	6	48	6 - Established Cirrhosis	TCGA-WX-AA44-F68251	272E007E-5500-4BDF-A858-979649EDE0C6	14	Not Applicable	615	Not Available	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	WITH TUMOR	YES	YES	YES	Alive	2014	FEMALE	152	Hepatocellular Carcinoma	Non-Alcoholic Fatty Liver Disease	Not Available	No	LEFT LATERAL HEPATECTOMY	C22.0	8170/3	C22.0	YES	0.9	1.2	4	G3	YES	YES	Not Available	246	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	Not Available	No	Not Available	YES	No	AA44	WITH TUMOR	215	150	350	NO	YES	0.9	WHITE	YES	Primary Tumor Field	TCGA-WX-AA44-R70654	23145CED-9A16-4516-9724-23CFB2C8E2A9	Not Available	27	357	357	Partial Response	2	1	0.29	NO	Internal	Not Applicable	Not Available	Not Available	Not Available	2015	NO	RX	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	WX	1.20	Liver	None	Hepatitis  C Antibody	Alive	61	2014	2011
TCGA-DD-A39Z	43	FEMALE	165	601	61	22.405876951331496	Hepatocellular Carcinoma	Liver	Dead	T2	NX	M0	Stage II	G2	0	601			TUMOR FREE																					Not Available	43	3.5	3.1	5.0	TCGA-DD-A39Z	42CB60F0-1A9E-4F59-8E2E-50C25E85CB98	0.1	1.2	1	B	0.6	0.9	0.7	5	-15930	601	0	Not Available	Not Available																								2	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-DD-A39Z-F42006	EB9C8429-E4C0-498D-8722-87CD7C3938B5	24	601	Not Available	Not Available	NO	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE	Unknown	Unknown	Unknown	Dead	2013	FEMALE	165	Hepatocellular Carcinoma	Alcohol consumption	extensive tobacco history	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	1	G2													Not Available	No	A39Z	TUMOR FREE	437	150	450	Not Available	Not Available	12.6	Not Available	Not Available																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2	NO	YES	DD	1.1	Liver	None	Unknown	Dead	61	2012	1996
TCGA-DD-AAD5	54	MALE	170	1345	70	24.22145328719723	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	1	130.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					Mild	54	3.8	3.7	5.3	TCGA-DD-AAD5	6312D5B5-68AD-4D4F-A0A9-03D895AE30F9	0.2	0.6	Not Available	A	0.7	1.5	0.6	7	-19748	Not Applicable	0	1037	Not Available																								0	NOT HISPANIC OR LATINO	0	8	73	3,4 - Fibrous Speta	TCGA-DD-AAD5-F68387	1D542944-32E5-4A8C-B165-50F04B145853	17	Not Applicable	1345	Not Available	NO	11	NO;NO;NO	NO;NO;NO	Not Available;Not Available;Not Available	130;130;130	Not Available;Not Available;Not Available	Liver;Lung;Other, specify	Intrahepatic Recurrence;Extrahepatic Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable;intraperitoneum	No;No;No	NO;NO;NO	No;No;No	Not Available;Not Available;Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	MALE	170	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	NO;NO;NO	NO;NO;NO	Not Available;Not Available;Not Available	130;130;130	Not Available;Not Available;Not Available	Liver;Lung;Other, specify	Intrahepatic Recurrence;Extrahepatic Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable;intraperitoneum	No;No;No	NO;NO;NO	No;No;No	Not Available;Not Available;Not Available	YES	No	AAD5	WITH TUMOR	349	130	400	NO	NO	1.2	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	70	2014	2011
TCGA-2Y-A9H7	81	FEMALE	157	1168	104	42.192381029656374	Hepatocellular Carcinoma	Liver	Alive	T1	N0	MX	Stage I	G2	1	1117.0	Liver	Locoregional Recurrence	WITH TUMOR		YES	Microwave	Not Applicable	1168	1	2	TCGA-2Y-A9H7-A69177	27B927A0-C518-45CA-9B20-9D2337439A9C	6	NO	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	11	2014		None	81	3.5	3.4	5	TCGA-2Y-A9H7	18602EC8-AED1-4515-B0D1-0DB6D1CBB2C4	0.2	0.3	Not Available	A	0.8	1.5	1.2	3	-29752	Not Applicable	0	1133	Not Available																								2	NOT HISPANIC OR LATINO	0	7	6	3,4 - Fibrous Speta	TCGA-2Y-A9H7-F69176	7C7BD471-1984-4CA9-A943-85F0120D0B89	30	Not Applicable	1168	Not Available	NO	12	NO	NO	Not Available	1117	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	Discrepancy	NO	NO	Alive	2014	FEMALE	157	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G2	NO	NO	Not Available	1117	Not Available	Liver	Locoregional Recurrence	Not Applicable	Discrepancy	NO	No	Not Available	YES	Yes	A9H7	WITH TUMOR	165	143	382	NO	NO	10.8	WHITE	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	NO	YES	2Y	1.3	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	104	2014	2011
TCGA-DD-A1EJ	71	FEMALE	154	1005	64	26.986001011975038	Hepatocellular Carcinoma	Liver	Dead	T1	N1	M0	Stage IIIC	G2	1	263.0	Liver	Intrahepatic Recurrence	WITH TUMOR		NO						TCGA-DD-A1EJ-A42216	CB81B953-600C-4EA2-A887-9AC76DF2AC04	15	YES	277;300;424;495;760	Not Available;Not Available;Other;Other;Other	Not Applicable;Not Applicable;Doxorubicin/mitomycin;Doxorubicin/mitomycin;chemoembolic mixture	Radioembolization;Radioembolization;Chemoembolization;Chemoembolization;Chemoembolization	Y-90 Therasphere;Y-90 Therasphere;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	4	2013		Mild	71	3.2	3.5	5.0	TCGA-DD-A1EJ	52292ffc-0902-4d97-b461-20723987a177	0.1	0.7	1	B	0.6	1.1	0.6	10	-26009	Not Applicable	0	887	Not Available	TCGA-DD-A1EJ-D42213	432C8670-CC86-4488-92AC-E4C37DB72327	Not Available	15	887	264	Sorafenib	Clinical Progressive Disease	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	2	NOT HISPANIC OR LATINO	0	6	18840	0 - No Fibrosis	TCGA-DD-A1EJ-F42209	90900509-D9C8-46F1-ABC5-E5C6C01A03F8	15	1005	Not Available	Not Available	NO	4	YES	NO	Not Available	263	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2013	FEMALE	154	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	10.8	5	G2													Not Available	No	A1EJ	WITH TUMOR	608	150	450	Not Available	Not Available	10.2	WHITE	Not Available																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	64	2011	2008
TCGA-DD-A4NG	77	MALE	164	802	94	34.94943486020226	Hepatocellular Carcinoma	Liver	Dead	T3a	NX	M0	Stage IIIA	G2	1	430.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					None	77	3.5	4.5	5.0	TCGA-DD-A4NG	89791F8F-DC06-4A04-B166-AFBFD6CF53DE	0.1	0.5	1	A	0.8	1.3	0.9	29	-28234	Not Applicable	0	445	Not Available																								1	NOT HISPANIC OR LATINO	0	6	3	Unknown	TCGA-DD-A4NG-F49648	6BA2BBF5-A838-491F-863A-92AD1AEEC638	7	802	Not Available	Not Available	NO	10	Unknown	Unknown	Not Available	430	Not Available	Liver	Locoregional Recurrence	Not Applicable	Unknown	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2013	MALE	164	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	10.8	1	G2	Unknown	Unknown	Not Available	430	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Unknown	NO	No	Not Available	YES	No	A4NG	WITH TUMOR	220	150	450	NO	NO	10.6	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T3a	NO	YES	DD	1.0	Liver	Micro	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	94	2013	2011
TCGA-CC-A9FS	55	MALE	174	211	72	23.781212841854934	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	1	109.0	Lung	New Primary Tumor	TUMOR FREE																					Not Available	55	Not Available	Not Available	Not Available	TCGA-CC-A9FS	F661A921-2E59-424B-A145-E22664B73728	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	22	-20157	Not Applicable	0	0	Not Available																								2	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A9FS-F69914	E217C55F-FAAA-4F83-8F53-C7F3A4C36C68	22	Not Applicable	211	Not Available	NO	1	NO	NO	Not Available	109	Not Available	Lung	New Primary Tumor	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2015	MALE	174	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9FS	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	72	2014	2013
TCGA-DD-A4NO	65	MALE	176	2245	109	35.18853305785124	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G1	1	990.0	Liver	Intrahepatic Recurrence	WITH TUMOR		YES	Radiofrequency Ablation;Other	Not Applicable;cryoablation	2244;2244	1;1	1;1	TCGA-DD-A4NO-A49664	229D0F16-E4C6-4694-8F51-BA228820B968	7	YES	1051;Not Available	Other;Not Available	embolic agent;Not Applicable	Chemoembolization;Not Available	Other, specify;Not Available	embolic agent;Not Applicable	10	2013		Mild	65	3.5	4.5	5.0	TCGA-DD-A4NO	75F78C38-6854-4390-AD11-789B4E549D63	0.1	0.4	Not Available	A	0.8	1.3	1.6	5	-24090	Not Applicable	0	1869	Not Available																								0	NOT HISPANIC OR LATINO	0	6	3	0 - No Fibrosis	TCGA-DD-A4NO-F49662	DFADFE4A-2362-440D-9207-EBB9A8FF783A	7	Not Applicable	2245	Not Available	NO	10	NO;NO;NO	NO;NO;NO	Not Available;Not Available;Not Available	990;2241;2241	Not Available;Not Available;Not Available	Liver;Other, specify;Liver	Locoregional Recurrence;Extrahepatic Recurrence;Locoregional Recurrence	Not Applicable;peritoneal;Not Applicable	Yes;Yes;Yes	NO;NO;NO	No;No;No	Not Available;Not Available;Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2013	MALE	176	Hepatocellular Carcinoma	Hepatitis C;Other	Tobacco use	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	2	G1	Not Available	Not Available	Not Available	990	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	Not Available	Not Available	Not Available	YES	No	A4NO	WITH TUMOR	201	150	450	NO	NO	9.9	WHITE	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis C Virus RNA;Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	109	2013	2007
TCGA-DD-AAVY	56	MALE	161	1970	63	24.304617877396705	Hepatocellular Carcinoma	Liver	Alive	T3	N0	M0	Stage IIIA	G2	0	1970			TUMOR FREE																					None	56	3.3	3.0	5.2	TCGA-DD-AAVY	C36F9FFE-515B-4895-B82A-AADC49FE3016	0.2	1.0	2	A	0.7	1.4	1.2	13	-20709	Not Applicable	0	1788	Not Available																								0	NOT HISPANIC OR LATINO	0	15	11	0 - No Fibrosis	TCGA-DD-AAVY-F67586	4B15816C-7237-4435-8053-F42FAD1DC88C	6	Not Applicable	1970	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	161	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	6	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAVY	TUMOR FREE	210	130	400	NO	NO	1.0	ASIAN	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	63	2014	2009
TCGA-G3-A25Y	52	FEMALE	158	452	57	22.83287934625861	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G3	1	355.0	Liver	Locoregional Recurrence	WITH TUMOR																					Mild	52	0.3	0.4	0.5	TCGA-G3-A25Y	239B4298-B090-480A-A19F-9758A827AA30	0.0	0.7	Not Available	A	0.4	1.1	0.6	27	-19055	452	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	10	35	3,4 - Fibrous Speta	TCGA-G3-A25Y-F40098	69284923-9341-4427-83C3-49846EFCCA50	12	452	Not Available	Not Available	NO	2	NO	NO	Not Available	355	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2013	FEMALE	158	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	7	G3													Not Available	No	A25Y	WITH TUMOR	166	150	400	Not Available	Not Available	1.1	ASIAN	Not Available																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	G3	1.2	Liver	None	Not Available	Dead	57	2011	2006
TCGA-BC-A3KF	66	FEMALE	173	8	58	19.37919743392696	Hepatocellular Carcinoma	Liver	Alive	T1	NX	M0	Stage I	G2	0	8			TUMOR FREE																					Not Available	66	Not Available	Not Available	Not Available	TCGA-BC-A3KF	07DD49FC-8A76-41E8-9EB3-107336F68701	Not Available	Not Available	2	Not Available	0.6	1.0	0.8	19	-24328	Not Applicable	0	8	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BC-A3KF-F38204	231538B0-C3FB-4D1B-A82E-A5A7F20F174C	11	Not Applicable	8	Not Available	YES	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Unknown	Unknown	Unknown	Alive	2012	FEMALE	173	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	4	G2													Not Available	No	A3KF	TUMOR FREE	171000	150000	440000	Not Available	Not Available	1.0	WHITE	Not Available																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1	YES	NO	BC	Not Available	Liver	None	Not Available	Alive	58	2012	2011
TCGA-DD-A119	40	MALE	160	223	58	22.65625	Hepatocellular Carcinoma	Liver	Dead	T3a	N0	M1	Stage IV	G3	0	223			Not Available																					None	40	3.5	3.9	5.0	TCGA-DD-A119	66c6f413-b7a8-4d7c-9e1d-c4fb257b9e5c	0.1	1.6	2	A	0.9	1.4	1.3	29	-14613	223	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	6	1836	0 - No Fibrosis	TCGA-DD-A119-F38783	135F37D9-7890-4633-A645-875906BC10CA	21	223	Not Available	Not Available	NO	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	Unknown	Unknown	Unknown	Dead	2012	MALE	160	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	12	G3													Not Available	No	A119	Not Available	572	150	450	Not Available	Not Available	1.0	ASIAN	Not Available																			YES	R2	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M1	N0	T3a	NO	YES	DD	1.0	Liver	Micro	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Dead	58	2010	2003
TCGA-DD-AAVR	44	MALE	165	2513	69	25.34435261707989	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	2513			TUMOR FREE																					None	44	3.3	3.6	5.2	TCGA-DD-AAVR	834CFF01-3C12-42FA-ABBE-AE0AE168C568	0.2	1.2	1	A	0.0	1.4	1.1	13	-16157	Not Applicable	0	2198	Not Available																								1	NOT HISPANIC OR LATINO	0	15	36	6 - Established Cirrhosis	TCGA-DD-AAVR-F67574	25C92A01-FFB8-409E-9746-9959F8274A10	6	Not Applicable	2513	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	165	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	6	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAVR	TUMOR FREE	174	130	400	NO	NO	1.0	ASIAN	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	69	2014	2007
TCGA-UB-A7MA	62	FEMALE	165	848	85	31.221303948576676	Hepatocholangiocarcinoma (Mixed)	Liver	Alive	T2b	N0	M0	Stage II	G2	1	221.0	Liver	Intrahepatic Recurrence	WITH TUMOR		YES	Radiofrequency Ablation	Not Applicable	295	4	1	TCGA-UB-A7MA-A63550	DD46242B-D31B-4035-9A6F-D3C7547F3F36	12	YES	294	Mitomycin C	Not Applicable	Chemoembolization	Other, specify	Ethiodol	8	2014		None	62	3.4	4.0	5.0	TCGA-UB-A7MA	10179EFC-A091-4119-8EC2-30DB6269D674	0	1.2	Not Available	A	0.4	0.90	0.7	12	-22843	Not Applicable	0	455	Not Available	TCGA-UB-A7MA-D63551;TCGA-UB-A7MA-D63552;TCGA-UB-A7MA-D67140;TCGA-UB-A7MA-D67138	AA478972-0FC7-49A8-991F-F69895F7266A;4E50B011-3187-4D5E-A047-470F592F99F1;30F9ADEB-3DCA-470C-B321-437EEFC241E7;4941EDDA-D11C-43C2-B550-76DAE03C8034	Not Available;Not Available;Not Available;Not Available	12;12;31;31	207;207;Not Available;Not Available	60;60;485;485	gemcitabine;cisplatin;temsirolimus;sorafenib	Clinical Progressive Disease;Clinical Progressive Disease;Not Applicable;Not Applicable	8;8;10;10	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;YES;YES	Chemotherapy;Chemotherapy;Targeted Molecular therapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;YES;YES	2014;2014;2014;2014	0	NOT HISPANIC OR LATINO	0	8	2008	0 - No Fibrosis	TCGA-UB-A7MA-F67133;TCGA-UB-A7MA-F72749	CA20DD09-AD0F-4FEA-85F6-0BC5EBD5FE44;F499AFB4-8E85-42E3-925B-7E307BBD3E06	31;24	Not Applicable;Not Applicable	535;848	Not Available;Not Available	NO;NO	10;11	YES;YES;Not Available	NO;NO;Not Available	Not Available;Not Available;Not Available	478;395;Not Available	Not Available;Not Available;Not Available	Liver;Lung;Not Available	Intrahepatic Recurrence;Extrahepatic Recurrence;Not Available	Not Applicable;Not Applicable;Not Applicable	No;No;Not Available	NO;NO;Not Available	No;No;Not Available	Not Available;Not Available;Not Available	YES;Unknown	WITH TUMOR;Not Available	NO;NO	NO;YES	NO;NO	Alive;Alive	2014;2015	FEMALE	165	Hepatocholangiocarcinoma (Mixed)	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8180/3	C22.0	YES	0.9	1.2	8	G2	NO;YES	NO;NO	Not Available;Not Available	221;449	Not Available;Not Available	Liver;Lung	Intrahepatic Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable	Yes;No	NO;NO	No;No	Not Available;Not Available	YES	No	A7MA	WITH TUMOR	600	140	450	NO	YES	0.9	WHITE	NO																			NO	R1	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	YES	NO	UB	1.0	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Core Antibody	Alive	85	2014	2013
TCGA-ZS-A9CG	55	MALE	179	341	94	29.33741144159046	Hepatocellular Carcinoma	Liver	Alive	T2	NX	MX	Stage II	G2	0	341			Unknown																					Mild	55	35	40	50	TCGA-ZS-A9CG	3F6A6891-C6D5-447B-AD32-325FD46EC32B	0	5	Not Available	A	62	106	72	30	-20100	Not Applicable	0	250	Not Available																								0	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	0 - No Fibrosis	TCGA-ZS-A9CG-F68446	0DF4278F-D93F-41B8-AA29-3B4829C60C93	18	Not Applicable	341	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	179	Hepatocellular Carcinoma	Unknown	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.5	14	4	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9CG	Unknown	382	150	400	NO	NO	10.8	WHITE	NO																			Unknown	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	NO	YES	ZS	21	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	94	2014	2013
TCGA-ES-A2HT	54	MALE	174	438	80	26.42356982428326	Hepatocellular Carcinoma	Liver	Dead	T1	NX	MX	Stage I	G2	0	438			TUMOR FREE																					Mild	54	3.5	4.1	5.0	TCGA-ES-A2HT	7DD3BDA9-3A0A-46FA-B052-A6D24B847804	0	0.6	0	A	0.8	1.2	0.7	30	-20023	438	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	10	4	0 - No Fibrosis																												MALE	174	Hepatocellular Carcinoma	Hepatitis C	no	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.3	1.1	9	G2													Not Available	No	A2HT	TUMOR FREE	135	150	450	Not Available	Not Available	1.1	BLACK OR AFRICAN AMERICAN	Not Available																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	ES	1.0	Liver	None	Not Available	Dead	80	2011	2007
TCGA-G3-A7M9	70	MALE	170	56	73	25.259515570934255	Hepatocellular Carcinoma	Liver	Dead	T3b	NX	MX	Stage IIIB	G2	0	56			Unknown																					None	70	3.3	3.3	4.8	TCGA-G3-A7M9	115B754D-8559-4F1D-AF44-FCD8C2CEF86A	0	0.4	Not Available	A	0.6	1.4	1	5	-25588	56	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	10	22868	6 - Established Cirrhosis	TCGA-G3-A7M9-F65815	00DEB904-1BCC-4B92-9B37-B8B7455AA86F	30	56	Not Available	Not Available	NO	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Unknown	NO	NO	NO	Dead	2014	MALE	170	Hepatocellular Carcinoma	Hemochromatosis	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	2	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Yes	A7M9	Unknown	187	150	400	NO	NO	1.1	WHITE	NO																			Unknown	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3b	YES	NO	G3	1.4	Liver	Macro	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Surface Antibody	Dead	73	2014	2013
TCGA-DD-AADI	43	FEMALE	165	1085	64	23.507805325987142	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	1085			TUMOR FREE																					Unknown	43	3.8	3.8	5.3	TCGA-DD-AADI	97472E71-66EB-434B-81B0-D727765F44CB	0.2	0.5	Not Available	A	0.7	1.5	0.8	7	-15928	Not Applicable	0	763	Not Available																								0	NOT HISPANIC OR LATINO	0	8	27	Unknown	TCGA-DD-AADI-F68395	59272D27-FB74-4E73-AE0A-07E26D8FDE85	17	Not Applicable	1085	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	165	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AADI	TUMOR FREE	141	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	64	2014	2011
TCGA-CC-A7IK	59	MALE	168	262	57	20.19557823129252	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G3	1	150.0		Locoregional Recurrence	TUMOR FREE																					Not Available	59	Not Available	Not Available	Not Available	TCGA-CC-A7IK	EBA5208B-404A-45DF-9133-31FF122E7FC0	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	22	-21552	Not Applicable	0	0	Not Available																								2	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A7IK-F69705	D3C543D7-0F9E-4EFC-A31F-26E043FFB067	16	262	Not Available	Not Available	NO	1	NO	NO	Not Available	150	Not Available	Not Available	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2015	MALE	168	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7IK	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	57	2014	2013
TCGA-DD-AADW	48	MALE	163	587	49	18.442545824080696	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	1	386.0	Liver	Locoregional Recurrence	TUMOR FREE																					None	48	3.8	4.3	4.3	TCGA-DD-AADW	1BCF1762-7926-45F6-A367-D45FC3AF7BC3	0.2	1.0	Not Available	A	0.7	1.5	0.8	14	-17781	Not Applicable	0	203	Not Available																								1	NOT HISPANIC OR LATINO	0	8	250	6 - Established Cirrhosis	TCGA-DD-AADW-F68408	44153E18-60CB-4599-B0A5-CEF3F6CA083D	17	Not Applicable	587	Not Available	NO	11	NO;NO	YES;YES	Not Available;Not Available	386;386	Not Available;Not Available	Liver;Liver	Locoregional Recurrence;Intrahepatic Recurrence	Not Applicable;Not Applicable	No;No	NO;NO	No;No	Not Available;Not Available	YES	Unknown	NO	NO	NO	Alive	2014	MALE	163	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AADW	TUMOR FREE	102	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	49	2014	2013
TCGA-FV-A4ZQ	52	MALE	Not Available	12	Not Available		Hepatocellular Carcinoma	Liver	Alive	T1	NX	M0	Stage I	G2	0	12			TUMOR FREE																					Unknown	52	3.8	2.4	5.0	TCGA-FV-A4ZQ	65E430E1-0C9A-4045-83A9-653B7CFF811D	0.2	1.8	Not Available	Unknown	0.7	1.0	1.0	15	-19090	Not Applicable	0	12	Not Available																								Unknown	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Unknown																												MALE	Not Available	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	2.0	3.0	3	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A4ZQ	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	1.1	WHITE	Unknown																			Unknown	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1	YES	NO	FV	1.2	Liver	None	Hepatitis C Virus RNA	Alive	Not Available	2013	2012
TCGA-DD-AADM	58	MALE	159	12	55	21.75546853368142	Hepatocellular Carcinoma	Liver	Dead	T2	N0	M0	Stage II	G3	0	12			TUMOR FREE																					Unknown	58	3.8	4.1	5.3	TCGA-DD-AADM	62C02DA8-E4B4-4294-9923-8992D187FC7B	0.2	0.5	Not Available	A	0.7	1.5	0.8	7	-21349	12	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	8	112	Unknown																												MALE	159	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AADM	TUMOR FREE	126	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.2	Liver	None	Unknown	Dead	55	2014	2012
TCGA-DD-AAW0	54	MALE	172	2015	75	25.351541373715524	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	2015			TUMOR FREE																					Mild	54	3.3	4.6	5.2	TCGA-DD-AAW0	109436AA-A655-429B-8D3B-1A43385C9016	0.2	0.2	Not Available	A	0.7	1.4	1.3	13	-19981	Not Applicable	0	1644	Not Available																								0	NOT HISPANIC OR LATINO	0	15	3	3,4 - Fibrous Speta	TCGA-DD-AAW0-F67590	DC8194C4-5289-4DCA-B939-FC525CA79D41	6	Not Applicable	2015	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	172	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	6	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAW0	TUMOR FREE	183	130	400	NO	NO	1.0	ASIAN	NO																			YES	R0	Total Hepatectomy with Transplant	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	75	2014	2009
TCGA-K7-AAU7	61	MALE	Not Available	359	Not Available		Hepatocholangiocarcinoma (Mixed)	Liver	Alive	T2a	NX	MX	Stage II	G2	1	58.0	Liver	Intrahepatic Recurrence	Unknown																					Not Available	61	Not Available	Not Available	Not Available	TCGA-K7-AAU7	1EACFCC0-1D05-4441-B3D8-B0790E1C40F1	Not Available	Not Available	2	A	Not Available	Not Available	Not Available	18	-22476	Not Applicable	0	113	Not Available	TCGA-K7-AAU7-D63781;TCGA-K7-AAU7-D63783	09A7B4A1-5613-47F5-977A-6055E11BF104;518D97F7-44E3-4366-ACEF-2F1B474EF5DA	Not Available;Not Available	18;18	Not Available;Not Available	42;42	gemcitabine;cisplatin	Unknown;Unknown	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	YES;YES	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	0	NOT HISPANIC OR LATINO	0	10	290	Not Available	TCGA-K7-AAU7-F70895	E43ED9D9-16BB-4AD3-B15C-30D44E14B5EB	10	Not Applicable	359	Not Available	NO	3	Not Available	Not Available	Not Available	58	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Not Available	Not Available	Not Available	Not Available	YES	WITH TUMOR	NO	YES	NO	Alive	2015	MALE	Not Available	Hepatocholangiocarcinoma (Mixed)	Hepatitis C;Hemochromatosis	Not Available	No	Not Applicable	C22.0	8180/3	C22.0	YES	0	1.9	8	G2	Not Available	Not Available	Not Available	58	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	YES	No	AAU7	Unknown	87	150	450	NO	YES	0.9	WHITE	NO																			YES	RX	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2a	YES	NO	K7	Not Available	Liver	Micro	Unknown	Alive	Not Available	2014	2013
TCGA-ED-A8O5	59	FEMALE	165	406	63	23.140495867768596	Hepatocellular Carcinoma	Liver	Alive	T3a	N0	M0	Stage IIIA	G3	0	406			TUMOR FREE																					Mild	59	3.8	4.2	5.1	TCGA-ED-A8O5	2BEA076B-C923-4A91-A37B-C6615FEC021C	0.1	0.4	Not Available	Unknown	4.1	5.8	3.4	12	-21648	Not Applicable	0	6	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	20	498	Not Available	TCGA-ED-A8O5-F67146	6DA9AE33-D84C-462A-8FAB-95BD5AA152E1	31	Not Applicable	406	Not Available	NO	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	165	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.3	1.3	2	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A8O5	TUMOR FREE	171	150	400	NO	Unknown	1.3	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3a	YES	NO	ED	1.3	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	63	2014	2013
TCGA-DD-A73G	73	FEMALE	155	3478	44	18.314255983350677	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	3478			TUMOR FREE																					None	73	3.5	3.2	5.0	TCGA-DD-A73G	4774367C-5D8F-4B23-934A-E6D33A89DCA8	0.1	0.5	1	A	0.7	1.2	0.7	1	-26949	Not Applicable	0	3071	Not Available																								0	NOT HISPANIC OR LATINO	0	6	2035400	0 - No Fibrosis	TCGA-DD-A73G-F66600	5494C426-A7D0-4933-BFCC-BA73F85026D4	21	Not Applicable	3478	Not Available	NO	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	155	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	10	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A73G	TUMOR FREE	460	150	450	NO	NO	11.7	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	44	2013	2005
TCGA-DD-A11B	73	MALE	181	14	134	40.90229235981808	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G2	0	14			TUMOR FREE																					Mild	73	3.5	3.9	5.0	TCGA-DD-A11B	1b1b1af0-b19b-4086-b1b7-669fa0b88235	0.1	1.6	Not Available	A	0.9	1.4	1.0	29	-26857	14	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	6	15	6 - Established Cirrhosis	TCGA-DD-A11B-F38785	2B54DE46-7BF8-4E8A-902A-F85839DC3BE3	21	14	Not Available	Not Available	NO	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Dead	2012	MALE	181	Hepatocellular Carcinoma	Non-Alcoholic Fatty Liver Disease	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	12	G2													Not Available	No	A11B	TUMOR FREE	90	150	450	Not Available	Not Available	10.2	WHITE	Not Available																			NO	RX	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Dead	134	2010	2005
TCGA-WX-AA46	61	MALE	156	756	75	30.81854043392505	Hepatocellular Carcinoma	Liver	Alive	T2	NX	MX	Stage II	G1	0	756			TUMOR FREE																					None	61	3.5	4.6	5.0	TCGA-WX-AA46	02C41E28-CF14-42E2-9E15-F43248AE16E0	0	1.3	3	A	0.5	1.2	1.2	10	-22639	Not Applicable	0	553	Not Available																								0	NOT HISPANIC OR LATINO	0	6	1	0 - No Fibrosis	TCGA-WX-AA46-F68250	0A88C7D4-F527-4A2F-922D-E95A7012897D	14	Not Applicable	756	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	156	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Right posterior hepatectomy	C22.0	8170/3	C22.0	YES	0.8	1.1	6	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AA46	TUMOR FREE	205	150	350	NO	NO	1.0	WHITE	NO																			YES	R0	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	NO	YES	WX	1.2	Liver	Macro	Hepatitis  C Antibody	Alive	75	2014	2012
TCGA-ED-A66X	35	MALE	170	406	61	21.10726643598616	Hepatocellular Carcinoma	Liver	Alive	T3a	N0	M0	Stage IIIA	G3	1	124.0	Liver	Intrahepatic Recurrence	TUMOR FREE																					Mild	35	3.8	4.7	5.1	TCGA-ED-A66X	B75CA9E4-A474-4960-9343-C8E9524CD096	0.1	9	Not Available	Unknown	4.1	5.6	4.5	3	-12947	Not Applicable	0	6	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	20	5840	Not Available	TCGA-ED-A66X-F56838	40296676-2917-4796-96F2-2EEF075840B5	24	Not Applicable	406	Not Available	NO	2	NO	Unknown	124	124	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	YES	No	R0	YES	TUMOR FREE	Unknown	NO	Unknown	Alive	2014	MALE	170	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.3	1.3	7	G3	Not Available	Not Available	Not Available	124	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	YES	No	A66X	TUMOR FREE	268	150	400	NO	NO	1	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3a	YES	NO	ED	1.3	Liver	Micro	Hepatitis B Surface Antigen	Alive	61	2013	2013
TCGA-BC-A10X	52	FEMALE	Not Available	770	65		Hepatocellular Carcinoma	Liver	Dead	T3a	N0	MX	Stage IIIA	G2	0	770			TUMOR FREE																					None	52	3.5	3.6	5.0	TCGA-BC-A10X	3dc48ea9-a3c6-437f-af5a-88feb300cc5f	0.0	0.3	2	Not Available	0.7	1.1	0.7	31	-19140	770	0	Not Available	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	264	Not Available	TCGA-BC-A10X-F9946	0CAC7B8C-D9DF-4D55-BBF7-7DCAF435FB86	4	770	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No New Tumor Event	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Dead	2011	FEMALE	Not Available	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G2													Not Available	No	A10X	TUMOR FREE	602	150	440	Not Available	Not Available	1.0	WHITE	Not Available																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3a	NO	YES	BC	1.2	Liver	Micro	Not Available	Dead	65	2011	2002
TCGA-DD-AADS	63	MALE	164	474	53	19.70553242117787	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	474			TUMOR FREE																					Unknown	63	3.8	3.7	5.3	TCGA-DD-AADS	460A3CBD-C63C-4E6F-B670-2619687AC5A0	0.2	0.7	1	A	0.7	1.5	0.9	7	-23227	Not Applicable	0	216	Not Available																								0	NOT HISPANIC OR LATINO	0	8	11	Unknown	TCGA-DD-AADS-F68405	7D08F65A-5C66-447E-A3AC-3A085E49C23F	17	Not Applicable	474	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	164	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AADS	TUMOR FREE	120	130	400	NO	NO	1.2	ASIAN	NO																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	53	2014	2013
TCGA-MR-A520	58	MALE	179	229	104	32.45841265878094	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G1	0	229			TUMOR FREE																					Not Available	58	Not Available	Not Available	Not Available	TCGA-MR-A520	25E893AD-A0FD-45AE-9AA9-9BCD7C2EC8E5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	-21398	Not Applicable	0	19	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-MR-A520-F48052	CFF17968-E60E-4AA7-B557-E229DB6EB1B3	14	Not Applicable	229	Not Available	NO	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2012	MALE	179	Hepatocellular Carcinoma	Other	Moderate alcohol consumption, anti TB drug used for TB positive testing	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	9	G1													Not Available	No	A520	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Available	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	MR	Not Available	Liver	Not Available	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Core Antibody	Alive	104	2012	2012
TCGA-LG-A9QD	68	MALE	168	366	74	26.218820861678005	Hepatocellular Carcinoma	Liver	Alive	T3a	N0	M0	Stage IIIA	G2	1				WITH TUMOR																					Mild	68	3.4	2.9	4.8	TCGA-LG-A9QD	948A9BBC-60B0-4FB7-A707-76BC41294217	0.0	0.5	3	Unknown	0.7	1.5	0.9	7	-24969	Not Applicable	0	130	Not Available	TCGA-LG-A9QD-D60838	CD39633C-91A8-4F9F-B06B-08ECCCD2300D	Not Available	17	Not Available	61	Sorafinib ( Nexavar)	Not Applicable	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Unknown	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Unknown	TCGA-LG-A9QD-F69200	F9C87B9D-3A10-47F6-9D77-C6A9CD26BB6A	30	Not Applicable	366	Not Available	NO	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	WITH TUMOR	NO	YES	NO	Alive	2014	MALE	168	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9QD	WITH TUMOR	320	150	450	NO	YES	Not Available	WHITE	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3a	YES	NO	LG	1.2	Liver	None	Not Available	Alive	74	2014	2013
TCGA-FV-A496	84	FEMALE	162	10	54	20.5761316872428	Hepatocellular Carcinoma	Liver	Alive	T1	NX	M0	Stage I	G2	0	10			TUMOR FREE																					None	84	3.8	2.8	5.0	TCGA-FV-A496	8AFA3140-DCBD-44C0-AB13-4ADA6A0444D4	0.3	0.9	3	Unknown	0.9	1.1	1.0	21	-30950	Not Applicable	0	10	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	8	67	0 - No Fibrosis																												FEMALE	162	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	2	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A496	TUMOR FREE	167	140	440	Unknown	Unknown	1.0	WHITE	Unknown																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1	YES	NO	FV	1.9	Liver	None	Not Available	Alive	54	2013	2012
TCGA-5C-A9VG	58	MALE	170	328	73	25.259515570934255	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	0	328			TUMOR FREE																					None	58	Not Available	Not Available	Not Available	TCGA-5C-A9VG	073E51F9-FB79-4A5F-9BA0-2C9AF03C0B85	Not Available	Not Available	Not Available	A	Not Available	Not Available	Not Available	26	-21273	Not Applicable	0	328	Not Available																								0	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-5C-A9VG-F68936	B7C9ECB5-D0A7-4D29-BCDA-A02BEA482156	23	Not Applicable	328	Not Available	NO	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	170	Hepatocellular Carcinoma	Other	Worker at steel factory	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	6	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9VG	TUMOR FREE	Not Available	Not Available	Not Available	NO	NO	Not Available	WHITE	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	5C	Not Available	Liver	Micro	Not Available	Alive	73	2014	2013
TCGA-BC-A10R	66	FEMALE	Not Available	308	Not Available		Hepatocellular Carcinoma	Liver	Dead	T3	NX	MX		G2	1	199.0		Intrahepatic Recurrence	WITH TUMOR		NO						TCGA-BC-A10R-A13748	7DC35BE0-5FF4-4075-ADBC-348F148D5887	4	YES	237	Not Available	Not Applicable	Chemoembolization	Not Available	Not Applicable	4	2011		Mild	66	Not Available	4.0	Not Available	TCGA-BC-A10R	0bf5bbd4-d9e8-42a6-9ab5-f2c174dec12c	Not Available	Not Available	1	Not Available	0.7	1.1	0.7	23	-24274	308	0	Not Available	Not Available	TCGA-BC-A10R-D9866	8A7781FE-13A4-4932-BBAF-7CD42290C62D	Not Available	1	237	237	Not Available	Not Available	4	1	Not Available	Not Available	PROGRESSION	Not Applicable	1	IH	NO	Other, specify in notes	chemoembolization	Not Available	Not Available	Not Available	2011	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	27	Not Available	TCGA-BC-A10R-F9867	E24498E6-B9E8-4F37-920C-9B2B2F3A33C8	1	308	Not Available	Not Available	Not Available	4	YES	NO	Not Available	199	Not Available	Not Available	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2011	FEMALE	Not Available	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G2													Not Available	No	A10R	WITH TUMOR	209000	150	440	Not Available	Not Available	0.9	WHITE	Not Available																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3	NO	YES	BC	Not Available	Liver	Micro	Not Available	Dead	Not Available	2011	1999
TCGA-DD-AA3A	81	FEMALE	151	410	60	26.314635323012148	Hepatocholangiocarcinoma (Mixed)	Liver	Dead	T1	N0	MX	Stage I	G4	0	410			TUMOR FREE																					None	81	3.5	4.9	5.0	TCGA-DD-AA3A	56ABD1C1-8F22-4856-8B0A-73D7E092BDB3	0.1	0.8	1	A	0.6	1.1	0.7	27	-29712	410	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	8	1	0 - No Fibrosis																												FEMALE	151	Hepatocholangiocarcinoma (Mixed)	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8180/3	C22.0	YES	0.9	1.2	5	G4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	No	AA3A	TUMOR FREE	256	150	450	NO	NO	1.1	WHITE	NO																			YES	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Dead	60	2014	2009
TCGA-DD-A73A	71	MALE	174	728	102	33.69005152596116	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	728			TUMOR FREE																					Mild	71	3.5	4.4	5.0	TCGA-DD-A73A	B6C0266A-CF34-464A-808D-1D3C28DC90F2	0.1	1.2	Not Available	A	0.8	1.3	1.4	30	-26136	Not Applicable	0	334	Not Available																								1	NOT HISPANIC OR LATINO	0	6	4	3,4 - Fibrous Speta	TCGA-DD-A73A-F66593	91AAB170-0FA3-4936-95AD-B603FEA6F8EC	21	Not Applicable	728	Not Available	NO	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	174	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.5	13.8	9	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A73A	TUMOR FREE	89	150	450	NO	NO	12.8	WHITE	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	102	2013	2012
TCGA-BW-A5NQ	63	MALE	Not Available	0	Not Available		Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G3	0	0			TUMOR FREE																					Unknown	63	Not Available	Not Available	Not Available	TCGA-BW-A5NQ	C7F1B389-AEC7-4993-8AFB-B7A56064F8FC	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	26	-23353	Not Applicable	0	0	Not Available																								Unknown	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	6 - Established Cirrhosis																												MALE	Not Available	Hepatocellular Carcinoma	Alcohol consumption;Other	cirrhosis	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Yes	A5NQ	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	WHITE	Unknown																			Unknown	RX	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	BW	Not Available	Liver	None	Not Available	Alive	Not Available	2014	2010
TCGA-DD-A4NB	25	MALE	185	989	69	20.160701241782323	Fibrolamellar Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	1	912.0	Other, specify	Extrahepatic Recurrence	TUMOR FREE																					Mild	25	Not Available	Not Available	Not Available	TCGA-DD-A4NB	1983FADE-44F1-41E0-8983-F2CE8D649655	0.1	1.0	2	Unknown	0.8	1.3	0.8	18	-9426	Not Applicable	0	391	Not Available																								1	NOT HISPANIC OR LATINO	0	6	3	Unknown	TCGA-DD-A4NB-F49641;TCGA-DD-A4NB-F59448	A8BF7884-CC9B-4E55-ACBF-8D47A86462FA;192EB58A-3FDD-4F21-B426-F4FF3A790B62	7;13	Not Applicable;Not Applicable	391;989	Not Available;Not Available	NO;NO	10;5	Not Available;NO	Not Available;NO	Not Available;913	Not Available;912	Not Available;Not Available	Not Available;Other, specify	Not Available;Extrahepatic Recurrence	Not Applicable;retroperitoneal lymph nodes	Not Available;No	Not Available;YES	Not Available;No	Not Available;R0	NO;YES	TUMOR FREE;TUMOR FREE	NO;NO	NO;NO	NO;NO	Alive;Alive	2013;2014	MALE	185	Fibrolamellar Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8171/3	C22.0	YES	9.5	13.8	12	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A4NB	TUMOR FREE	296	150	450	NO	NO	13.9	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Unknown	Alive	69	2012	2011
TCGA-DD-AADO	55	MALE	168	453	58	20.549886621315192	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	453			TUMOR FREE																					Unknown	55	3.8	4.5	5.3	TCGA-DD-AADO	9F056388-7529-4FD1-AF11-C82CC350F51C	0.2	0.4	Not Available	A	0.7	1.5	0.6	7	-20139	Not Applicable	0	92	Not Available																								0	NOT HISPANIC OR LATINO	0	8	176037	Unknown	TCGA-DD-AADO-F68401	1D7929F0-0561-4925-828E-56F2B460CA15	17	Not Applicable	453	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	168	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AADO	TUMOR FREE	180	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	58	2014	2013
TCGA-FV-A3R3	38	FEMALE	161	366	97	37.42139577948382	Hepatocellular Carcinoma	Liver	Dead	T1	NX	MX	Stage I	G2	0	366			TUMOR FREE																					Not Available	38	3.4	2.0	5.0	TCGA-FV-A3R3	3DD7C93D-8194-44EE-8014-10DD81EF6441	0.0	0.4	Not Available	Not Available	0.6	1.3	1.3	25	-14231	Not Applicable	0	4	Not Available																								1	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-FV-A3R3-F64062	E5F61BCA-6866-4343-A3E9-A341748F1DE6	25	366	Not Available	Not Available	NO	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	NO	NO	NO	Dead	2014	FEMALE	161	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Partial Hepatectomy	C22.0	8170/3	C22.0	YES	9.5	11.9	9	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A3R3	TUMOR FREE	323	150	450	Unknown	Unknown	10.7	WHITE	Unknown																			NO	R0	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	FV	1.0	Liver	None	Not Available	Alive	97	2012	2012
TCGA-RC-A7SB	53	MALE	166	588	61	22.136739730004354	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	0	588			TUMOR FREE																					None	53	3.1	4.8	5.2	TCGA-RC-A7SB	26D93D77-AB66-45AA-A162-98D091221AFB	0.1	3.7	Not Available	B	0.3	1.20	1.1	21	-19698	Not Applicable	0	588	Not Available																								0	NOT HISPANIC OR LATINO	0	20	3	0 - No Fibrosis																												MALE	166	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.30	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7SB	TUMOR FREE	196000	150000	400000	NO	NO	1	ASIAN	NO																			Unknown	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	RC	1.3	Liver	None	Not Available	Alive	61	2014	2012
TCGA-DD-AAD2	66	MALE	156	658	52	21.367521367521366	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	658			TUMOR FREE																					Mild	66	3.8	3.5	5.3	TCGA-DD-AAD2	03F5DE7D-45A9-4A73-8C61-ED816D4A3AC5	0.2	0.3	Not Available	A	0.7	1.5	0.8	29	-24221	Not Applicable	0	658	Not Available																								0	NOT HISPANIC OR LATINO	0	8	25	1,2 - Portal Fibrosis	TCGA-DD-AAD2-F68385	67CACAF8-6D67-4EAD-A191-ED58713BBA88	17	Not Applicable	658	Not Available	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	156	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAD2	TUMOR FREE	172	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	52	2014	2010
TCGA-DD-A1EG	76	MALE	168	1372	82	29.05328798185941	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G3	1	875.0	Liver	Intrahepatic Recurrence	WITH TUMOR		NO						TCGA-DD-A1EG-A43855	3171B121-F52B-4493-B41C-B53451B22CD5	4	YES	1034;1070;1156;1198	Other;Other;Other;Other	TheraSpere infusion;chemoembolic mixture;chemoembolic mixture;chemoembolic mixture	Chemoembolization;Chemoembolization;Chemoembolization;Chemoembolization	Y-90 Therasphere;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	6	2013		Mild	76	3.5	4.2	5.0	TCGA-DD-A1EG	6C79F64B-63FE-46F5-BF7B-77208231B0F2	0.1	0.7	1	A	0.8	1.3	0.6	9	-28108	1372	0	Not Available	Not Available	TCGA-DD-A1EG-D43858	55D863E7-C0D9-44E5-8BCE-EE5A1587A652	Not Available	4	1310	1154	Sorafenib	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	NOT HISPANIC OR LATINO	0	6	16	1,2 - Portal Fibrosis	TCGA-DD-A1EG-F42003	643FFA7A-4953-46BF-9B9B-DEB26E2ABBB7	9	1372	Not Available	Not Available	NO	4	NO;YES	NO;NO	880;Not Available	875;1006	Not Available;Not Available	Liver;Liver	Intrahepatic Recurrence;Intrahepatic Recurrence	Not Applicable;Not Applicable	No;Yes	YES;NO	No;No	R0;Not Available	YES	WITH TUMOR	YES	YES	NO	Dead	2013	MALE	168	Hepatocellular Carcinoma	Alcohol consumption;Non-Alcoholic Fatty Liver Disease	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	4	G3	YES	NO	880	875	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	YES	No	R0	YES	No	A1EG	WITH TUMOR	146	150	450	YES	YES	9.1	WHITE	NO																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen	Dead	82	2013	2007
TCGA-G3-A3CI	71	MALE	167	180	98	35.139302233855645	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	180			TUMOR FREE																					Mild	71	0.3	0.4	0.5	TCGA-G3-A3CI	B5465221-78FE-40A8-ABEC-BED600602DD4	0	0.3	Not Available	A	0.6	1.4	0.9	16	-26224	Not Applicable	0	180	Not Available																								1	NOT HISPANIC OR LATINO	0	10	2	0 - No Fibrosis	TCGA-G3-A3CI-F40231	8C0DD4DB-2878-43B4-9417-10C388F542FC	14	Not Applicable	Not Available	Not Available	YES	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	Unknown	Unknown	Unknown	Alive	2013	MALE	167	Hepatocellular Carcinoma	Non-Alcoholic Fatty Liver Disease	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	1	G2													Not Available	No	A3CI	TUMOR FREE	186	150	400	Not Available	Not Available	1.3	WHITE	Not Available																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	G3	0.8	Liver	None	Not Available	Alive	98	2012	2011
TCGA-DD-AAD1	51	FEMALE	161	564	44	16.974653755642144	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G4	1	127.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					Unknown	51	3.8	4.5	5.3	TCGA-DD-AAD1	1F482810-433A-4D46-B81B-F7909FFF8C09	0.2	0.6	Not Available	A	0.7	1.5	0.5	29	-18794	Not Applicable	0	564	Not Available																								1	NOT HISPANIC OR LATINO	0	8	451	Unknown	TCGA-DD-AAD1-F68384	EAFCD73D-C290-4CDF-9E1A-4C754C0A685F	21	Not Applicable	564	Not Available	NO	12	NO	NO	Not Available	127	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	FEMALE	161	Hepatocellular Carcinoma	Hepatitis B;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G4	NO	NO	Not Available	127	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AAD1	WITH TUMOR	157	130	400	NO	NO	0.9	ASIAN	NO																			NO	R1	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	44	2014	2010
TCGA-DD-A11C	69	MALE	186	662	123	35.55324314949705	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	662			TUMOR FREE																					None	69	3.5	3.6	5.0	TCGA-DD-A11C	023a1ad1-fb16-437e-9806-5063b47f76bd	0.1	2.3	1	A	0.9	1.4	0.9	29	-25403	Not Applicable	0	662	Not Available																								1	NOT HISPANIC OR LATINO	0	6	11	0 - No Fibrosis	TCGA-DD-A11C-F38786	3C9E4CD1-2B50-40E4-A6FF-B08D0F112AA0	21	Not Applicable	662	Not Available	YES	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2012	MALE	186	Hepatocellular Carcinoma	Not Available	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	12	G3													Not Available	No	A11C	TUMOR FREE	391	150	450	Not Available	Not Available	1.0	WHITE	Not Available																			YES	RX	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	123	2010	2006
TCGA-WX-AA47	33	FEMALE	168	556	63	22.321428571428573	Hepatocellular Carcinoma	Liver	Dead	T3a	NX	MX	Stage IIIA	G2	1	103.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					Mild	33	3.5	2.8	5.0	TCGA-WX-AA47	39E147C9-2ACB-4BA8-A991-E43E1719B2D8	Not Available	0.2	Not Available	A	0.5	1.2	0.6	10	-12056	556	0	Not Available	Not Available	TCGA-WX-AA47-D60468	922F00F2-DA7A-4866-B953-CE6B32C5B780	Not Available	10	493	331	Sorafenib	Clinical Progressive Disease	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	2	NOT HISPANIC OR LATINO	0	6	1	0 - No Fibrosis																												FEMALE	168	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.1	6	G2	YES;Not Available	YES;Not Available	Not Available;485	103;485	Not Available;Not Available	Liver;Brain	Intrahepatic Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable	No;Not Available	NO;YES	No;No	Not Available;R0	YES	No	AA47	WITH TUMOR	423	150	350	NO	YES	0.9	WHITE	YES	Regional site	TCGA-WX-AA47-R60470	7C0B3A36-0D89-4466-BB17-34D7001A5DF9	Not Available	10	340	156	Radiographic Progressive Disease	6	Not Available	Not Available	NO	Internal	Not Applicable	Not Available	Not Available	Not Available	2014	NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3a	NO	YES	WX	1.2	Liver	Macro	Hepatitis  C Antibody	Dead	63	2014	2012
TCGA-NI-A4U2	71	MALE	171	1791	82	28.04281659313977	Hepatocellular Carcinoma	Liver	Dead	T3	NX	MX	Stage IIIA	G1	1	106.0	Liver	Locoregional Recurrence	WITH TUMOR																					None	71	Not Available	Not Available	Not Available	TCGA-NI-A4U2	9AEA3437-572A-48C6-BEB9-9BDBCB243875	Not Available	Not Available	3	Unknown	Not Available	Not Available	0.8	28	-26011	1791	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	Not Available	Not Available	5	1,2 - Portal Fibrosis																												MALE	171	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	6	G1	NO;YES;YES	YES;NO;NO	Not Available;Not Available;1305	106;939;1285	Not Available;Not Available;Not Available	Liver;Liver;Other, specify	Locoregional Recurrence;Locoregional Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable;Small Bowel	Yes;Yes;No	NO;NO;YES	No;No;No	Not Available;Not Available;Not Available	YES	No	A4U2	WITH TUMOR	299	Not Available	Not Available	NO	NO	1.0	WHITE	NO																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3	NO	YES	NI	Not Available	Liver	None	Unknown	Dead	82	2013	2005
TCGA-2Y-A9H3	45	MALE	179	1516	105	32.770512780499985	Hepatocellular Carcinoma	Liver	Alive	T2	NX	MX	Stage II	G1	1	22.0	Liver	Locoregional Recurrence	TUMOR FREE		NO						TCGA-2Y-A9H3-A66938	27ADBB25-B09A-416B-AA11-22851BE807AA	28	YES	42	Not Available	Not Applicable	Radioembolization	Y-90 Therasphere	Not Applicable	10	2014		None	45	3.5	5.3	5	TCGA-2Y-A9H3	9B69D7F9-38EB-48E1-BDC0-A092A53BC709	0.2	0.3	3	Unknown	0.8	1.5	0.9	3	-16443	Not Applicable	0	1257	Not Available																								2	HISPANIC OR LATINO	0	7	5640	1,2 - Portal Fibrosis	TCGA-2Y-A9H3-F69086	403D91DF-C0ED-4455-B76C-4CC6AF05042C	29	Not Applicable	1516	Not Available	NO	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	Discrepancy	NO	NO	Alive	2014	MALE	179	Hepatocellular Carcinoma	Alcohol consumption;Non-Alcoholic Fatty Liver Disease	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G1	NO	NO	Not Available	22	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	A9H3	TUMOR FREE	245	143	382	YES	NO	10.5	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	NO	YES	2Y	1.3	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	105	2014	2010
TCGA-BC-A216	62	FEMALE	164	1351	151	56.142177275431294	Hepatocellular Carcinoma	Liver	Alive	T3	NX	M0	Stage IIIA	G2	0	1351			TUMOR FREE																					Mild	62	3.5	3.4	5.0	TCGA-BC-A216	4bbdbe77-f3cb-4b64-9826-72debb734784	0.0	0.6	2	Not Available	0.5	1.5	0.9	8	-22968	Not Applicable	0	1144	Not Available																								Not Available	Not Available	0	8	831	0 - No Fibrosis	TCGA-BC-A216-F22055	2EEFD625-0E3C-4E5A-B391-C97608CA083C	23	Not Applicable	1351	Scheduled Follow-up Submission	Not Available	2													NO	TUMOR FREE	NO	NO	NO	Alive	2012	FEMALE	164	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	7	G2													Not Available	No	A216	TUMOR FREE	211000	140000	440000	Not Available	Not Available	1.4	WHITE	Not Available																			YES	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T3	NO	YES	BC	1.5	Liver	None	Not Available	Alive	151	2011	2008
TCGA-2Y-A9H5	59	FEMALE	157	555	69	27.99302202929125	Hepatocellular Carcinoma	Liver	Dead	T1	N0	MX	Stage I	G3	1	258.0	Liver	Locoregional Recurrence	WITH TUMOR																					Unknown	59	3.5	4.9	5	TCGA-2Y-A9H5	51810579-E20D-4F08-93E7-891D645931DB	0.2	0.3	2	Unknown	0.8	1.5	0.6	3	-21818	555	0	Not Available	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	7	11700	1,2 - Portal Fibrosis																												FEMALE	157	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G3	NO	NO	Not Available	258	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	A9H5	WITH TUMOR	204	143	382	NO	NO	10.2	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	NO	YES	2Y	1.3	Liver	None	Hepatitis  C Antibody;Hepatitis C Virus RNA;HCV Genotype	Dead	69	2014	2010
TCGA-EP-A12J	62	MALE	173	570	Not Available		Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G1	0	570			TUMOR FREE																					Not Available	62	3.8	4.2	5.1	TCGA-EP-A12J	959918d7-cb84-4745-a72f-d138176b1ecb	0.2	0.4	1	B	0.7	1.3	0.8	31	-22997	Not Applicable	0	129	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-EP-A12J-F18469;TCGA-EP-A12J-F40456	2E4FC593-392E-4FA5-BB29-30A02252D11D;24C1DCB6-2D99-47B5-BF61-88C2E4A871C2	17;20	Not Applicable;Not Applicable	330;570	Scheduled Follow-up Submission;Not Available	Not Available;NO	11;2	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	NO;NO	TUMOR FREE;TUMOR FREE	NO;NO	NO;NO	NO;NO	Alive;Alive	2011;2013	MALE	173	Hepatocellular Carcinoma	Hepatitis C	Sarcoidosis	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G1													Not Available	No	A12J	TUMOR FREE	187	150	400	Not Available	Not Available	1.1	BLACK OR AFRICAN AMERICAN	Not Available																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	EP	1.0	Liver	None	Not Available	Alive	Not Available	2011	2010
TCGA-DD-AACP	64	MALE	155	415	62	25.806451612903224	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	415			Unknown																					None	64	3.8	4.1	5.3	TCGA-DD-AACP	7AD77384-0946-4FB5-9B10-BDC8A5FC8D87	0.2	1.1	Not Available	A	0.7	1.5	1.1	29	-23728	Not Applicable	0	400	Not Available																								0	NOT HISPANIC OR LATINO	0	8	227	Unknown	TCGA-DD-AACP-F68374	A4DE4BD1-9A6E-4C04-B16F-4BA9292A1703	17	Not Applicable	415	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Unknown	NO	NO	NO	Alive	2014	MALE	155	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AACP	Unknown	151	130	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	62	2014	2009
TCGA-DD-A3A2	76	FEMALE	178	2131	85	26.82742078020452	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G1	0	2131			TUMOR FREE																					None	76	3.5	4.2	5.0	TCGA-DD-A3A2	357C1C08-F368-4CAE-8F20-9BE241B30479	0.1	0.5	Not Available	A	0.6	0.9	0.8	5	-27930	2131	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	0 - No Fibrosis	TCGA-DD-A3A2-F42706	FF40877E-FD66-43C0-908F-B1654F1D567F	27	2131	Not Available	Not Available	NO	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE	NO	NO	NO	Dead	2013	FEMALE	178	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	1	G1													Not Available	No	A3A2	TUMOR FREE	326	150	450	Not Available	Not Available	8.8	WHITE	Not Available																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.1	Liver	None	Unknown	Dead	85	2012	1998
TCGA-DD-A3A0	70	MALE	178	785	88	27.77427092538821	Hepatocellular Carcinoma	Liver	Dead	T1	NX	M0	Stage I	G2	1	359.0		New Primary Tumor	WITH TUMOR																					None	70	3.5	3.3	5.0	TCGA-DD-A3A0	AE99D9FD-1735-4217-B4EF-33B377FBD594	0.1	1.4	Not Available	A	0.8	1.2	2.7	5	-25889	785	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	6	1	0 - No Fibrosis	TCGA-DD-A3A0-F42710	21E88DB0-7327-453C-9995-A5F0485564BB	27	785	Not Available	Not Available	NO	4	NO	YES	Not Available	359	Not Available	Not Available	New Primary Tumor	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2013	MALE	178	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	1	G2													Not Available	No	A3A0	WITH TUMOR	138	150	450	Not Available	Not Available	13.2	WHITE	Not Available																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Dead	88	2012	2001
TCGA-DD-A4ND	56	FEMALE	162	2746	89	33.91251333638165	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	1	15.0	Other, specify	New Primary Tumor	WITH TUMOR																					None	56	3.5	3.9	5	TCGA-DD-A4ND	C0BF9278-9CBB-4361-B4D8-AB172B67E276	0.1	0.5	3	A	0.6	1.1	0.7	18	-20782	Not Applicable	0	2141	Not Available	TCGA-DD-A4ND-D43026	8E76F1B7-7EFB-4AF9-A238-BF6BDDD6587F	Not Available	13	218	20	Adriamycin/Cytoxan	Complete Response	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	1	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	0 - No Fibrosis	TCGA-DD-A4ND-F43021;TCGA-DD-A4ND-F66592	86893488-3590-4212-B57C-D69012ACCA07;82C537E3-5160-464C-9446-34B869BA0CFA	5;21	Not Applicable;Not Applicable	2232;2746	Not Available;Not Available	NO;NO	6;10	NO;Not Available	NO;Not Available	Not Available;Not Available	20;Not Available	Not Available;Not Available	Other, specify;Not Available	New Primary Tumor;Not Available	stage IV breast carcinoma;Not Applicable	No;Not Available	NO;Not Available	No;Not Available	Not Available;Not Available	YES;NO	WITH TUMOR;TUMOR FREE	NO;NO	NO;NO	NO;NO	Alive;Alive	2013;2014	FEMALE	162	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12	12	G3	NO	NO	16	15	Not Available	Other, specify	New Primary Tumor	breast cancer	No	YES	No	R0	YES	Yes	A4ND	WITH TUMOR	Not Available	Not Available	Not Available	NO	NO	8.8	WHITE	NO																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1	Liver	None	Unknown	Alive	89	2012	2007
TCGA-G3-AAV5	67	MALE	165	354	88	32.323232323232325	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	1	117.0	Liver	Locoregional Recurrence	WITH TUMOR		NO						TCGA-G3-AAV5-A62435	ACCB5A02-760D-4F04-8AF4-635EC10BB039	16	YES	-57;144	Not Available;Doxorubicin	Not Applicable;Not Applicable	Chemoembolization;Chemoembolization	Not Available;Other, specify	Not Applicable;Renegade Hi-Flo microcatheter	7	2014		Not Available	67	3.3	4.2	4.8	TCGA-G3-AAV5	4DFF4242-4A53-4F46-B200-7ED83F6B7808	0	0.4	Not Available	A	0.6	1.4	0.8	16	-24655	Not Applicable	0	266	Not Available	TCGA-G3-AAV5-D65944	2DE0F885-BD8A-44B0-88C8-28FC3BA649F3	Chemotherapy	1	Not Available	227	HEC.1 - Sorafenib vs Sorafenib plus Doxorubicin	Not Applicable	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	YES	2014	1	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	6 - Established Cirrhosis	TCGA-G3-AAV5-F65955	23C4DFC8-45CA-4E2E-9721-FFC2B8C41D88	1	Not Applicable	354	Not Available	NO	10	YES;YES	NO;NO	Not Available;Not Available	117;266	Not Available;Not Available	Liver;Other, specify	Locoregional Recurrence;Extrahepatic Recurrence	Not Applicable;Adrenal Nodule	Yes;No	NO;NO	No;No	Not Available;Not Available	YES	WITH TUMOR	YES	YES	Discrepancy	Alive	2014	MALE	165	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	7	G2	Not Available;YES;YES	Not Available;NO;NO	Not Available;Not Available;Not Available	Not Available;117;266	Not Available;Not Available;Not Available	Not Available;Liver;Other, specify	Not Available;Intrahepatic Recurrence;Extrahepatic Recurrence	Not Applicable;Not Applicable;Adrenal Nodule	Not Available;Yes;No	Not Available;NO;NO	Not Available;No;No	Not Available;Not Available;Not Available	YES	No	AAV5	WITH TUMOR	326	150	400	NO	NO	1	WHITE	YES																			Unknown	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	G3	1.4	Liver	Macro	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	88	2014	2013
TCGA-DD-AAEB	60	MALE	161	478	75	28.934068901662744	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	478			TUMOR FREE																					Unknown	60	3.8	4.1	5.3	TCGA-DD-AAEB	F0ECE8E2-A6B0-4ED9-A613-D2FBB20E51B1	0.2	0.3	Not Available	A	0.7	1.5	0.6	14	-22121	Not Applicable	0	370	Not Available																								1	NOT HISPANIC OR LATINO	0	8	1	Unknown	TCGA-DD-AAEB-F68423	D4873E20-9C13-4998-A072-66D6B2032855	17	Not Applicable	478	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	161	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAEB	TUMOR FREE	270	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	75	2014	2012
TCGA-2Y-A9H8	85	FEMALE	150	633	40	17.77777777777778	Hepatocellular Carcinoma	Liver	Dead	T1	NX	MX		G2	1	398.0	Other, specify	Extrahepatic Recurrence	WITH TUMOR																					Unknown	85	3.5	4.2	5	TCGA-2Y-A9H8	3528DD91-1A6D-4D41-A3EE-829C857CC904	0.2	0.3	2	Unknown	0.8	1.5	0.6	3	-31322	633	0	Not Available	Not Available	TCGA-2Y-A9H8-D67250;TCGA-2Y-A9H8-D67251;TCGA-2Y-A9H8-D68658	A041658C-D57C-4048-B642-6BC1038DE85E;D29ED18B-0AEF-4D85-B579-589538D17FC5;300E5076-567C-411A-8977-EE9BCC5CE0B2	Not Available;Not Available;Not Available	3;3;5	491;608;608	398;498;498	Naxavar;everolimus;SOM 230	Unknown;Stable Disease;Stable Disease	11;11;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;YES;YES	2014;2014;2014	2	NOT HISPANIC OR LATINO	0	7	234000	Unknown																												FEMALE	150	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G2	YES	NO	Not Available	398	Not Available	Other, specify	Extrahepatic Recurrence	Kidney	No	NO	No	Not Available	YES	No	A9H8	WITH TUMOR	255	143	382	NO	NO	10.3	WHITE	NO																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	2Y	1.3	Liver	Unknown	Hepatitis C Virus RNA;HBV Surface Antibody;HBV DNA	Dead	40	2014	2011
TCGA-G3-A25S	64	MALE	166	416	73	26.49150820148062	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G2	1	37.0	Other, specify	Extrahepatic Recurrence	WITH TUMOR																					Mild	64	0.3	0.4	0.5	TCGA-G3-A25S	B865DEC4-F051-4FBE-9405-F832FF2010D7	0	1.2	0	A	0.6	1.4	1.0	27	-23571	Not Applicable	0	37	Not Available	TCGA-G3-A25S-D45076;TCGA-G3-A25S-D45077	A74505A0-B326-4F72-8BBF-BF23538A5960;128B2718-B773-4D49-876C-19E3615F5E36	Sunitinib VS Sorafenib;Not Available	4;4	348;369	313;351	Sunitinib;Sorafenib	Clinical Progressive Disease;Clinical Progressive Disease	7;7	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;NO	2013;2013	1	NOT HISPANIC OR LATINO	0	10	281	6 - Established Cirrhosis	TCGA-G3-A25S-F33638	8B36BA5D-87E5-4CFD-9280-D629EE30810B	11	416	Not Available	Scheduled Follow-up Submission	Not Available	7	YES	YES	Not Available	37	Not Available	Other, specify	Extrahepatic Recurrence	Bone and Lung	Not Available	NO	Not Available	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2012	MALE	166	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	7	G2													Not Available	No	A25S	WITH TUMOR	313	150	400	Not Available	Not Available	1.0	WHITE	Not Available	Distant Recurrence	TCGA-G3-A25S-R45075	6EA61973-F61F-4EB9-AB42-B9DA6CA57045	Not Available	4	393	129	Radiographic Progressive Disease	7	25	76	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	NO	R1	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	G3	1.4	Liver	Micro	Not Available	Alive	73	2011	2009
TCGA-RC-A6M5	20	FEMALE	Not Available	15	Not Available		Fibrolamellar Carcinoma	Liver	Alive	T1	N1	M0	Stage IVA	G2	0	15			Unknown																					Not Available	20	3.5	3.9	4.8	TCGA-RC-A6M5	D504EE30-6955-4A7B-9311-55AD3DECADD5	0.2	0.5	Not Available	A	0.8	1.3	0.4	9	-7634	Not Applicable	0	15	Not Available																								Not Available	Unknown	Not Available	Not Available	Not Available	Not Available																												FEMALE	Not Available	Fibrolamellar Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8171/3	C22.0	YES	0.9	1.2	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	No	A6M5	Unknown	317000	150000	400000	NO	Unknown	1.2	WHITE	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1	NO	YES	RC	1.3	Liver	None	Not Available	Alive	Not Available	2015	2012
TCGA-DD-AAE4	49	FEMALE	157	608	62	25.153150229218223	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G1	1	111.0	Liver	Locoregional Recurrence	TUMOR FREE		YES	Radiofrequency Ablation	Not Applicable	139	1	Not Available	TCGA-DD-AAE4-A68415	26E1A96C-4564-4BFE-9354-F0AA2EB77E4F	3	NO	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	11	2014		None	49	3.8	4.0	5.3	TCGA-DD-AAE4	C797D6AD-05D4-4322-BAD2-29801A986B4E	0.2	0.8	Not Available	A	0.7	1.5	0.5	14	-18009	Not Applicable	0	259	Not Available																								0	NOT HISPANIC OR LATINO	0	8	7	6 - Established Cirrhosis	TCGA-DD-AAE4-F68414	63DA3464-3DF6-4223-BE57-45649AB79803	17	Not Applicable	608	Not Available	NO	11	NO	NO	Not Available	111	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	FEMALE	157	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G1	NO	NO	Not Available	111	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AAE4	TUMOR FREE	113	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	62	2014	2013
TCGA-DD-AACH	69	MALE	160	195	53	20.703125	Hepatocellular Carcinoma	Liver	Dead	T2	N0	M0	Stage II	G3	1	83.0	Liver	Intrahepatic Recurrence	TUMOR FREE																					Mild	69	3.8	4.3	5.3	TCGA-DD-AACH	219B067C-522F-4971-B0D0-86F9971D369D	0.2	1.5	Not Available	A	0.7	15	1.2	28	-25544	195	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	8	7	6 - Established Cirrhosis																												MALE	160	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	NO	NO	Not Available	83	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AACH	TUMOR FREE	290	130	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.2	Liver	Micro	Unknown	Dead	53	2014	2008
TCGA-DD-AAD8	73	FEMALE	152	1219	57	24.67105263157895	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	1219			TUMOR FREE																					Mild	73	3.8	4.3	5.3	TCGA-DD-AAD8	24B66729-242B-4771-819D-77C9A1FCBB10	0.2	0.3	Not Available	A	0.7	1.5	0.6	7	-26781	Not Applicable	0	959	Not Available																								0	NOT HISPANIC OR LATINO	0	8	4	1,2 - Portal Fibrosis	TCGA-DD-AAD8-F68389	3AB0D44A-2EB5-4724-BB09-25A3C6A78677	17	Not Applicable	1219	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	152	Hepatocellular Carcinoma	Hepatitis B;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAD8	TUMOR FREE	130	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	57	2014	2011
TCGA-CC-A7IH	58	MALE	175	365	56	18.285714285714285	Hepatocellular Carcinoma	Liver	Alive	T3	N0	M0	Stage IIIA	G1	0	365			TUMOR FREE																					Not Available	58	Not Available	Not Available	Not Available	TCGA-CC-A7IH	E4E0BC11-AD61-4419-857C-44FB5C7877A3	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	22	-21381	Not Applicable	0	0	Not Available																								3	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A7IH-F69920	28788384-37B7-4B17-8270-AF24B0E8BBFC	22	Not Applicable	365	Not Available	NO	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2015	MALE	175	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7IH	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	56	2014	2013
TCGA-DD-AAE9	69	MALE	165	722	63	23.140495867768596	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	722			TUMOR FREE																					Mild	69	3.8	4.1	5.3	TCGA-DD-AAE9	4C960EEE-E4B5-499D-A596-238AA78745A4	0.2	0.7	Not Available	A	0.7	1.5	0.9	14	-25451	Not Applicable	0	386	Not Available																								0	NOT HISPANIC OR LATINO	0	8	3	1,2 - Portal Fibrosis	TCGA-DD-AAE9-F68857	828CA4EC-5E78-4CFE-B25C-B3BDE3642F68	21	Not Applicable	722	Not Available	NO	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	165	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAE9	TUMOR FREE	138	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	63	2014	2012
TCGA-DD-AADA	66	FEMALE	147	1233	59	27.303438382155583	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	1233			TUMOR FREE																					Unknown	66	3.8	4.1	5.3	TCGA-DD-AADA	E50EDBA1-8EC4-47E7-A01E-9F1B2CD75FD7	0.2	0.5	Not Available	A	0.7	1.5	0.6	7	-24288	Not Applicable	0	930	Not Available																								0	NOT HISPANIC OR LATINO	0	8	8698	Unknown	TCGA-DD-AADA-F68390	77B4F506-E05D-47BF-B3EB-2E607F7CC840	17	Not Applicable	1233	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	147	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AADA	TUMOR FREE	173	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	Macro	Unknown	Alive	59	2014	2011
TCGA-DD-A39X	78	FEMALE	152	1694	48	20.775623268698062	Hepatocellular Carcinoma	Liver	Dead	T1	NX	M0	Stage I	G2	1	1032.0	Liver	Intrahepatic Recurrence	WITH TUMOR		YES	Radiofrequency Ablation	Not Applicable	1039	1	1	TCGA-DD-A39X-A42569	23D1697E-FE5C-4B31-9308-534FE20BB62E	25	NO	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	4	2013		None	78	3.5	4.1	5.0	TCGA-DD-A39X	0D0A10B4-7B99-4043-A129-89844F258156	0.1	0.5	2	A	0.6	0.9	0.9	5	-28528	1694	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	6	10	0 - No Fibrosis	TCGA-DD-A39X-F42568	08417BFB-D2A4-4757-865B-C453C3C5FB2F	24	1694	Not Available	Not Available	NO	4	NO	NO	Not Available	1032	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	Unknown	YES	NO	NO	Dead	2013	FEMALE	152	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	1	G2													Not Available	No	A39X	WITH TUMOR	180	150	450	Not Available	Not Available	9.8	WHITE	Not Available																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody	Dead	48	2012	1998
TCGA-DD-AADE	50	MALE	166	1202	63	22.8625344752504	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G4	1	168.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					Mild	50	3.8	3.9	5.3	TCGA-DD-AADE	0904FD43-E25C-4D0F-ACEE-29FAA3FD933B	0.2	0.5	Not Available	A	0.7	1.5	1.1	7	-18482	Not Applicable	0	918	Not Available																								0	NOT HISPANIC OR LATINO	0	8	7	3,4 - Fibrous Speta	TCGA-DD-AADE-F68393	B45B3175-A736-4D7D-ABB6-A2C107DEAB1B	17	Not Applicable	1202	Not Available	NO	11	NO	NO	Not Available	168	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	MALE	166	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G4	NO	NO	Not Available	168	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	AADE	WITH TUMOR	148	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	63	2014	2011
TCGA-K7-A5RG	66	MALE	173	519	123	41.097263523672694	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G1	0	519			TUMOR FREE																					Not Available	66	Not Available	Not Available	Not Available	TCGA-K7-A5RG	4FD3ED02-7B66-47BF-8B92-31FEE1093A87	Not Available	Not Available	1	Unknown	Not Available	Not Available	Not Available	21	-24218	Not Applicable	0	120	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	19	Not Available	TCGA-K7-A5RG-F64039	B402E796-500F-4E51-BF97-F97CE43EF6B8	25	Not Applicable	519	Not Available	NO	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	173	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	6	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A5RG	TUMOR FREE	Not Available	Not Available	Not Available	NO	NO	Not Available	BLACK OR AFRICAN AMERICAN	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	K7	Not Available	Liver	None	HCV Genotype	Alive	123	2013	2012
TCGA-DD-AAVW	35	MALE	162	2317	62	23.62444749276025	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	2317			TUMOR FREE																					None	35	3.3	4.6	5.2	TCGA-DD-AAVW	11823A8A-194F-4E6B-A373-EF5A3FC7D2B9	0.2	1.4	Not Available	A	0.7	1.4	1.1	13	-12986	Not Applicable	0	1867	Not Available																								0	NOT HISPANIC OR LATINO	0	15	927	6 - Established Cirrhosis	TCGA-DD-AAVW-F67582	2C933DC1-B112-4161-90A5-B44BEA7CE9DF	6	Not Applicable	2317	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	162	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.2	6	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAVW	TUMOR FREE	212	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	62	2014	2008
TCGA-G3-A5SI	44	MALE	177	768	74	23.620287912158066	Hepatocellular Carcinoma	Liver	Dead	T2	N0	M0	Stage II	G2	1	348.0	Liver	Intrahepatic Recurrence	WITH TUMOR		NO						TCGA-G3-A5SI-A42749	79DD2140-0ABD-4E38-86EB-5D34A1015117	30	YES	370;435;447	Doxorubicin;Doxorubicin;Doxorubicin	Not Applicable;Not Applicable;Not Applicable	Chemoembolization;Chemoembolization;Chemoembolization	Plastic Beads;Plastic Beads;Plastic Beads	Not Applicable;Not Applicable;Not Applicable	4	2013		Mild	44	3.3	2.8	4.8	TCGA-G3-A5SI	14201DA5-4446-47BE-AF72-120B7780C6BF	0	0.7	Not Available	A	0.6	1.4	0.4	15	-16126	Not Applicable	0	447	Not Available	TCGA-G3-A5SI-D59275	EF0713F1-6FF0-47EA-92BC-BE9682F0B8A6	Not Available	7	733	599	Sorafenib	Clinical Progressive Disease	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	NOT HISPANIC OR LATINO	0	10	9	6 - Established Cirrhosis	TCGA-G3-A5SI-F59276	E0D448CC-F26E-4F31-AA6A-A4D1573B06A9	7	768	Not Available	Not Available	NO	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	WITH TUMOR	NO	NO	NO	Dead	2014	MALE	177	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	5	G2	NO	NO	Not Available	348	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	A5SI	WITH TUMOR	145	150	400	NO	NO	1.4	ASIAN	NO																			Unknown	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	G3	1.4	Liver	None	Not Available	Alive	74	2013	2011
TCGA-MR-A8JO	34	MALE	196	330	90	23.4277384423157	Fibrolamellar Carcinoma	Liver	Alive	T1	N0	MX	Stage I	G3	0	330			TUMOR FREE																					Not Available	34	3.9	4.1	5.1	TCGA-MR-A8JO	8574D285-E02A-4D2B-931B-73556A9FDA02	0.2	0.8	Not Available	Unknown	Not Available	Not Available	Not Available	9	-12669	Not Applicable	0	52	Not Available																								Unknown	Unknown	Not Available	Not Available	2	Not Available	TCGA-MR-A8JO-F58923	3A733C3A-32ED-48D4-8AAF-C4897EF1A87C	28	Not Applicable	330	Not Available	NO	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	196	Fibrolamellar Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8171/3	C22.0	YES	Not Available	Not Available	10	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A8JO	TUMOR FREE	162	150	450	NO	NO	Not Available	WHITE	NO																			NO	RX	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	YES	NO	MR	1.3	Liver	None	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Core Antibody	Alive	90	2013	2013
TCGA-DD-AAE1	52	MALE	169	552	62	21.707923392038094	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	552			TUMOR FREE																					Mild	52	3.8	4.1	5.3	TCGA-DD-AAE1	3BBFF405-DAE4-4DC9-985A-33E7AC9CB2DD	0.2	0.4	Not Available	A	0.7	1.5	0.8	14	-19073	Not Applicable	0	293	Not Available																								0	NOT HISPANIC OR LATINO	0	8	2693	6 - Established Cirrhosis	TCGA-DD-AAE1-F68411	D5FA22AD-EE8D-4F33-A2C5-C06C90820D8D	17	Not Applicable	552	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	169	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAE1	TUMOR FREE	102	130	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	62	2014	2013
TCGA-DD-A4NN	56	FEMALE	163	899	59	22.20633068613798	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G3	1	166.0	Lung	Extrahepatic Recurrence	WITH TUMOR																					Unknown	56	3.5	4.3	5.0	TCGA-DD-A4NN	B96B7620-5506-4DEF-AFF2-5E888EAF3EA5	0.1	0.5	1	A	0.7	1.2	0.9	5	-20548	899	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	6	4223	0 - No Fibrosis	TCGA-DD-A4NN-F49659	076A5388-DAFB-476B-A78A-FD44AEB68A5A	7	899	Not Available	Not Available	NO	10	NO	NO	Not Available	166	Not Available	Lung	Extrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2013	FEMALE	163	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.0	12.0	2	G3	Not Available	Not Available	Not Available	166	Not Available	Lung	Extrahepatic Recurrence	Not Applicable	Not Available	Not Available	Not Available	Not Available	YES	No	A4NN	WITH TUMOR	307	150	450	NO	NO	8.8	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Unknown	Dead	59	2013	2004
TCGA-BW-A5NP	26	FEMALE	Not Available	0	Not Available		Hepatocellular Carcinoma	Liver	Alive	T2	N0	M1	Stage IV	G3	1	102.0	Liver	Extrahepatic Recurrence	WITH TUMOR																					Mild	26	Not Available	Not Available	Not Available	TCGA-BW-A5NP	56A82A56-0241-4D3D-9DE2-696B0C36DF91	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	26	-9809	Not Applicable	0	0	Not Available	TCGA-BW-A5NP-D42457	164C944A-AF81-454A-BAAE-E3F547B863F9	Not Available	26	289	128	Nexavar	Clinical Progressive Disease	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	2	HISPANIC OR LATINO	Not Available	Not Available	143684	3,4 - Fibrous Speta																												FEMALE	Not Available	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G3	YES	NO	Not Available	102	Not Available	Liver	Extrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	A5NP	WITH TUMOR	Not Available	Not Available	Not Available	NO	YES	Not Available	WHITE	NO																			Unknown	RX	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1	N0	T2	YES	NO	BW	Not Available	Liver	Micro	Not Available	Alive	Not Available	2014	2010
TCGA-CC-A8HV	51	FEMALE	159	279	51	20.173252640322772	Hepatocellular Carcinoma	Liver	Dead	T2	N0	M0	Stage II	G2	1	149.0		Locoregional Recurrence	TUMOR FREE																					Not Available	51	Not Available	Not Available	Not Available	TCGA-CC-A8HV	5B32D3F4-9B88-42DE-AAAC-22D1D2F5CDE0	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	22	-18935	Not Applicable	0	0	Not Available	TCGA-CC-A8HV-D69786	6872A373-FAF3-48CD-8D7D-A20B18E9A041	Not Available	19	188	158	Nexavar	Clinical Progressive Disease	1	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Targeted Molecular therapy	Not Available	Not Available	Not Available	NO	2015	2	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A8HV-F69784	556F635B-AF24-4B37-B424-C20A9F0A4A7C	19	279	Not Available	Not Available	NO	1	YES;NO	NO;NO	Not Available;Not Available	149;241	Not Available;Not Available	Not Available;Lung	Locoregional Recurrence;New Primary Tumor	Not Applicable;Not Applicable	No;No	NO;NO	No;No	Not Available;Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2015	FEMALE	159	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A8HV	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	51	2014	2013
TCGA-G3-A3CK	61	MALE	170	585	67	23.18339100346021	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	585			TUMOR FREE																					Mild	61	0.3	0.2	0.5	TCGA-G3-A3CK	39EB1DB0-2722-4AF4-8254-D0E10256C64D	0	0.8	1	A	0.6	1.4	1.1	16	-22462	Not Applicable	0	27	Not Available																								0	NOT HISPANIC OR LATINO	0	10	3	6 - Established Cirrhosis	TCGA-G3-A3CK-F40227	9A4499F6-A47E-432B-BBEB-565C5FD20B4A	14	Not Applicable	585	Not Available	NO	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2013	MALE	170	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	1	G2													Not Available	No	A3CK	TUMOR FREE	143	150	400	Not Available	Not Available	1.0	ASIAN	Not Available																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	G3	1.4	Liver	None	Not Available	Alive	67	2012	2011
TCGA-EP-A26S	70	MALE	168	608	41	14.526643990929704	Hepatocellular Carcinoma	Liver	Alive	T1	N0	MX	Stage I	G2	0	608			TUMOR FREE																					Mild	70	3.8	3.5	5.1	TCGA-EP-A26S	B7D6621C-8BCE-4A01-8588-9D7761D9372B	0.2	0.4	Not Available	Not Available	Not Available	Not Available	Not Available	19	-25677	Not Applicable	0	111	Not Available																								1	NOT HISPANIC OR LATINO	0	Not Available	Not Available	0 - No Fibrosis	TCGA-EP-A26S-F19566;TCGA-EP-A26S-F39041	1081B2A6-E407-492D-A9F6-287A664CD238;7D5EAB38-01D0-4AA5-8338-8AA36F53ED7A	14;9	Not Applicable;Not Applicable	237;608	Scheduled Follow-up Submission;Not Available	Not Available;NO	12;1	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	NO;NO	TUMOR FREE;TUMOR FREE	NO;NO	NO;NO	NO;NO	Alive;Alive	2011;2013	MALE	168	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.5	12.5	7	G2													Not Available	No	A26S	TUMOR FREE	234	140	415	Not Available	Not Available	12.9	WHITE	Not Available																			NO	Not Available	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1	YES	NO	EP	1.0	Liver	None	Not Available	Alive	41	2011	2011
TCGA-2Y-A9GX	68	MALE	175	2442	104	33.95918367346939	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G2	1	2133.0	Liver	Locoregional Recurrence	WITH TUMOR																					None	68	3.5	4.3	5	TCGA-2Y-A9GX	D6C2C6CE-3483-4FE5-AEF6-E40419F728CF	0.2	0.4	Not Available	Unknown	0.8	1.5	0.7	3	-24963	Not Applicable	0	2442	Not Available																								1	NOT HISPANIC OR LATINO	0	7	1	Unknown	TCGA-2Y-A9GX-F69170	4D97DAB1-99B1-40BB-95B1-BB86EDEEFA5F	30	Not Applicable	2442	Not Available	NO	12	NO	NO	Not Available	2133	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	MALE	175	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G2	NO	NO	Not Available	2133	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	A9GX	WITH TUMOR	155	143	382	NO	NO	10.3	WHITE	NO																			NO	R1	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	2Y	1.3	Liver	Unknown	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	104	2014	2007
TCGA-RC-A7S9	47	FEMALE	161	640	58	22.37567995061919	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	640			TUMOR FREE																					Mild	47	3.1	4.3	5.2	TCGA-RC-A7S9	F5DE6712-4DE4-43DE-8EB5-EC2A798C8438	0.1	0.8	Not Available	A	0.3	1.20	0.7	21	-17403	Not Applicable	0	640	Not Available																								0	NOT HISPANIC OR LATINO	0	20	10	6 - Established Cirrhosis																												FEMALE	161	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.8	1.30	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7S9	TUMOR FREE	178000	150000	400000	NO	NO	1.1	ASIAN	NO																			Unknown	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	YES	NO	RC	1.3	Liver	None	Not Available	Alive	58	2014	2012
TCGA-YA-A8S7	68	MALE	164	412	73	27.14158239143367	Hepatocellular Carcinoma	Liver	Dead	T3a	N0	MX	Stage IIIA	G3	1	398.0	Brain	Extrahepatic Recurrence	WITH TUMOR																					Mild	68	3.5	2.1	5.0	TCGA-YA-A8S7	BB2069D3-E699-4A8A-BB61-B3C28B98A66B	0.2	3.8	Not Available	Unknown	0.60	1.3	0.7	8	-25188	412	0	Not Available	Not Available																								Unknown	HISPANIC OR LATINO	Not Available	8	56	Unknown																												MALE	164	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Right Hepatectomy	C22.0	8170/3	C22.0	YES	0.9	1.2	4	G3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	398;398	Not Available;Not Available	Brain;Liver	Extrahepatic Recurrence;Intrahepatic Recurrence	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES	No	A8S7	WITH TUMOR	Not Available	Not Available	Not Available	NO	YES	1.2	WHITE	NO																			NO	R0	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T3a	NO	YES	YA	1.0	Liver	None	Unknown	Dead	73	2014	2012
TCGA-DD-A3A3	45	MALE	167	535	71	25.458065904119906	Hepatocellular Carcinoma	Liver	Dead	T1	N0	M0	Stage I	G2	0	535			Not Available																					None	45	Not Available	Not Available	Not Available	TCGA-DD-A3A3	516C8594-2973-41E5-A5CE-76D177EDFA48	0.1	0.9	Not Available	B	0.8	1.2	1.2	6	-16708	535	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	6	6	0 - No Fibrosis	TCGA-DD-A3A3-F42700	CB91DB32-A4C4-47B8-BB03-74DC8C9C9CA1	27	535	Not Available	Not Available	NO	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	Unknown	Unknown	Unknown	Dead	2013	MALE	167	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	1	G2													Not Available	No	A3A3	Not Available	276	150	450	Not Available	Not Available	8.8	ASIAN	Not Available																			NO	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.1	Liver	Macro	Not Available	Dead	71	2012	1999
TCGA-O8-A75V	54	MALE	180	538	92	28.395061728395063	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G2	0	538			TUMOR FREE																					Mild	54	2.9	3.8	4.4	TCGA-O8-A75V	76CC9C06-0827-465E-BAB3-5F4115295EBE	0.3	1.9	1	A	0.50	1.50	1	29	-19850	Not Applicable	0	135	Not Available																								Unknown	HISPANIC OR LATINO	0	7	7	6 - Established Cirrhosis	TCGA-O8-A75V-F66431	9EF4DB84-7557-45BB-B660-299C23AF5FCF	16	Not Applicable	538	Not Available	NO	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Unknown	NO	NO	NO	Alive	2014	MALE	180	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B;Hepatitis C	Not Available	No	wedge resection	C22.0	8170/3	C22.0	YES	9.3	13.1	10	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A75V	TUMOR FREE	211	140	450	NO	NO	9.1	Unknown	NO																			YES	R1	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	O8	1.2	Liver	None	Unknown	Alive	92	2013	2013
TCGA-ZP-A9D0	67	FEMALE	165	1091	78	28.650137741046834	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX		G1	0	1091			TUMOR FREE																					Mild	67	3.5	4.1	5.2	TCGA-ZP-A9D0	396EF7C2-343E-4D5C-9B20-ADC0A52C1978	0.2	1.4	Not Available	A	0.5	1.1	0.9	28	-24525	Not Applicable	0	717	Not Available																								0	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	0 - No Fibrosis	TCGA-ZP-A9D0-F57744;TCGA-ZP-A9D0-F65764;TCGA-ZP-A9D0-F68255;TCGA-ZP-A9D0-F69077	539FFB5B-C3A8-4243-BC4B-8D82E94EE35A;58152C82-8098-482C-A370-24FEB526257B;79B3DC1F-C7EE-48B6-AF43-C3E51F504A57;E6F3DE6D-7D7B-4E8D-B369-1F7A5EDD760E	28;30;14;29	Not Applicable;Not Applicable;Not Applicable;Not Applicable	717;909;909;1091	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	3;9;11;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE;TUMOR FREE	NO;NO;NO;NO	NO;NO;NO;NO	NO;NO;NO;NO	Alive;Alive;Alive;Alive	2014;2014;2014;2014	FEMALE	165	Hepatocellular Carcinoma	Non-Alcoholic Fatty Liver Disease	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.6	12.6	3	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9D0	TUMOR FREE	185000	163000	369000	NO	NO	11	BLACK OR AFRICAN AMERICAN	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	ZP	1.2	Liver	None	Unknown	Alive	78	2014	2011
TCGA-DD-A1EE	73	MALE	175	349	77	25.142857142857142	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G3	1	44.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					Severe	73	3.5	2.7	5.0	TCGA-DD-A1EE	654af137-70d9-4ee4-9f69-793e352d30f8	0.1	0.5	Not Available	B	0.8	1.3	1.2	10	-26858	Not Applicable	0	204	Not Available																								2	NOT HISPANIC OR LATINO	0	6	3	6 - Established Cirrhosis	TCGA-DD-A1EE-F42208	D55A4FF7-4491-47F8-B109-C4B07E5B5D02	15	349	Not Available	Not Available	NO	4	NO	NO	Not Available	44	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2013	MALE	175	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	5	G3													Not Available	No	A1EE	WITH TUMOR	208	150	450	Not Available	Not Available	14.3	WHITE	Not Available																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	NO	YES	DD	1.0	Liver	None	Hepatitis C Virus RNA;HCV Genotype;Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	77	2011	2006
TCGA-DD-A3A6	72	FEMALE	175	3258	52	16.979591836734695	Hepatocellular Carcinoma	Liver	Dead	T2	N0	M0	Stage II	G2	0	3258			TUMOR FREE																					None	72	3.5	4.3	5.0	TCGA-DD-A3A6	C4C4820B-6F4C-4CDD-B233-4D22F5933FD9	0.1	0.4	Not Available	A	0.6	0.9	1.0	6	-26319	3258	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	0 - No Fibrosis	TCGA-DD-A3A6-F42703	791E8328-55D8-4487-9C71-8D3B2A7C5173	27	3258	Not Available	Not Available	NO	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Dead	2013	FEMALE	175	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	1	G2													Not Available	No	A3A6	TUMOR FREE	4	0	6	Not Available	Not Available	9.3	WHITE	Not Available																			NO	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.1	Liver	Micro	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Dead	52	2012	1997
TCGA-RC-A6M4	74	FEMALE	Not Available	22	87		Hepatocellular Carcinoma	Liver	Alive	T3	NX	MX	Stage IIIA	G2	0	22			Unknown																					Not Available	74	3.5	2.3	4.8	TCGA-RC-A6M4	2D1DC64D-27DE-4C83-A7FA-88DA5B48BF24	0.2	0.6	2	A	0.8	1.3	0.9	9	-27327	Not Applicable	0	22	Not Available																								1	NOT HISPANIC OR LATINO	0	44	5	Not Available																												FEMALE	Not Available	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	No	A6M4	Unknown	Not Available	Not Available	Not Available	NO	Unknown	Not Available	WHITE	Unknown																			YES	R1	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3	NO	YES	RC	1.3	Liver	None	Not Available	Alive	87	2015	2010
TCGA-DD-AAD6	66	MALE	167	672	93	33.34648069131199	Hepatocellular Carcinoma	Liver	Alive	T3a	N0	M0	Stage IIIA	G3	1	50.0	Liver	Locoregional Recurrence	TUMOR FREE																					Unknown	66	3.8	2.7	5.3	TCGA-DD-AAD6	418E79D1-51C7-4CEF-A1B6-E291FB13C2A5	0.2	0.6	Not Available	A	0.7	1.5	1.1	7	-24185	Not Applicable	0	672	Not Available																								1	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Unknown	TCGA-DD-AAD6-F68388	FCA52C9E-5B84-4B29-A2D7-23CCCB1D9C93	17	Not Applicable	672	Not Available	NO	11	NO	NO	Not Available	50	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	167	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	NO	NO	Not Available	50	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AAD6	TUMOR FREE	185	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3a	NO	YES	DD	1.2	Liver	None	Unknown	Alive	93	2014	2011
TCGA-K7-A5RF	64	MALE	177	631	75	23.939480992052093	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G1	1	205.0	Liver	Intrahepatic Recurrence	WITH TUMOR		NO						TCGA-K7-A5RF-A63821	CFA73AF8-20C4-43EC-B5EA-C17F5563D3B2	19	YES	240;275	Doxorubicin;Doxorubicin	Not Applicable;Not Applicable	Chemoembolization;Chemoembolization	Plastic Beads;Plastic Beads	Not Applicable;Not Applicable	8	2014		Not Available	64	Not Available	Not Available	Not Available	TCGA-K7-A5RF	3134F7D1-3359-497A-B8BE-1F317D8DDAAA	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	24	-23557	Not Applicable	0	240	Not Available																								Unknown	NOT HISPANIC OR LATINO	Not Available	Not Available	5	Not Available	TCGA-K7-A5RF-F64037	39C01A13-096E-49FC-9456-E201DC7B785A	25	Not Applicable	631	Not Available	NO	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	YES	NO	NO	Alive	2014	MALE	177	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	6	G1	Not Available	NO	Not Available	205	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Not Available	Not Available	No	Not Available	YES	No	A5RF	WITH TUMOR	Not Available	Not Available	Not Available	YES	NO	Not Available	WHITE	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	K7	Not Available	Liver	Unknown	Hepatitis C Virus RNA	Alive	75	2013	2012
TCGA-CC-A8HS	18	MALE	172	300	62	20.9572742022715	Hepatocellular Carcinoma	Liver	Dead	T3	N1	M0	Stage IIIC	G1	1	201.0		Locoregional Recurrence	TUMOR FREE																					Not Available	18	Not Available	Not Available	Not Available	TCGA-CC-A8HS	D18CD259-267E-47B5-9353-AD3454E048A0	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	22	-6617	Not Applicable	0	0	Not Available																								3	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A8HS-F69707	B1FC5D14-200A-4A90-A3AE-2547B31FC6B3	16	300	Not Available	Not Available	NO	1	NO	NO	Not Available	201	Not Available	Not Available	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2015	MALE	172	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	8	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A8HS	TUMOR FREE	Not Available	Not Available	Not Available	Unknown	Unknown	Not Available	ASIAN	Unknown																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3	YES	NO	CC	Not Available	Liver	Unknown	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	62	2014	2013
TCGA-G3-A5SK	58	MALE	169	744	67	23.458562375266972	Hepatocellular Carcinoma	Liver	Alive	T1	NX	M0	Stage I	G1	1	483.0	Liver	Intrahepatic Recurrence	TUMOR FREE		YES	Radiofrequency Ablation	Not Applicable	575	1	1	TCGA-G3-A5SK-A62746	9B6947A8-DE71-4F9B-B433-2C88224A8374	24	YES	671	Doxorubicin	Not Applicable	Chemoembolization	Plastic Beads	Not Applicable	7	2014		Mild	58	3.3	3.3	4.8	TCGA-G3-A5SK	24259D55-20AC-4359-861F-DCAD7AD88CEE	Not Available	Not Available	Not Available	A	0.6	1.4	0.6	15	-21320	Not Applicable	0	302	Not Available																								0	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	6 - Established Cirrhosis	TCGA-G3-A5SK-F62745	A4185ED5-2AED-4C0A-B804-86B0DB9F8B43	24	Not Applicable	744	Not Available	NO	7	NO;NO;NO	NO;NO;NO	Not Available;Not Available;Not Available	483;483;616	Not Available;Not Available;Not Available	Liver;Liver;Liver	Intrahepatic Recurrence;Intrahepatic Recurrence;Intrahepatic Recurrence	Not Applicable;Not Applicable;Not Applicable	Yes;Yes;Yes	NO;NO;NO	No;No;No	Not Available;Not Available;Not Available	YES	WITH TUMOR	YES	NO	NO	Alive	2014	MALE	169	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	5	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A5SK	TUMOR FREE	106	150	400	NO	NO	1.1	WHITE	NO																			Unknown	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1	NO	YES	G3	Not Available	Liver	Unknown	Not Available	Alive	67	2013	2012
TCGA-DD-A4NQ	60	MALE	159	373	75	29.666548000474666	Hepatocellular Carcinoma	Liver	Dead	T2	N0	M0	Stage II	G3	1	126.0	Liver	Intrahepatic Recurrence	WITH TUMOR		NO						TCGA-DD-A4NQ-A43378	73A0E12B-2408-4494-9858-C79A32E695B3	20	YES	148;211	Not Available;Not Available	Not Applicable;Not Applicable	Radioembolization;Radioembolization	Y-90 Therasphere;Y-90 Therasphere	Not Applicable;Not Applicable	5	2013		Mild	60	3.5	4.4	5.0	TCGA-DD-A4NQ	C05720FE-19C1-4CFF-819B-6806B26FC312	0.1	0.7	1	A	0.8	1.3	0.8	11	-22111	373	0	Not Available	Not Available	TCGA-DD-A4NQ-D43379	AF94B879-0ED7-4F2A-A418-B3B3C6DA6FA0	Not Available	20	290	151	Sorafenib	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	HISPANIC OR LATINO	0	6	141	Unknown	TCGA-DD-A4NQ-F49669	BB6C349B-C1A3-452F-BE57-D007A52948ED	7	373	Not Available	Not Available	NO	10	YES	NO	Not Available	126	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2013	MALE	159	Hepatocellular Carcinoma	Hepatitis B;Other	tobacco	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	2	G3	YES	NO	Not Available	126	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	Not Available	Not Available	Not Available	YES	No	A4NQ	WITH TUMOR	283	150	450	NO	NO	10.1	WHITE	NO																			YES	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.0	Liver	Macro	Hepatitis C Virus RNA;Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Dead	75	2013	2007
TCGA-DD-A1ED	68	MALE	168	2301	85	30.116213151927436	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G1	0	2301			TUMOR FREE																					None	68	3.5	4.2	5.0	TCGA-DD-A1ED	0ff6364a-e6f4-47ca-a7e7-14705bf0a8df	0.1	0.8	Not Available	A	0.8	1.3	1.3	16	-25039	Not Applicable	0	1629	Not Available																								1	NOT HISPANIC OR LATINO	0	6	3	0 - No Fibrosis	TCGA-DD-A1ED-F42202	2691A76E-77FC-40EC-877C-CFD8682EA033	15	Not Applicable	2301	Not Available	NO	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2013	MALE	168	Hepatocellular Carcinoma	Alcohol consumption	tattoos	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	5	G1													Not Available	No	A1ED	TUMOR FREE	219	150	450	Not Available	Not Available	8.9	WHITE	Not Available																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	85	2011	2006
TCGA-G3-AAV3	58	FEMALE	168	412	85	30.116213151927436	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	0	412			TUMOR FREE																					Severe	58	3.4	4.4	4.8	TCGA-G3-AAV3	EFC865FD-7C74-4361-9D7A-EEF923DBCD24	0	0.6	1	A	0.5	0.9	0.6	15	-21449	Not Applicable	0	279	Not Available																								1	NOT HISPANIC OR LATINO	0	7	5	6 - Established Cirrhosis	TCGA-G3-AAV3-F67247	5CC0815E-99C4-4815-A883-ED1FAD638E7E	3	Not Applicable	412	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	FEMALE	168	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis C;Non-Alcoholic Fatty Liver Disease	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAV3	TUMOR FREE	113	150	450	NO	NO	1.1	WHITE	NO																			YES	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	YES	NO	G3	1.4	Liver	None	Unknown	Alive	85	2014	2013
TCGA-ZP-A9CV	59	MALE	173	1088	59	19.713321527615356	Hepatocellular Carcinoma	Liver	Dead	T1	NX	MX		G1	1				TUMOR FREE																					Severe	59	3.5	4	5.7	TCGA-ZP-A9CV	91909C63-DEBC-42AD-B4BE-56870195BDCB	0.2	0.5	Not Available	A	0.7	1.3	0.8	28	-21633	Not Applicable	0	142	Not Available																								1	NOT HISPANIC OR LATINO	0	8	48	Not Available	TCGA-ZP-A9CV-F57756	DDD21153-5A5D-4885-B13C-F3F57895E5AA	28	1088	Not Available	Not Available	NO	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	WITH TUMOR	NO	NO	NO	Dead	2014	MALE	173	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A9CV	TUMOR FREE	114000	163000	369000	NO	NO	Not Available	WHITE	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	ZP	1.0	Liver	None	Unknown	Alive	59	2014	2011
TCGA-DD-AACV	53	MALE	169	1531	70	24.5089457652043	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	1	344.0	Liver	Intrahepatic Recurrence	WITH TUMOR		NO						TCGA-DD-AACV-A66126	78616A41-C91B-46B3-8DA4-1A7FD79F8516	2	YES	345;803;855;968	Other;Other;Other;Other	adriamycin;adriamycin;adriamycin;adriamycin	Chemoembolization;Chemoembolization;Chemoembolization;Chemoembolization	Other, specify;Other, specify;Other, specify;Other, specify	lipidol;lipidol;lipidol;lipidol	10	2014		Unknown	53	3.8	4.3	5.3	TCGA-DD-AACV	8E79EA29-787E-4A33-8465-9891776F47ED	0.2	0.6	Not Available	A	0.7	1.5	1.2	29	-19660	Not Applicable	0	1210	Not Available																								0	NOT HISPANIC OR LATINO	0	8	9	Unknown	TCGA-DD-AACV-F68379	6A991288-C668-4E73-B146-FBB7DBB87A40	17	Not Applicable	1531	Not Available	NO	11	NO	NO	Not Available	344	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	YES	NO	NO	Alive	2014	MALE	169	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	NO	NO	Not Available	344	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AACV	WITH TUMOR	164	130	400	YES	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	70	2014	2010
TCGA-DD-AACG	52	MALE	168	469	65	23.030045351473923	Hepatocellular Carcinoma	Liver	Dead	T2	N0	M0	Stage II	G4	1	125.0	Liver	Intrahepatic Recurrence	WITH TUMOR																					Mild	52	3.8	3.6	5.3	TCGA-DD-AACG	B5BEF77A-F46C-406C-9AA8-55F7A61AA885	0.2	1.0	Not Available	A	0.7	1.5	1.5	28	-19174	469	0	Not Available	Not Available																								0	NOT HISPANIC OR LATINO	0	8	11718	6 - Established Cirrhosis																												MALE	168	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G4	NO	NO	Not Available	125	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AACG	WITH TUMOR	196	130	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.2	Liver	Micro	Unknown	Dead	65	2014	2008
TCGA-CC-A3MA	61	MALE	168	303	66	23.3843537414966	Hepatocellular Carcinoma	Liver	Dead	T3	N0	M0	Stage IIIA	G2	1	261.0		Locoregional Recurrence	TUMOR FREE																					Not Available	61	Not Available	Not Available	Not Available	TCGA-CC-A3MA	613DDB95-14D7-4941-B374-FB5CD344D1BB	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	-22375	Not Applicable	0	2	Not Available																								3	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-CC-A3MA-F70907	4A6FB027-DBE2-438C-991F-8943B7FCF2DF	10	303	Not Available	Not Available	NO	3	NO	NO	Not Available	261	Not Available	Not Available	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Dead	2015	MALE	168	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	G2													Not Available	No	A3MA	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	YES	NO	CC	Not Available	Liver	Not Available	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	66	2012	2011
TCGA-2V-A95S	Not Available	MALE	173		78	26.061679307694877	Hepatocellular Carcinoma	Liver		T2	NX	MX	Stage II	G3	0				WITH TUMOR																					Severe	Not Available	3.5	4.2	5.2	TCGA-2V-A95S	2C041473-EAAA-4B7C-9B2E-B9DA3543AD18	0	1.5	Not Available	A	.7	1.2	.6	15	Not Available	Not Applicable	Not Available	Not Available	Not Available																								4	NOT HISPANIC OR LATINO	0	8	10793	6 - Established Cirrhosis																												MALE	173	Hepatocellular Carcinoma	Other	former smoker	No	Not Applicable	C22.0	8170/3	C22.0	YES	2	3	6	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	No	A95S	WITH TUMOR	107	140	370	NO	NO	2.0	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	NO	YES	2V	.2	Liver	Micro	Unknown	Alive	78	2015	Not Available
TCGA-2Y-A9H1	58	MALE	171	1229	89	30.43671557060292	Hepatocellular Carcinoma	Liver	Dead	T1	NX	MX	Stage I	G2	1	321.0	Liver	Locoregional Recurrence	WITH TUMOR		NO						TCGA-2Y-A9H1-A66956	6FF2F78D-C736-4E2F-A197-E82382551E44	28	YES	178	Not Available	Not Applicable	Radioembolization	Y-90 Therasphere	Not Applicable	10	2014		Unknown	58	3.5	4.4	5	TCGA-2Y-A9H1	9C5E2438-F587-4935-92F0-4BFD57468EAA	0.2	0.5	Not Available	Unknown	0.8	1.5	0.9	3	-21222	1229	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	7	3	1,2 - Portal Fibrosis																												MALE	171	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G2	NO;NO	NO;NO	468;Not Available	321;770	Not Available;Not Available	Liver;Liver	Locoregional Recurrence;Locoregional Recurrence	Not Applicable;Not Applicable	Yes;No	YES;NO	No;No	R0;Not Available	YES	No	A9H1	WITH TUMOR	213	143	382	YES	NO	10	WHITE	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	NO	YES	2Y	1.3	Liver	Unknown	Hepatitis  C Antibody	Dead	89	2014	2010
TCGA-DD-A4NF	72	MALE	173	942	86	28.734672057202044	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	1	656.0	Bone	Extrahepatic Recurrence	TUMOR FREE																					Mild	72	3.5	4	5.0	TCGA-DD-A4NF	1043BC90-72C9-48C9-AE24-F617D0485E78	0.1	0.5	Not Available	A	0.8	1.3	0.9	29	-26330	Not Applicable	0	428	Not Available																								0	NOT HISPANIC OR LATINO	0	6	6	6 - Established Cirrhosis	TCGA-DD-A4NF-F49646;TCGA-DD-A4NF-F59456	40FF7950-AC4F-471D-8CE9-D63EEDB5C809;A8C3ED55-58FD-4913-9F42-E15C9EEC8FCB	7;13	Not Applicable;Not Applicable	428;942	Not Available;Not Available	NO;NO	10;5	Not Available;NO;NO	Not Available;YES;NO	Not Available;Not Available;Not Available	Not Available;656;656	Not Available;Not Available;Not Available	Not Available;Bone;Liver	Not Available;Extrahepatic Recurrence;Intrahepatic Recurrence	Not Applicable;Not Applicable;Not Applicable	Not Available;No;No	Not Available;NO;NO	Not Available;No;No	Not Available;Not Available;Not Available	NO;YES	TUMOR FREE;WITH TUMOR	NO;NO	NO;NO	NO;NO	Alive;Alive	2013;2014	MALE	173	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	9.5	13.8	1	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A4NF	TUMOR FREE	97	150	450	NO	NO	12.7	WHITE	NO	Distant site	TCGA-DD-A4NF-R59457	6C4CEA2F-8A49-4F13-9D5E-D9FA162BC397	Not Available	13	847	841	Stable Disease	5	10	3000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.0	Liver	None	Hepatitis C Virus RNA;HCV Genotype;Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Alive	86	2013	2011
TCGA-DD-A3A1	65	MALE	185	233	78	22.790357925493062	Hepatocellular Carcinoma	Liver	Dead	T3b	N0	M0	Stage IIIA	G2	0	233			TUMOR FREE																					None	65	3.5	3.8	5.0	TCGA-DD-A3A1	877B9F6B-9B34-40ED-933F-8FEF204EDF21	0.1	0.8	1	A	0.8	1.2	1.1	6	-24046	233	0	Not Available	Not Available																								0	Not Available	0	6	6	0 - No Fibrosis	TCGA-DD-A3A1-F42704	329F38BF-FFA2-479C-A082-40C29BCFA689	27	233	Not Available	Not Available	NO	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE	NO	NO	NO	Dead	2013	MALE	185	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.4	12.0	1	G2													Not Available	No	A3A1	TUMOR FREE	178	150	450	Not Available	Not Available	11.2	Not Available	Not Available																			YES	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3b	NO	YES	DD	1.1	Liver	Macro	Unknown	Dead	78	2012	2001
TCGA-KR-A7K2	64	MALE	166	829	79	28.668892437218755	Hepatocholangiocarcinoma (Mixed)	Liver	Alive	T1	N0	M0	Stage I	G1	0	829			TUMOR FREE																					Unknown	64	3.5	3.3	4.9	TCGA-KR-A7K2	FBB398FE-2BA8-4845-8083-6533ECB4A52E	0.2	1.5	Not Available	Unknown	0.7	1.3	1.1	28	-23699	Not Applicable	0	360	Not Available																								Unknown	Not Evaluated	0	8	14	Not Available	TCGA-KR-A7K2-F71275;TCGA-KR-A7K2-F72748	839B0FCA-D9E9-4062-8159-B7BA4AD68243;4EB39E66-C8C0-4224-925C-B27C7F318406	24;24	Not Applicable;Not Applicable	657;829	Not Available;Not Available	NO;NO	3;11	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;Unknown	TUMOR FREE;Not Available	NO;NO	NO;NO	NO;NO	Alive;Alive	2015;2015	MALE	166	Hepatocholangiocarcinoma (Mixed)	Hepatitis C	Not Available	No	open liver resection	C22.0	8180/3	C22.0	YES	Not Available	Not Available	5	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7K2	TUMOR FREE	178	150	400	NO	NO	1	WHITE	NO																			Unknown	R0	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	KR	1.2	Liver	None	HCV Genotype	Alive	79	2014	2013
TCGA-DD-AAC9	51	MALE	174	347	81	26.7538644470868	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G2	0	347			TUMOR FREE																					Mild	51	3.8	4.2	5.3	TCGA-DD-AAC9	AC6A1E0C-DBA0-4B21-B12B-A501ED796BEC	0.2	0.7	Not Available	A	0.7	1.5	1.3	28	-18911	Not Applicable	0	347	Not Available																								0	NOT HISPANIC OR LATINO	0	8	5	6 - Established Cirrhosis	TCGA-DD-AAC9-F68363	A93BA789-B037-4720-8C46-03AC21261F27	17	Not Applicable	Not Available	Not Available	YES	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2014	MALE	174	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AAC9	TUMOR FREE	149	130	400	NO	NO	0.9	ASIAN	NO																			NO	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	81	2014	2008
TCGA-DD-AACJ	75	MALE	159	2102	73	28.87544005379534	Hepatocellular Carcinoma	Liver	Alive	T2	N0	M0	Stage II	G2	1	100.0	Liver	Locoregional Recurrence	WITH TUMOR																					Not Available	75	3.8	3.6	5.3	TCGA-DD-AACJ	93AFBFA1-4D03-4105-8DDA-B095F0AB308A	0.2	1.0	Not Available	A	0.7	1.5	1.0	15	-27528	Not Applicable	0	1828	Not Available																								2	NOT HISPANIC OR LATINO	0	8	25	Not Available	TCGA-DD-AACJ-F68368	27AFAA74-5C9A-4AF8-BAA6-81FBBC2252DE	17	Not Applicable	2102	Not Available	NO	11	NO	NO	Not Available	100	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	MALE	159	Hepatocellular Carcinoma	Unknown	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G2	NO	NO	Not Available	100	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AACJ	WITH TUMOR	213	130	400	NO	NO	0.8	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.2	Liver	Micro	Unknown	Alive	73	2014	2008
TCGA-DD-AACN	32	MALE	171	1302	70	23.938989774631512	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	1	357.0	Liver	Intrahepatic Recurrence	WITH TUMOR		NO						TCGA-DD-AACN-A66125	276C8689-15A0-4900-8451-29E56E7794D9	2	YES	379	Other	adriamycin	Chemoembolization	Other, specify	lipidol	10	2014		Unknown	32	3.8	3.9	5.3	TCGA-DD-AACN	0AFD4283-7311-4D69-A2F5-779628DA45FC	0.2	2.2	Not Available	A	0.7	1.5	1.5	29	-12007	Not Applicable	0	1292	Not Available																								0	NOT HISPANIC OR LATINO	0	9	699	Unknown	TCGA-DD-AACN-F68372	856E9DD8-A3A9-4A61-B8F2-69D29BB8ECA5	17	Not Applicable	1302	Not Available	NO	11	NO	NO	Not Available	357	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	WITH TUMOR	YES	NO	NO	Alive	2014	MALE	171	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	6	G3	NO	NO	Not Available	357	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	No	AACN	WITH TUMOR	185	130	400	YES	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	70	2014	2009
TCGA-GJ-A6C0	75	FEMALE	160	31	90	35.15625	Hepatocellular Carcinoma	Liver	Dead	T2	NX	MX	Stage II	G2	0	31			Unknown																					Unknown	75	Not Available	Not Available	Not Available	TCGA-GJ-A6C0	1B326242-4BE6-4F05-B5FB-07ED76B49850	Not Available	Not Available	1	Unknown	Not Available	Not Available	Not Available	27	-27626	31	0	Not Available	Not Available																								Unknown	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Unknown																												FEMALE	160	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	partial hepatectomy	C22.0	8170/3	C22.0	YES	Not Available	Not Available	11	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A6C0	Unknown	Not Available	Not Available	Not Available	NO	NO	Not Available	WHITE	NO																			YES	RX	Other (specify)	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	YES	NO	GJ	Not Available	Liver	Micro	Not Available	Dead	90	2013	2012
TCGA-DD-AAE8	45	MALE	170	664	78	26.98961937716263	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	1	28.0	Liver	Locoregional Recurrence	TUMOR FREE		NO						TCGA-DD-AAE8-A68420	DBFF28C6-BF0D-4E71-B32A-E9AFF7087A66	3	YES	138	Other	adriamycin + Lipiodol	Chemoembolization	Gelfoam	Not Applicable	11	2014		Unknown	45	3.8	4.3	5.3	TCGA-DD-AAE8	B929ECE7-6CAF-4081-83D3-9923306B4A8A	0.2	3.0	Not Available	A	0.7	1.5	0.6	14	-16549	Not Applicable	0	344	Not Available																								0	NOT HISPANIC OR LATINO	0	8	3	6 - Established Cirrhosis	TCGA-DD-AAE8-F68419	4E44A7A7-0380-4F1A-BF82-55351D738ABD	17	Not Applicable	664	Not Available	NO	11	NO	NO	Not Available	113	Not Available	Liver	Intrahepatic Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	170	Hepatocellular Carcinoma	Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	NO	NO	Not Available	28	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	NO	No	Not Available	YES	Yes	AAE8	TUMOR FREE	125	130	400	NO	NO	1.1	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	78	2014	2012
TCGA-DD-AADV	50	MALE	176	574	64	20.66115702479339	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G3	0	574			TUMOR FREE																					None	50	3.8	3.8	5.3	TCGA-DD-AADV	4C78B999-4797-4E19-8BC5-9FFD01CF768A	0.2	0.8	Not Available	A	0.7	1.5	0.9	14	-18300	Not Applicable	0	230	Not Available																								0	NOT HISPANIC OR LATINO	0	8	11	6 - Established Cirrhosis	TCGA-DD-AADV-F68407	1D492F56-6F7D-406E-AF09-5353D078459C	17	Not Applicable	574	Not Available	NO	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2014	MALE	176	Hepatocellular Carcinoma	Alcohol consumption;Hepatitis B	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	1.0	1.0	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	Yes	AADV	TUMOR FREE	187	130	400	NO	NO	1.0	ASIAN	NO																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	DD	1.2	Liver	None	Unknown	Alive	64	2014	2013
TCGA-FV-A3I1	81	FEMALE	Not Available	247	Not Available		Hepatocellular Carcinoma	Liver	Dead	T2	N0	MX	Stage II	G2	0	247			TUMOR FREE																					Not Available	81	Not Available	Not Available	Not Available	TCGA-FV-A3I1	BFD20D71-18A5-4F01-8D56-84378AD92359	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	16	Not Available	Not Applicable	0	0	Not Available																								Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	0 - No Fibrosis	TCGA-FV-A3I1-F42771	327CE090-8DE2-47AE-8134-B659AC36EA91	30	247	Not Available	Not Available	NO	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Dead	2013	FEMALE	Not Available	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	4	G2													Not Available	Yes	A3I1	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			NO	R0	Segmentectomy, Multiple	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2	YES	NO	FV	Not Available	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen;HBV Surface Antibody	Alive	Not Available	2012	2011
TCGA-BC-A10Q	72	FEMALE	Not Available	1135	Not Available		Hepatocellular Carcinoma	Liver	Dead	T2	NX	MX		Not Available	1	340.0		Intrahepatic Recurrence	WITH TUMOR		NO						TCGA-BC-A10Q-A13754	38B7049A-E74F-4548-9AAE-D604D4C697BD	4	YES	217	Other	Doxorubicon and Mitomycin C	Chemoembolization	Other, specify	PVA particles	4	2011		Not Available	72	3.5	4.1	5.0	TCGA-BC-A10Q	dfa15fbe-bb14-40ce-afc6-70694112e3e2	Not Available	.5	1	Not Available	0.7	1.1	0.6	23	-26400	1135	0	Not Available	Not Available	TCGA-BC-A10Q-D9848;TCGA-BC-A10Q-D9850;TCGA-BC-A10Q-D9855;TCGA-BC-A10Q-D10102	A0F6AA78-BFC6-40A0-9127-D0F7F9AA42CF;1BBDDEC2-4EE9-40B6-B907-EE429CE7D03A;13C1ADC9-69D2-4F78-AB39-39032DEE9E83;E5E8B541-F299-40DF-A792-7514B166B09F	Not Available;Not Available;Not Available;Not Available	1;1;1;7	217;217;408;751	217;217;359;426	adriamycin;Mitomycin C;Tamoxifen;Gemcitabine	Not Available;Not Available;Not Available;Not Available	4;4;4;4	1;1;Not Available;Not Available	20;5;Not Available;Not Available	mg;mg;Not Available;Not Available	ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;2	IH;IH;Not Available;Not Available	NO;NO;NO;NO	Other, specify in notes;Other, specify in notes;Hormone Therapy;Chemotherapy	chemoembolization;chemoembolization;Not Available;Not Available	20;5;Not Available;Not Available	mg;mg;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	TCGA-BC-A10Q-F9852	40B443A9-BAED-4DA5-A36C-F6A5DDE121BD	1	1135	Not Available	Not Available	Not Available	4	YES	NO	Not Available	340	Not Available	Not Available	Intrahepatic Recurrence	Not Applicable	No	NO	Not Available	Not Available	YES	WITH TUMOR	YES	YES	NO	Dead	2011	FEMALE	Not Available	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	3	Not Available													Not Available	No	A10Q	WITH TUMOR	287000	150	440	Not Available	Not Available	0.9	WHITE	Not Available																			YES	R1	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	NO	YES	BC	Not Available	Liver	None	Not Available	Dead	Not Available	2011	1998
TCGA-2Y-A9GS	58	MALE	162	724	92	35.05563176345069	Hepatocellular Carcinoma	Liver	Dead	T2	NX	MX		G2	1	102.0	Lung	Extrahepatic Recurrence	WITH TUMOR																					None	58	3.5	4	5	TCGA-2Y-A9GS	95B97198-1A1B-4F01-90F3-6C66638371D1	0.2	0.7	Not Available	Unknown	0.8	1.5	1.6	3	-21318	724	0	Not Available	Not Available																								Unknown	HISPANIC OR LATINO	0	6	74	Unknown																												MALE	162	Hepatocellular Carcinoma	Alcohol consumption	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	8.3	11.5	11	G2	NO	NO	Not Available	102	Not Available	Lung	Extrahepatic Recurrence	Not Applicable	No	NO	No	Not Available	YES	No	A9GS	WITH TUMOR	168	143	382	NO	NO	9.9	WHITE	NO																			Unknown	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2	NO	YES	2Y	1.3	Liver	Unknown	HCV Genotype;Hepatitis B Surface Antigen;HBV Core Antibody	Dead	92	2014	2006
TCGA-ED-A7PX	48	FEMALE	161	6	43	16.58886617028664	Hepatocellular Carcinoma	Liver	Alive	T2	NX	M0	Stage II	G3	0	6			TUMOR FREE																					None	48	Not Available	Not Available	Not Available	TCGA-ED-A7PX	470D52B8-3D74-4789-B714-B9869A96657B	0.1	0.9	Not Available	Unknown	4.1	5.8	17.0	3	-17638	Not Applicable	0	6	Not Available																								Unknown	NOT HISPANIC OR LATINO	0	20	24	Not Available	TCGA-ED-A7PX-F62650	3F42CEC0-C66C-475C-B9B6-81F1AFD1086C	30	Not Applicable	Not Available	Not Available	YES	9													Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2014	FEMALE	161	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	1	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7PX	TUMOR FREE	239	150	400	NO	Unknown	Not Available	ASIAN	NO																			NO	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2	YES	NO	ED	1.3	Liver	Micro	Hepatitis B Surface Antigen	Alive	43	2014	2013
TCGA-DD-A3A8	75	MALE	177	11	99	31.60011490950876	Hepatocellular Carcinoma	Liver	Dead	T2	N0	M0	Stage II	G2	0	11			TUMOR FREE																					None	75	Not Available	Not Available	Not Available	TCGA-DD-A3A8	69D6881B-9E9A-407B-8B02-BAD5FC2455BF	0.1	1.0	3	A	0.8	1.2	0.9	6	-27524	11	0	Not Available	Not Available																								1	NOT HISPANIC OR LATINO	0	6	4	0 - No Fibrosis	TCGA-DD-A3A8-F42570	B5CBCD8F-052A-42CB-9E3B-B3AE6A01008F	24	11	Not Available	Not Available	NO	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Dead	2013	MALE	177	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	1	G2													Not Available	Yes	A3A8	TUMOR FREE	251	150	450	Not Available	Not Available	Not Available	WHITE	Not Available																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	NO	YES	DD	1.0	Liver	None	Hepatitis B Surface Antigen;HBV Surface Antibody;HBV Core Antibody	Dead	99	2012	2001
TCGA-G3-A7M6	60	FEMALE	158	632	77	30.84441595898093	Hepatocellular Carcinoma	Liver	Alive	T1	NX	MX	Stage I	G3	1	293.0	Liver	Locoregional Recurrence	WITH TUMOR																					Mild	60	3.3	3.6	4.8	TCGA-G3-A7M6	2681F83D-233F-4EA2-B5E6-3C05AF81F123	0	0.5	Not Available	A	0.4	1.1	0.6	5	-22205	Not Applicable	0	366	Not Available																								0	NOT HISPANIC OR LATINO	0	10	24	1,2 - Portal Fibrosis	TCGA-G3-A7M6-F67241	09174147-C9C9-4397-BD1A-E3A4A0547CBB	3	Not Applicable	632	Not Available	NO	11	NO	NO	Not Available	584	Not Available	Liver	Locoregional Recurrence	Not Applicable	No	NO	No	Not Available	YES	WITH TUMOR	NO	NO	NO	Alive	2014	FEMALE	158	Hepatocellular Carcinoma	Hepatitis C	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	0.9	1.1	2	G3	NO	NO	366	293	Not Available	Liver	Locoregional Recurrence	Not Applicable	Yes	YES	No	R2	YES	No	A7M6	WITH TUMOR	273	150	400	NO	NO	0.9	WHITE	NO																			Unknown	R0	Segmentectomy, Single	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1	YES	NO	G3	1.2	Liver	None	Unknown	Alive	77	2014	2013
TCGA-KR-A7K8	57	MALE	170	906	109	37.71626297577855	Hepatocellular Carcinoma	Liver	Alive	T1	N0	M0	Stage I	G1	0	906			TUMOR FREE																					None	57	3.5	3.3	4.9	TCGA-KR-A7K8	4B0E544C-4090-4EBB-B3E5-2623AA91356C	0.2	1.9	1	Unknown	0.7	1.3	1.1	28	-20914	Not Applicable	0	741	Not Available																								Unknown	Not Evaluated	0	8	154	Not Available	TCGA-KR-A7K8-F71274	D6A75463-AA7E-49EC-94EC-03993026E430	24	Not Applicable	906	Not Available	NO	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE	NO	NO	NO	Alive	2015	MALE	170	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	Not Available	Not Available	5	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	A7K8	TUMOR FREE	103	150	400	NO	NO	1.3	Unknown	NO																			YES	R0	Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1	NO	YES	KR	1.2	Liver	None	Unknown	Alive	109	2014	2012
TCGA-5R-AA1D	17	FEMALE	161	449	59	22.761467535974692	Hepatocellular Carcinoma	Liver	Alive	T3a	N0	M0	Stage IIIA	G3	0	449			TUMOR FREE																					None	17	3.2	3.3	4.6	TCGA-5R-AA1D	D3D3DBA9-139E-4F57-AC70-B741553D1687	0	0.5	Not Available	B	0.5	1.3	0.7	14	-6545	Not Applicable	0	61	Not Available																								1	NOT HISPANIC OR LATINO	0	15	5	0 - No Fibrosis	TCGA-5R-AA1D-F68307;TCGA-5R-AA1D-F70155	81BF7B8A-CB43-4255-9F3B-5029242F5689;F0E3B19B-A088-4172-9208-6468F9A7D228	14;28	Not Applicable;Not Applicable	337;449	Not Available;Not Available	NO;NO	11;1	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE	NO;NO	NO;NO	YES;YES	Alive;Alive	2014;2015	FEMALE	161	Hepatocellular Carcinoma	No History of Primary Risk Factors	Not Available	No	Not Applicable	C22.0	8170/3	C22.0	YES	11	15	11	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	NO	No	AA1D	TUMOR FREE	333000	150000	450000	NO	NO	19	WHITE	YES	Regional site	TCGA-5R-AA1D-R68305	89A693E4-DF01-4228-AD49-B39900362C19	Not Available	14	40	33	Complete Response	11	3	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	NO	R0	Extended Lobectomy	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3a	YES	NO	5R	1.2	Liver	Micro	Hepatitis  C Antibody;Hepatitis B Surface Antigen	Alive	59	2014	2013
